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The major outer membrane protein (MOMP) of Chlamydia shares several
biochemical properties with classical porin proteins. Secondary structure analysis
by circular dichroism now reveals that MOMP from Chlamydia psittaci, purified by
hydroxyapatite chromatography, has a predominantly (3-sheet content (62%), typical
of bacterial porins. To directly test the "porin channel" hypothesis at the molecular
level, MOMP was reconstituted into planar lipid bilayers where it gave rise to
"triple-barrelled" channels which were modified by an anti-MOMP neutralising
monoclonal antibody. These observations are consistent with the well characterised
homo-oligomeric nature of MOMP previously revealed by biochemical analysis,
and the "triple-barrelled" behaviour of other porins. MOMP channels were weakly
anion selective (Pci/Pk ~ 2) and permeable to ATP. They may therefore be a route
by which Chlamydia can take advantage of host nucleoside triphosphates, and
explain why some anti-MOMP antibodies neutralise infection.
In order to undertake more detailed studies of the MOMP structure/function
relationship, recombinant MOMP from both C. psittaci and C. pneumoniae have
been cloned and expressed. The recombinant proteins were functionally
reconstituted in planar lipid and analysed at the single channel level. Both form
porin-like ion channels that are functionally similar to the native protein. The C.
psittaci recombinant porin was modified by the same anti-MOMP neutralising
monoclonal antibody that affected the native protein. In contrast to the native
protein, both recombinant C. psittaci (Pci/Pk ~ 0.38) and C. pneumoniae (Pci/Pk ~
0.49) proteins were marginally cation selective. This is the first time native function
has been demonstrated for recombinant chlamydial MOMP and will have an
important impact on the future development of subunit vaccines.
The method by which chlamydiae attach to and infect eukaryotic cells is
unclear. It has been suggested that Chlamydia synthesise a heparan-sulphate-like
glycosaminoglycan which acts as a bridge by binding to receptors on both the
eukaryotic cell and chlamydiae. The addition of an exogenous source of heparin
resulted in a dose-dependent decrease in the levels of infection of the OEA isolate
of C. psittaci as did pre-treatment of chlamydiae with heparan-sulphate lyase.
Radioactively labelled heparin was found to bind specifically to Western blots of





1.1 Chlamydiales and their taxonomy
Chlamydia have been assigned to their own order Chlamydiales (Storz and
Page, 1971) within which there is one family Chlamydiaceae, comprising a single
genus Chlamydia and, at present, four species. The classification of Chlamydia in
their own order reflects their unique obligate intracellular, biphasic lifecycle which
alternates between the infectious, metabolically inert elementary body (EB) and the
non-infectious, metabolically active reticulate body (RB). In the past, the unusual
properties of chlamydiae has lead to their mis-classification. In 1907 Halberstaedter
and von Prowazek (1907) isolated what they determined to be a protozoan from the
conjunctival scrapings of an infected patient and called this parasite chlamydazoon.
Subsequently, as they could not be grown by normal plating techniques, chlamydiae
were identified as viruses and this theory continued until 1966 when Moulder
finally identified them as intracellular gram negative bacteria (Moulder 1966).
Sarov and Becker (1968) were the first to discover that Chlamydia had all
the requisite properties of bacteria. Indeed, Weisburg et al. (1986) found that
comparison of the 16S rRNA gene sequences of C. psittaci with those of other
organisms indicated that Chlamydia are eubacterial in origin. Phylogenetic analysis
of these sequences revealed that the Chlamydiales may be peripherally related to the
Planctomyces. However, the link may be tenuous as the only phenotypic
characteristics the two groups are known to have in common is a cell wall without
detectable peptidoglycan (Section 1.5.1) (Liesack et al., 1986).
Until recently, only two species of Chlamydia were recognised, Chlamydia
trachomatis and Chlamydia psittaci, assigned to the genus on the basis of
differences in: (1) inclusion body morphology (2) glycogen content (3)
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susceptibility to sulfadiazine and (4) natural hosts. C. trachomatis is primarily a
human pathogen. In addition to causing blinding trachoma in arid regions, C.
trachomatis infections of the genital tract are now recognised as a major cause of
pelvic inflammatory disease, often resulting in infertility (Batteiger and Jones,
1987). C. psittaci is largely a pathogen of animals. However, avian strains of C.
psittaci are still an occasional cause of fatal human infection and are a widespread
problem in domestic turkeys, ducks and pet birds. Mammalian strains of C. psittaci
are a major cause of abortion in ruminants and can also cause abortion in women
infected during pregnancy (Section 1.2.3) (Buxton 1986).
These two species of Chlamydia share only 10% DNA homology as shown
by DNA hybridisation experiments and are easily differentiated on the basis of
restriction endonuclease analysis (Kingsbury and Weiss, 1968; Weiss et al., 1970).
The species C. trachomatis is further divided into 3 biovars, mouse,
lymphogranuloma venereum (LGV) and trachoma. The trachoma biovar currently
consists of 19 serovariants (serovars). The LGV biovar is divided into 4 serovars
LI, L2, L2a and L3. The classification of the highly diverse C. psittaci strain has
been based on a number of biological, immunological and genetic criteria. Perez-
Martinez and Storz (1985) proposed 9 immunotypes of mammalian C. psittaci
strains while Tayofuku et al. (1986) indicated the presence of 7 avian strains. C.
psittaci isolated from ruminants were grouped into immunotype 1 (abortion and
some intestinal types), immunotype 2 (polyarthritus, conjunctivitis, encephalitis and
enteritis types) and immunotypes 3 and 9 (types isolated from bovine and ovine
faeces) according to the system of Perez-Martinez and Storz.
The realisation that the novel Chlamydia agent, designated TWAR (Taiwan
acute respiratory strain), was an important human respiratory pathogen drew
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attention to its mis-classification within the C. psittaci species (Grayston et al.,
1986, 1989). With respect to the criteria used to differentiate species of Chlamydia,
TWAR was more closely related to C. psittaci than C. trachomatis. However, DNA
analysis revealed less than 10% relatedness between TWAR and other C. psittaci
strains (Cox et al., 1988). Homology among TWAR strains is 94% or greater.
These results prompted the establishment of a new third species of Chlamydia,
called Chlamydia pneumoniae (Grayston et al., 1989).
The genus Chlamydia has recently been further expanded to accommodate a
new species of ruminant strains proposed by Fukushi and Hirai (1992) and called
Chlamydia pecorum. It has long been established that at least two types of
Chlamydia infect ruminants, the immunotype 1 strains associated with abortions
and occasionally found in faeces, and other strains which are associated with
polyarthritis, polyserositis, encephalitis and inapparent enteric infections. Studies of
a subset of 5 strains of this latter type have found them to be genetically and
antigenically distinct from all other Chlamydia species and to form a new fourth
species, C. pecorum (Fukushi and Hirai, 1988, 1989).
PCR-based methods have substantially advanced the typing of Chlamydia.
The major outer membrane protein (MOMP) gene (Section 1.8), the site of most
strain and species antigenic variation, provides an ideal target for PCR as it has
highly conserved regions at both ends flanking variable regions. Numerous typing
protocols have involved the amplification of the coding regions of the MOMP gene
followed by RE analysis or sequencing of the amplified product (Kaltenboeck et al.,
1991; Rodriguez et al., 1991; Frost et al., 1991). This combination of typing
techniques has proved highly effective. However, the recent sequencing of the 16S
and 23S intergenic regions of chlamydial ribosomal DNA has provided an
alternative, rapid and reproducible method for the identification and classification of
chlamydial strains (Everett and Andersen, 1997). Indeed, phylogenetic analysis of
data obtained using this technique have called into question the appropriateness of
the current classification of Chlamydia.
1.2 Chlamydial disease
1.2.1 Chlamydia trachomatis
Members of the genus Chlamydia are important pathogens of humans, birds
and other animals. Indeed, Chlamydia are one of the most ubiquitous pathogens in
the animal kingdom. C. trachomatis, the best studied of the four chlamydial
species, is a significant agent of sexually-transmitted and ocular infections in
humans (Schachter et al., 1975). Trachoma is the leading cause of preventable
blindness in the world with over six million blind as a result of the disease. The
onset of the disease is often inconspicuous, appearing as a mucopurulent
conjunctivitis. Over time, scarring of the conjunctivae develops and the cornea may
also be affected by the formation of a pannus (vascularization of the corneal
limbus). The contraction of the scars within the conjunctiva distort the eyelid and
cause an in-turning of the eyelashes so that they abrade the cornea. Severe lid
deformity may not develop until 20 or 30 years after infection. Subsequent bacterial
infections lead to the progressive deterioration of the diseased eye. Treatment of
trachoma is currently based on the topical application of tetracycline ointments.
In industrialised countries C. trachomatis is the most prevalent cause of
sexually transmitted disease (Schachter et al., 1975) resulting in the less serious
conditions of urethritis, cervicitis, and the more serious infections epididymitis,
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ectopic pregnancy and pelvic inflammatory disease (PID). Chlamydial infections in
the male urethra result in a broad range of symptoms, from infections producing a
discharge to those which are asymptomatic. However, chlamydial urethritis is
usually seen as a mucopurulent discharge in a man suffering from dysuria and has
an incubation period of 1-3 weeks (Oriel and Ridgeway, 1982). While chlamydial
urethritis superficially appears to be a trivial infection, untreated it can result in
severe complications. Ascending urethritis can occur, resulting in epididymitis
(Berger et al., 1978).
The cervix is the area of female genitalia most commonly affected by
chlamydial infection, where the organism can result in cervicitis (Paavonen et al.
1982; Storz and Krauss, 1983). Again, infection is not always accompanied by
easily diagnosed symptoms, however, discharge is common. Ascending C.
trachomatis infection is also common in females, usually targeting the endometrium
or fallopian tubes (Mardh et al., 1977). The resulting damage and scarring from
these acute infections can lead to tubal factor infertility and ectopic pregnancy
(Cates, 1984). Uncomplicated genital tract conditions can be treated with
tetracycline, however, more chronic infections require long term therapy.
1.2.2 Chlamydia pneumoniae
C. pneumoniae, a recent addition to the genus Chlamydia, has been shown to
cause community acquired and nosocomial pneumonias and to be a common
infectious agent throughout the world (Kauppinen and Saikku, 1995; Lieberman et
al., 1996). An association between C. pneumoniae and vascular atheroma and
ischaemic heart disease resulting in acute myocardial infarction was established
using the classical micro-immunofluorescence test (MIF) (Saikku et al., 1988) and
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has been verified seroepidemiologically in over 20 studies (Danesh et al., 1997).
Data presented at the 9th International Symposium on Human Chlamydial Infection,
Napa, California, USA appears to confirm a causal role for C. pneumoniae in the
development of atherosclerotic disease. Using a transgenic mouse model deficient
in apolipoprotein, Moazed et al. (1998) reported that C. pneumoniae infection
resulted in an 136% increase in atherosclerotic lesion size, compared with
uninfected controls, at 16 weeks postinfection. However, difference in lesion size at
20 weeks was not so marked suggesting that C. pneumoniae infection accelerates
the atherosclerotic process in the early to intermediate stages of lesion development.
There is little evidence to date describing how C. pneumoniae initiates or
contributes to the development of atherosclerosis. Atheroma initiation and
development is thought to involve macrophage foam cells, subendothelial
macrophages which have ingested cholesterol. Kalayoglu and Byrne (1998) have
reported that human monocyte-derived macrophages infected with C. pneumoniae,
accumulate neutral lipids and cholesteryl esters thereby developing into foam cells,
suggesting a possible causal role for C. pneumoniae in atherosclerosis.
1.2.3 Chlamydia psittaci
C. psittaci commonly infects a wide variety of mammals and birds and has
been implicated in a range of disease conditions. One of the best studied and most
economically important C. psittaci-caused diseases is ovine enzootic abortion
(OEA) (Aitken et al., 1990). Indeed, placental and fetal infections with chlamydiae
are a significant cause of reproductive failure and abortion in cattle, goats and many
other domestic animals, in addition to sheep (Storz and Krauss, 1985). The ovine
abortion strains of C. psittaci, infecting pregnant ewes, result in a necrotizing
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placentitis and consequent abortion, usually within the final month of gestation.
Bovine Chlamydia-induced abortions tend to occur in the last trimester.
Pathological examination of an infected placenta post partem reveals the appearance
of placental necrotic lesions, the margins of which consist of zones of hyperemia
and haemorrhage. Contact with C. psittaci-infected sheep during pregnancy can
lead to the abortion of a human fetus (Buxton 1986).
It has been demonstrated that C. psittaci-infection can result in ocular
disease in several animal species. Severe conjunctivitis is observed in many species
and is often associated with a more serious secondary chlamydial infection. This is
exemplified by calves which have systemic chlamydial infections, leading to
polyarthritis, also developing conjunctivitis. In addition, Stephenson et al. (1974)
noted that virtually all lambs diagnosed with polyarthritis also had conjunctivitis.
The same strain of Chlamydia was cultured from the conjunctiva and joint samples
of these lambs.
Avian chlamydiosis is a major public health risk and results in large
economic losses in the poultry industry. The most common route of chlamydial
infection for birds is via the respiratory tract. Transmission occurs predominantly
by inhalation of infected dust. Infected birds shed the organism within their faeces
and the dried excrement remains infectious for several months (Page 1959). The
acute disease in cage birds is characterised by diarrhoea and anorexia. These
symptoms can be accompanied by respiratory distress and conjunctivitis.
1.2.4 Chlamydia pecorum
C. pecorum, until recently classified as a subtype of C. psittaci, has several
interesting properties. It possesses a broad host range from bovine to swine, even
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koala. Associated diseases range from severe encephalitis, pneumonia, and enteritis
in cattle and infectious polyarthritis in sheep. In addition, one subtype of C.
pecorum has been implicated in bovine metritis resulting in hypofertility
(Wittenbrink et al., 1993).
1.3 Pathogenesis
Chlamydial infections are characterised by intense and persistent local
inflammation. The host response to primary infection at mucosal surfaces occurs
within 1-2 days and is characterised by inflammation and mucosal infiltration with
neutrophils and small numbers of monocytes. In addition, T-cells accumulate at the
site of infection and play a crucial role in controlling infection. Recently,
Rasmussen et al. (1998) demonstrated that Chlamydia-infected epithelial cells
express and secrete increased levels of chemokines IL-8 and GRO-a, in addition to
cytokines GM-CSF, IL-la and EL-6. Several of these cytokines are potent
chemoattractants and activators of neutrophils, monocytes and T-lymphocytes. It is
proposed that they stimulate the recruitment of the inflammatory cells to the site of
infection. In most cases the response to primary infection is transient, however, a
prolonged inflammatory response may well contribute to fibrosis and tissue
scarring, characteristic of chronic ocular and genital C. trachomatis disease.
It has long been established that chlamydial infection can illicit delayed-type
hypersensitivity (DTH). Grayston et al. (1985) presented strong evidence to suggest
re-infection is required and enhances disease. Over a 10 year period they monitored
32 families with incidence of C. trachomatis infection. The most severe and
progressive trachoma infections, with panus and scar formation, occurred only after
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re-infection (Grayston et al., 1985). Previous studies using animal models showed
that repeated ocular exposure to infectious chlamydiae is necessary to establish the
chronic inflammation characteristic of trachoma (Wang and Grayston, 1962; Wang
and Grayston, 1967; Taylor et al., 1982). Interestingly, repeated challenge with
infectious chlamydiae produces a sub-mucosal cellular infiltrate of lymphocytes and
macrophages, like that observed in individuals with trachoma. Collectively, both
human and animal studies argue for a pathogenic role of DTH in disease.
A direct mechanistic link between DTH and disease has not been
established. Replication of the organism in the host is not required to illicit the
heightened tissue reaction suggesting that a constitutive antigen found in
chlamydiae and not unique to actively growing chlamydiae is sufficient to trigger
the deleterious immune response (Taylor et al., 1981; Taylor et al., 1982; Watkins
et al., 1986). As heterologous strains of C. trachomatis prime the immune system
for an immune response upon re-infection, the hyper-sensitive antigen is most likely
cross-reactive and shared among different chlamydial strains. A wide range of
research suggests that a single 57 kDa protein is centrally involved in pathogenesis.
Brunham et al. (1985) observed that 11 out of 13 women with C. trachomatis-
associated tubal infertility had serum antibodies to a 57 kDa chlamydial antigen,
compared to 1/11 healthy C. trachomatis seropositive control women.
Subsequently, the gene for this 57 kDa protein was cloned, sequenced (Cerrone et
al., 1991) and evaluated in animal models of disease pathogenesis (Morrison et al.,
1989). The protein was identified as a chlamydial GroEL homologue (member of
the hsp60 family) that is common to the Chlamydia genus (Bavoil et al., 1990).
Purified recombinant hsp60 protein was a potent T-cell antigen and elicited an
intense inflammatory response when applied to the mucosal surfaces of the fallopian
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tube of prior immunised animals (Patton et al., 1994).
The actual mechanism by which hsp60 can illicit a hyper-immune response
has not been determined, however, several hypotheses have been proposed
(Brunham and Peeling, 1994). Hsp60 is a highly conserved protein, with the human
and chlamydial sequences sharing 48% identity at the amino acid level (Cerrone et
al., 1991). The recognition of hsp60 by the host immune system may incite an
autoimmune inflammatory reaction. Alternatively, high level antibody responses to
chlamydial hsp60 may signal chronic persistent or repeated chlamydial infection
with other chlamydial antigens sustaining the chronic inflammatory reaction.
There is evidence to suggest that genetic pre-disposition may play some part
in the development of scarring sequelae after chlamydial infection. Holland et al.
(1996) proposed that individuals who develop conjunctival scarring, after infection
with C. trachomatis, lack a Thl cell-mediated immune response and cannot clear
the infection. Therefore individuals developing a chronic infection would
presumably have a strong Th2 response with high antibody titres to the organism
and weak Thl responses. This hypothesis is based on observations that patients
with conjunctival scarring appear to have reduced proliferative responses to C.
trachomatis EBs.
In conclusion, both clinical and experimental data indicate that disease
pathogenesis is due to immunologically mediated tissue injury. Immune responses
to the chlamydial hsp60 correlate with the severity of the disease and long term
damage. However, the precise nature of the immune-mediated tissue damage and
relationship to hsp60 is unclear.
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1.4 Chlamydial lifecycle
1.4.1 Adhesion and internalisation
The initial events in chlamydial pathogenesis, attachment of the infectious
EB to a susceptible cell followed by internalisation, are poorly understood and
studies concerning these processes have produced conflicting results. However, it
would seem reasonable to assume that the surface components which must play an
important role in these early steps of chlamydial infection are key virulence
determinants. Their identification and molecular characterisation are crucial to our
understanding of chlamydial pathogenesis and the development of anti-chlamydial
strategies.
Chlamydiae infect columnar epithelial cell of mucous membranes, while
serotypes LI-3 of C. trachomatis also proliferate in lymphatic tissue causing
systemic infection. The binding of EBs to host cells obeys saturation kinetics
suggesting the involvement of a specific ligand-receptor interaction (Byrne 1978).
The quest to identify chlamydial adhesins has focused on the roles of chlamydial
proteins. The involvement of a proteinaceous component was demonstrated by
Joseph and Bose (1991) who found that both heat and trypsin treated EBs failed to
competitively inhibit the adherence of untreated EBs in an in vitro binding assay.
Many candidates have been implicated as the proteinaceous component
mediating the attachment of EBs to target cells. The MOMP is an obvious
candidate as a potential adhesin because of its predominance in the outer membrane.
MOMPs role in adherence is based primarily on the inhibitory properties of trypsin
and monoclonal antibodies which target its surface exposed variable domains. Su et
al. (1990) demonstrated that trypsin proteolysis of the MOMP, cleaving sites in
variable segments II and IV (Section 1.8.3) resulted in a significant loss of
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attachment for two serovars of C. trachomatis. Monoclonal antibodies specific to
antigenic determinants located on these segments neutralise the infectivity of C.
trachomatis serovar B by blocking adhesion (Collett et al.t 1989). It has been
proposed that the MOMP functions as a chlamydial adhesin by promoting non¬
specific (electrostatic and hydrophobic) interactions and that the binding of
monoclonal antibodies to the MOMP blocks attachment by inhibiting the
electrostatic interactions with the host cell (Hatch et al., 1981). Other proteins
implicated in the attachment process include a 38 kDa chlamydial protein shown to
be surface exposed by radio-iodination and found to be thermolabile and trypsin
sensitive (Joseph and Bose, 1991). This 38 kDa protein was found to bind
specifically to glutaraldehyde-fixed HeLa cells and binding was competitively
inhibited by whole EBs, indicating a shared receptor. In addition, the cysteine rich
Omp2 (Section 1.5.1) has also been suggested as a possible cytadhesin despite the
ambiguity over its location in the chlamydial envelope (Ting et al., 1995). The
participation of glycoproteins in the mechanism of attachment to eukaryotic cells
has also been proposed due to inhibition in chlamydial binding assays upon the
addition of the lectin wheat germ agglutinin.
Recent studies have suggested that the MOMP of C. trachomatis may be
glycosylated (Section 1.8.1) (Swanson and Kuo, 1991). The [^H] glycan was shown
to attach readily to HeLa cells and binding was found to be competitive with whole
EBs indicating a role in the attachment process (Kuo et al., 1996).
Perhaps the most convincing hypothesis for chlamydial attachment to
eukaryotic cells is that recently proposed by Zhang and Stephens (1992). This
involves the synthesis of a molecular mimic of heparan-sulphate by Chlamydia,
which can bind to the host cell exploiting receptors used for eukaryotic cell-cell
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interactions. This glycosaminoglycan (GAG) is thought to mediate attachment by
bridging mutual GAG receptors on the host cell surface and on the chlamydial outer
membrane surface. Attachment of radio-labelled C. trachomatis (Chen and
Stephens, 1997) and fluorescently labelled C. psittaci (Gutierrez-Martin et al.,
1997) were inhibited by the presence of heparin or heparan sulphate, however, low
concentrations of heparan sulphate potentiated attachment. Treatment of chlamydiae
with heparan sulphate lyase was found to ablate infectivity, whereas the addition of
exogenous heparan sulphate restored their ability to attach and infect (Gutierrez-
Martin et al., 1997; Chen and Stephens, 1997). Despite this convincing evidence it
is not suggested that this GAG mediated pathway is the only mode of attachment
and infection exploited by Chlamydia. Indeed, differences have been observed
between C. trachomatis biovars in the extent to which heparin effects their
adherence and infectivity. The LGV biovar appears to predominantly use a heparin-
inhibitable mechanism for attaching to host cells, whereas the trachoma biovar uses
both heparin-dependent and independent mechanisms to adhere and a heparin-
dependent pathway to enter host cells.
The chlamydial outer membrane proteins that bind heparan sulphate are
unknown. Possible candidates include MOMP and the 60 kDa protein. A MOMP
fusion protein which is known to bind specifically to epithelial cells has been shown
to be inhibitable by the addition of heparan sulphate or by the heparitinase treatment
of the cells (Su et al., 1996). Furthermore, the attachment of the MOMP fusion
protein was markedly reduced to mutant cell lines defective in heparan sulphate
synthesis. These results strongly suggest that the MOMP is the chlamydial GAG
receptor.
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Studies concerning the process of entry into host cells have produced
conflicting results, and most workers believe that Chlamydia utilise more than one
mode of entry. Proposed mechanisms of uptake include parasite-specified
phagocytosis, receptor-mediated endocytosis in clathrin coated pits and pinocytosis
in non-coated pits. The most convincing in vitro approach used to address this
question was the use of hormonally maintained primary cultures of human
endometrial gland epithelial cells in polarised culture. Applying this technique,
Wyrick and co-workers (Wyrick et al., 1993) were able to visualise C. trachomatis
in coated vesicles and pits using transmission electron microscopy indicating that
there is a role for the clathrin facilitated uptake of chlamydiae. This observation
supports the earlier work of Soderlund and Kihlstrom (1988) who found that
primary amines, inhibitors of host cell receptor recycling, interfere with the
internalisation of chlamydiae, suggesting that coated pit pinocytosis may be
involved. However, Ward and Murray (1984) failed to see chlamydiae associated
with coated pits over a 30 minute period, but did observe a reduction in entry of
chlamydiae following treatment of host cells with cytochalasin D, an inhibitor of
microfilament-dependent phagocytosis. Pearce and Reynolds (1991) obtained data
suggesting that at least two pinocytic entry mechanisms are exploited by
chlamydiae. They proposed that chlamydiae can enter through a pathway involving
coated pits and through an inducible pathway independent of coated pit uptake.
Therefore, it would seem that chlamydiae can utilise several entry mechanisms
enabling them to infect a wide variety of cell types in a variety of conditions.
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1.4.2 EB to RB transition
Regardless of mode of entry, EBs are found to exist intracellularly within
vesicles derived from the host cell plasma membrane. Whereas C. trachomatis
containing vesicles fuse together shortly after entry to form one large vesicle,
termed the inclusion, C. psittaci-contaming vesicles remain separate from one
another resulting in multiple inclusions (Gordon and Quan, 1965). At 2-12 hours
post-infection, the EB transforms into the replicative, metabolic+ally active RB. As
a result of this transformation, the EB loses its prominent electron-dense DNA core,
the cell envelope becomes less rigid, its size increases from approximately 0.3 to 1.0
pm in diameter and its cytoplasm becomes granular due to the production of
ribosomes. The RB has an osmotically fragile cell wall resulting from the reduction
of the disulphide bond cross-linking of the proteins in the chlamydial envelope, it
has a fibrillar nucleoid, is non-infectious and metabolically active.
One of the first biochemical events to occur after the uptake of EBs is the
reduction of disulphide bond cross-linking of native MOMP to its monomeric form.
Hatch et al. (1986) demonstrated the reduction of the cross-linked MOMP, within 1
hour of entry of C. psittaci EBs into L cells, by the appearance of monomeric
MOMP in electrophoretically separated sarkosyl extracts. The reduction of MOMP
is inhibited by chloramphenicol but not by cycloheximide indicating that
chlamydial, not host, protein synthesis is required for MOMP reduction (Hatch et
al., 1986). This suggests that a chlamydial protein component may facilitate the
reduction of the envelope proteins (Section 1.5.1). The signal that triggers initiation
of intracellular growth and multiplication is unknown, however, it is clear that
reduction of the disulphide bond cross-linked MOMP is a critical early event in the
differentiation of EBs to RBs. Several investigators have stimulated enzymatic
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activity, usually seen in the RB, by treating host-free EBs with reducing agents.
High resolution 31p NMR was used to demonstrate ATPase activity in host-free
EBs of trachoma and LGV biovars of C. trachomatis that had been reduced with 2-
mercaptoethanol (Peeling et al., 1989). In addition, EBs of C. trachomatis LGV
biovar exhibit a DNA-dependent RNA polymerase activity that is doubled by
treatment with 2-mercaptoethanol (Crenshaw et al., 1990). It would seem that the
reduction of disulphide cross-linking is sufficient to mimic EB-RB transition. It has
been postulated that the reduction of MOMP allows it to form channels for the
passage of ATP and other metabolites from the host cell into the newly ingested
chlamydial cells (Bavoil et al., 1984), however, this will be discussed more fully in
Section 1.8.6.
1.4.3 Multiplication
By 8-12 hours post-infection, almost all EBs have differentiated into RBs.
Once mature RBs have appeared, multiplication occurs by binary fission As
bacterial multiplication proceeds, the inclusion membrane must expand to
accommodate up to 100 progeny. While it is assumed that the membrane
surrounding newly internalised bacteria is derived from the host plasma membrane,
the source of membrane forming the expanding inclusion is unclear.
1.4.4 Inclusion membrane
Despite EB entry of host cells through an endocytic mechanism, the
inclusion fails to fuse with the terminal compartment of the endocytic pathway, the
lysosome. This evasion of lysosomal fusion was demonstrated by the absence of
acid phosphatase, a lysosomal marker enzyme, within live C. psittaci-laden
inclusions (Heinzen et al., 1996). Purified EB envelopes have also been shown to
avoid lysosomal fusion while heat-killed chlamydiae are directed to vacuoles
containing acid phosphatase. This data supports a role for chlamydial surface
components in directing intracellular trafficking.
Using fluorescent pH-sensitive probes conjugated to chlamydiae, Schramm
et al. (1996) directly measured the pH of C. trachomatis-containing vesicles. The
pH remained above 6 for up to 12 hours post infection, while vacuoles containing
heat-killed organisms fell to pH 5.3. The absence of significant vacuolar
acidification was partially attributed to chlamydial reliance on the activity of
Na+/K+-ATPases rather than H+-ATPases for intracellular survival and replication.
However, the small drop in pH from 7 to 6 has been suggested to be sufficient to
catalyse the conversion of EBs to replicative RBs, and trigger the recycling of
receptors. Schramm hypothesises that the avoidance of acidification may be a
determining factor in the failure of the inclusion to complete the endocytic pathway
and fuse with the lysosome.
It is accepted that survival of chlamydiae within the host is dependent upon
inhibition of lysosomal fusion, however, the mechanism of avoiding fusion has yet
to be determined. It has been suggested that chlamydiae remove themselves entirely
from the endocytic pathway thereby avoiding their destruction by lysosomes.
Evidence for this hypothesis is based largely on the use of probes demonstrating the
absence of early or late endosome components and fluid phase markers in or around
the inclusion. If the chlamydial inclusion is, indeed, removed from the endocytic
pathway the question of how it sequesters nutrients and other requirements for
growth from the host cell remains. Hackstadt et al. (1996) propose that the
inclusion interrupts an exocytic pathway, receiving host-derived lipids and possibly
other nutrients by fusing directly with golgi-derived vesicles. This is supported by
the demonstration that the inclusion and individual bacteria incorporated
sphingomyelin-NBD endogenously synthesised in the golgi apparatus from C6-
NBD ceramide, a fluorescent analogue of ceramide (Heinzen et al., 1996). In
addition, antibody probes for golgi-specific proteins were found to closely associate
with the chlamydial inclusion. In contrast, C6-NBD-sphingomyelin introduced
directly into the host plasma membrane was not delivered in significant amounts to
the chlamydial inclusion. This indicates that the primary route of sphingomyelin
delivery to the inclusion is by anterograde vesicular traffic directly from the Golgi
apparatus rather than from the plasma membrane as a result of fusion with endocytic
vesicles. Correlating these results, Hackstadt and co-workers propose that the
inclusion acts as an aberrant Golgi-derived vesicle and as such is not recognised by
the host cell as a vesicle of the endocytic pathway destined to fuse with lysosomes.
In direct contradiction to this work, van Ooij et al. (1997) have recently
reported that markers of the endocytic pathway do indeed interact with both early
and late forms of the inclusion. Using identical antibodies, cell line and C.
trachomatis serotypes utilised by Hackstadt and colleagues, they found an
accumulation of both the transferrin receptor and the cation-independent mannose-
6-phosphate receptor, markers of early and late endosomes respectively, around the
inclusion. However, no evidence of fluid phase transfer could be found. Further
evidence of an interaction between the inclusion and the endocytic pathway was the
reduction in the rate of transferrin recycling in infected cells in comparison to
uninfected cells. Again these results contrast with those of Scidmore et al. (1996)
who found no reduction in the rate of transferrin recycling in Chlamydia-infected
cells. In light of these results van Ooij and co-workers believe that the chlamydial
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inclusion remains part of the endocytic pathway interacting additionally with
elements of the exocytic pathway. They propose that avoidance of lysosomal fusion
is achieved by arresting the maturation of the inclusion along the endocytic
pathway, a technique employed by several inclusion-dwelling intracellular parasites.
Expansion of the inclusion membrane is unaffected by cycloheximide-
mediated inhibition of host protein synthesis (Ripa and Mardh, 1977) which
suggests that protein components of the inclusion membrane do not result from de
novo host protein synthesis. Tarasaka and co-workers (1996) reported that
antibodies produced against isolated inclusion membranes from Chlamydia
infected mouse cells solely recognise Chlamydia-derived proteins. Indeed, a 39
kDa chlamydial protein (Inc A) has been identified which is released from the RB
and found to localise in the inclusion membrane (Rockey et al., 1995). In addition,
3 more inclusion membrane localised proteins have been identified in C. psittaci
termed Inc B-D (Scidmore et al., 1998). The function of these proteins is, as yet,
unknown.
The inclusion membrane constitutes a barrier between the replicating
bacteria and the nutrient-rich environment of the host cytoplasm. It is clear that
parasites existing exclusively within an intracellular vacuole must have a
mechanism for host nutrient acquisition. As discussed previously, it is believed that
the chlamydial inclusion may not be involved in the endosomal/lysosomal pathway
and therefore is unlikely to fuse with nutrient-filled vesicles of that pathway.
Heinzen and Hackstadt (1997) determined that the inclusion membrane of C.
trachomatis was not passively permeable to low molecular weight compounds, a
mechanism exploited by several protozoan parasites. Using fluorescent tracer
molecules introduced into the cytoplasm of infected cells, they were unable to
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determine any passive diffusion through the inclusion membrane. Alternatively, the
inclusion may employ specific membrane transporter proteins to transfer nutrients
from the cell cytoplasm to the lumen of the vacuole. This mechanism of nutrient
acquisition would be unique amongst inclusion dwelling intracellular parasites,
however, it is tempting to suggest that proteins within the inclusion membrane, such
as IncA-D, may facilitate specific nutrient acquisition.
1.4.5 Energy metabolism
Moulder (1962) was the first to hypothesise that the Chlamydia are energy
parasites, incapable of generating their own energy source. Evidence supporting
this theory was largely circumstantial. Several researchers noted the absence from
chlamydiae of key enzymes essential in the synthesis of ATP (Weiss 1965; Moulder
et al., 1965; Vender and Moulder, 1967). The requirement of an exogenous source
of ATP and other nucleotides for macromolecular synthesis represent more positive
evidence for the 'energy parasite' hypothesis (Moulder 1962; Hatch et al., 1982;
Hatch et al., 1985). Weiss and Wilson (1968) found that an exogenous source of
ATP either stimulated or was required by isolated chlamydiae for carbohydrate
catabolism and the incorporation of low molecular weight substrates into lipids. In
addition, Sarov and Becker (1971) noted that host-free synthesis of RNA required
the addition of ATP. Hatch et al. (1982) directly demonstrated that host-free RBs of
C. psittaci could transport ATP by a ADP-ATP exchange mechanism. ADP was a
competitive inhibitor of ATP transport, however, other nucleotides had no effect.
No transport of ATP was evident in EBs. Hatch and co-workers incubated RBs in
phosphate buffer and noted that transported ATP was quickly hydrolysed to ADP by
a magnesium-dependent ATPase. Hydrolysis of the ATP resulted in the energising
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of the chlamydial membrane. These researchers hypothesise that Chlamydia
hydrolyse ATP to generate a proton motive force which drives the acquisition of
other host nutrients, such as lysine. Another putative method of ATP transport is
discussed in Section 1.8.6. However, the recent sequencing of the entire C.
trachomatis serovar D genome by Stephens et al. (1998) has revealed that
Chlamydia possess the majority of the enzymes present in the glycolytic, pentose
phosphate and tricarboxylic acid pathways. The identification of these enzymes
indicate that, in addition to obtaining ATP from the host cell, Chlamydia are
capable of producing their own energy source.
1.4.6 RB to EB transition
By 18 to 20 hours post-infection, most RBs within the inclusion have
commenced re-organisation back into the infectious EBs. The RBs progress
through several intermediate developmental forms before becoming mature EBs.
Structural changes occurring during the re-organisation of RBs include a reduction
in size, internal condensation, the formation of electron-dense nucleoids and the
rigidification of the cell walls. RBs tend to cluster close to the inclusion membrane,
where they are near to host cell mitochondria and endoplasmic reticulum.
In maturing from RB to EB, the chlamydial envelope undergoes dramatic
changes. MOMP becomes extensively disulphide bond cross-linked forming high
molecular weight cross-linked oligomers with the cysteine rich proteins (Newhall
and Jones, 1983; Bavoil et al., 1984) (Section 1.5.1). It is not clear if the formation
of intracellular disulphide bonds is mediated by specific chlamydial enzymes or by a
non-enzymatic mechanism.
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The signal that triggers differentiation of the RB to the EB is unknown.
cAMP and cGMP act as regulatory signals in many prokaryotic and eukaryotic cells
and it has been proposed that these cyclic nucleotides are involved in the regulation
of RB to EB transition. Significantly, RBs have a cAMP-binding protein which is
absent from the mature EB. Kaul and Wenman (1986) observed that when HeLa
cells are infected with the trachoma biovar, cAMP reversibly inhibits the conversion
of RBs to EBs. When synthesis of MOMP is used as a marker for general protein
synthesis, cAMP abolishes the increased rate of MOMP synthesis normally
witnessed at 18-36 hours post-infection. The action of cAMP appears to be at the
level of transcription. It has been observed to decrease the concentration of MOMP
mRNA in C. trachomatis LGV-infected HeLa cells, and blocks the transcription of
a recombinant MOMP gene in vitro (Kaul et al., 1992). It would appear that cAMP
acts as an inhibitor of RB-EB transition, and it has been hypothesised that this
developmental process may be under bi-directional cyclic nucleotide control with
cGMP acting as a stimulator.
1.4.7 Release from the host cell
As with modes of chlamydial entry, there seems to be several mechanisms
by which chlamydiae can be released from the host cell. The method of release
seems to vary according to species, strain and host cell-type. One mode of release
shared by LGV and trachoma biovars of C. trachomatis, in addition to C. psittaci
6BC, is lysis of the host cell. In a time-lapse micro-cinematographic study of the
trachoma biovar in McCoy cells, inclusions were seen to burst while apparently still
inside the host cells (De La Maza and Peterson, 1982). Subsequently the host cells
lysed and chlamydiae diffused away from the cell debris. Intact inclusions are also
23
released from host cells. De la Maza and Peterson (1982) used scanning electron
microscopy to study the release of C. trachomatis-containing inclusions from
McCoy cells. The host cell membranes were observed to distend, finally rupturing
releasing both chlamydial inclusion and McCoy cell nuclei. In contrast, some host
cells were seen to form a focal distension of their cytoplasmic membranes allowing
the inclusion to be expelled from the cell without apparent harm to the rest of the
cell surface.
The study of this particular area of the chlamydial lifecycle has been
hampered as the mechanisms of release from specialised cells and tissues of intact
host cells are undoubtedly more complex than in cell culture monolayers. To
overcome this problem, Doughri et al. (1973) observed the release of a polyarthritis
strain of C. psittaci from the intestinal epithelial cells of calves. At least three
distinct modes of release were noted using this model: rupture of the infected cells,
expulsion of whole infected cells into the intestinal lumen, and exocytosis of large
chlamydiae-containing vesicles.
1.5 Architecture of the chlamydial envelope
1.5.1 Components of the chlamydial envelope
Experimental determination of the location and interaction of proteins within
the chlamydial envelope structure are hampered by the biphasic developmental
lifecycle of Chlamydia. Due to the asynchronous nature of events in the growth
cycle, no preparation of EBs is likely to be totally free of RBs and intermediate
forms of unknown stability. Therefore usual methods designed to detect surface
exposure of proteins, such as radio-iodination, must be interpreted with caution.
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Chlamydial envelopes were believed to be atypical in that they appeared to
lack a traditional peptidoglycan layer. Using gas chromatographic mass
spectrometry, Fox et al. (1990) could detect no muramic acid in purified EBs of C.
psittaci or C. trachomatis. N-acetyl muramic acid forms links with N-acetyl
glucosamine in the glycan backbone of peptidoglycan and, as it has been found in
all gram-negative bacteria to date, is a good indication of the presence of
peptidoglycan. Supporting observations include the failure to detect a
peptidoglycan layer by electron microscopy and the failure of antibodies directed
against peptidoglycan to react with Chlamydia (How et al., 1984; Hatch et al.,
1984). Paradoxically Barbour et al. (1982) demonstrated that C. trachomatis
contains 3 penicillin-binding proteins, enzymes associated with the synthesis of
peptidoglycan. This perplexing area has been further confused by the discovery of
20 genes bearing significant homology to enzymes involved in the peptidoglycan
synthetic pathway (Stephens et al., 1998). It is now evident that Chlamydia have the
potential to synthesise some form of peptidoglycan, perhaps at very low levels.
The question remains - what would be the function of this small quantity of
peptidoglycan, presumably not sufficient to form a complete sacculus? Despite the
apparent deficiency of a complete peptidoglycan sacculus, EBs are found to be
osmotically stable, however, RBs are readily lysed. It is proposed that chlamydial
envelope proteins form a disulphide crosslinked supramolecular structure, a
functional equivalent of a sacculus, providing osmotic stability to Chlamydia in
extracellular environments (Newhall 1987).
The predominant proteins in the chlamydial envelope, and those believed to
be involved in the disulphide crosslinked complex are the MOMP, one large
cysteine rich protein (CRP) at 60 kDa termed Omp2, and a small CRP with a
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molecular mass of 12 kDa and called Omp3. Hatch et al. (1981) were the first to
report that MOMP of C. psittaci EBs was insoluble in SDS in the absence of a
reducing agent, and suggested that disulphide bonds might account for the
maintenance of the structural integrity of the organism. Newhall and Jones (1983),
however, were the first to propose the disulphide cross-linkage of proteins as a
substitute for peptidoglycan by demonstrating that MOMP forms inter-peptide
crosslinks to itself in C. trachomatis EB preparations. Following this, it was
reported that EBs of C. psittaci possess a 12 kDa and a 60 kDa cysteine rich protein,
which runs as a doublet (Hatch et al., 1984). These proteins are absent from the
logarithmically dividing RBs. Hatch and co-workers (Hatch et al., 1981) have
demonstrated that the CRPs and MOMP are so extensively disulphide crosslinked in
EBs that they fail to enter into a stacking gel during SDS-PAGE, under non-
reducing conditions after boiling.
Newhall (1987) detected the synthesis of the MOMP and the 60 kDa CRP of
C. trachomatis by 18 h postinfection. The 12 kDa CRP was not detectable until 30
h into the lifecycle. In contrast, while studying C. psittaci, Hatch et al. (1986) did
not detect synthesis and incorporation of the CRPs until the RBs had begun to re¬
organise into EBs at 20-22 h post-infection. In this study, synthesis and
incorporation of MOMP were detected early in the infection cycle (12 h post¬
infection).
The mechanism by which chlamydial envelope proteins become crosslinked
has not been determined. Hatch et al. (1986) found that the CRPs and MOMP
remain in a largely reduced state as long as C. psittaci remains intracellular, but,
spontaneously crosslink when host cells are lysed and EBs are exposed to the
extracellular environment. However, Newhall and Jones (1983) reported the
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formation of crosslinks in C. trachomatis late in the intracellular section of the
lifecycle suggesting an enzymatic mechanism for disulphide bond formation.
Recently, membrane associated and periplasmic protein disulphide isomerases have
been discovered in gram-negative bacteria, and enzymes similar to these may
mediate the crosslinking process. Indeed, the large CRP itself may serve this
function as a potential sulphydryl oxidoreductase active site has been located in the
protein within C. trachomatis, C. psittaci and C. pneumoniae (Everett and Hatch,
1991).
The genes encoding the CRPs of many chlamydial strains have been cloned
and sequenced. The deduced amino acid sequence of the small CRP contains 15
cysteine residues, while the 557 amino acid sequence of the large CRP contains 37
cysteines (Everett and Hatch, 1991). The position of these cysteine residues are
highly conserved in all species of Chlamydia.
The location of the CRPs in the chlamydial envelope is still the cause of
much debate. Hydropathy plots and conformational analysis of the small CRP
amino acid sequence indicates that it is likely to be directly embedded in a
membrane. However, the 12 kDa protein was specifically labelled in host cells
incubated with [3H] palmitic acid and therefore may be membrane associated
through a covalently attached lipid portion. This evidence, combined with a
predicted signal peptidase II cleavage site in the small CRP deduced amino acid
sequence, suggest the 12 kDa protein is associated with the outer membrane through
a lipid modification. The small CRP appears to resemble the Braun lipoprotein of
Escherichia coli which links the peptidoglycan layer to the outer membrane
(Everett and Hatch, 1991).
27
The location of the large CRP remains unclear. The 60 kDa protein is
insoluble in Triton X-114 and sarkosyl, and is not labelled by 3'-(trifluoromethyl)-
3-(m-[I125]iodophenyl)diazirine ([I125]TID), a lipophilic agent (Everett and Hatch,
1995). This evidence combined with the presence of a predicted signal peptidase I
sequence in the large CRP open reading frame (Allen and Stephens, 1989) suggest
that this protein, unlike Omp3, is not associated with a membrane and may be
translocated through the inner chlamydial membrane to the periplasm. Alternatively,
there is convincing evidence indicating the surface exposure of the Omp2 CRP in
both C. psittaci and C. trachomatis. Ting et al. (1995) demonstrated that Omp2
from C. psittaci GPIC binds to HeLa cells and contains a terminal trypsin site that is
accessible in native EBs indicating surface exposure. In addition, Birkelund et al.
(1996) used immunoelectron microscopy to show that the N-terminal portion of the
60 kDa CRP in C. trachomatis L2 was surface exposed.
1.5.2 The POMP family
Several researchers have identified a group of proteins in the region of 90
kDa which have recently been shown to be surface exposed and therefore are
potential mediators of chlamydial invasion. Longbottom et al. (1998b) identified a
unique multigene family encoding these 90 kDa proteins in the ovine abortion sub¬
type of C. psittaci termed POMPs (putative outer membrane proteins). Analysis of
the genome has uncovered a homologous multigene family in C. trachomatis
serovar D containing 9 members, while analysis of the partially sequenced C.
pneumoniae genome has identified 18 open reading frames (ORFs) encoding
homologues to the C. trachomatis POMPs (Stephens et al., 1998). The
demonstration that POMPs are surface exposed on C. psittaci (Longbottom et al.,
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1998a) and the fact that homologues have been identified in C. trachomatis and C.
pneumoniae has focused interest in these proteins. As yet a function has not been
assigned, however, with so many variants this protein may play a crucial role in
chlamydial pathogenesis. It is feasible that the POMPs are involved in the process
of chlamydial attachment and entry into the host cell, which would make these
proteins important vaccine candidates.
1.5.3 Chlamydial surface projections
Chlamydiae possess a unique ultrastructural feature, the presence of
macromolecular surface projections that extend from the cytoplasmic membrane
and range from 45-90 nm in length. These projections average 6 nm in diameter
with a 10 nm bulge at one end. On the EB surface, the projections are hexagonally
arranged with each EB displaying approximately 18-20 projections (Matsumoto,
1982). At the base of each projection is a nine component 'rosette' of unknown
origin.
These surface projections are also present on chlamydial RBs and have been
shown by electron microscopy to associate with the inclusion membrane thus
prompting suggestions of a possible role in nutrient acquisition. Most recently,
Bavoil and Hsia (1998) have hypothesised that the surface projections and the
rosette-like structures surrounding their base form Type III secretion apparatus and
genes encoding Type III secretion machinery have been identified in Chlamydia
(Hsia et al., 1997; Stephens et al., 1998). Similar type ID secretion-associated
structures have been observed in other bacteria (Galan et al., 1992; Hueck, 1998).
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1.5.4 Lipopolysaccharide
Lipopolysaccharide (LPS) is a major surface antigen of Chlamydia
(Nurminen et al., 1983) and chemically resembles the Re type LPS of Salmonella
species (Kochetkou and Knirel, 1993). Like that of other bacteria, chlamydial LPS
is composed of a lipid A portion and a saccharide moiety which contains a genus-
specific epitope composed of a unique 2-8 linkage of the linear 3-deoxy-D-manno-
octulosonic acid (Kdo). The structure of this saccharide was established using the
LPS from a recombinant E. coli transformed with the chlamydial gseA gene
(Belunis et al., 1992). The product of this gene is a multifunctional
glycosyltransferase catalysing all three glycosylation steps in the assembly of the
Kdo trisaccharide. Surprisingly, homology of gseA genes, at the nucleic acid and
amino acid level, is low, despite this, the Chlamydia-specific determinant is
conserved (Mamat et al., 1993).
Chlamydial LPS is phenotypically of the rough type, however, recent data
suggests that chlamydiae also produce a smooth LPS variant. Lukaccova et al.
(1994) observed that smooth LPS was preferentially expressed in chlamydiae grown
in the yolk sacs of embryonated eggs. In addition, smooth LPS was also detected by
immunoflourescence in tissue culture-grown chlamydiae. These authors suggest
that the ability of Chlamydia to phase shift between rough and smooth LPS
synthesis, as observed in many other bacteria, would be highly advantageous in
surviving the host cell immune system.
The significance of chlamydial LPS in infection is unclear. Several
researchers have suggested that LPS may act in the protection of Chlamydia from
the host immune system. Using immunoelectron microscopy, Birkelund et al.
(1989) demonstrated that binding of LPS-specific monoclonal antibodies to the
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chlamydial membrane stripped LPS from the surface. It is not clear if the unique 2-
8 Kdo linkage of chlamydial LPS is intrinsically unstable, resulting in the breakage
of the linkage upon antibody binding. However, as LPS is immunogenic, it has
been hypothesised that chlamydial LPS may be sacrificed to secure the survival of
the chlamydiae. In addition, chlamydial LPS has been found to accumulate in the
plasma membranes of infected host cells. Karimi et al. (1989) proposed that the
incorporation of chlamydial LPS in eukaryotic plasma membranes reduces
membrane fluidity and makes infected host cells less susceptible to cytotoxic T-cell
attack.
Despite the high levels of anti-LPS antibodies resulting from chlamydial
infection, these antibodies are not found to be protective. A possible explanation
for this anomaly was proposed by Salinas et al. (1994). Using immunogold
labelling they demonstrated that LPS of C. psittaci EBs localised to the inner side
of the external membrane, while LPS localised to the outer side of the RB
membrane. The internal localisation of LPS in EBs, shown in this study, could
explain the lack of neutralising LPS-specific antibodies.
1.5.5 Other potential envelope proteins
Our understanding of the protein components that make up the chlamydial
outer membrane is largely based on experimental designs that employ detergent
extraction of non-reduced EBs. This approach eliminates non-cysteine crosslinked
outer membrane proteins from analysis. In addition, the use of monoclonal
antibodies to probe for surface-exposed proteins positively selects for the dominant
proteins of the outer membrane. Due to the prohibitively small amounts of antigen
available from tissue culture growth of Chlamydia, researchers have been restricted
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to these analytical techniques. The results of such experiments may lead us to
believe that the envelope of Chlamydia is a homogenous mass of MOMP, however,
this is not the case. Using techniques such as (1) radio-iodination of the EB surface
(2) sensitivity upon exposure to protease or (3) presence in COMC preparations,
proteins of 155, 96, 45 and 30 kDa have been suggested to associate with the
chlamydial envelope.
Batteiger et al. (1993) used COMC from the GPIC strain of C.psittaci to
analyse their effectiveness in eliciting immunity in a guinea-pig genital model. In
addition to the ubiquitous MOMP and 60 kDa CRP, the resultant anti-sera also
reacted with putative envelope proteins of 84, 72, 47 and 35 kDa. These OG-DTT-
solubilised COMCs provided protection from genital challenge, however, it is
unclear if this is purely as a result of the protective role of MOMP.
In C. trachomatis, a 27 kDa protein with homology to the Legionella
pneumophila macrophage infectivity potentiator (MIP) protein has been
characterised (Lundemose et al., 1992). This protein has a peptidyl-prolyl cis/trans
isomerase activity, which, when inhibited, interferes with the early stages of
chlamydial development. The chlamydial MlP-like protein is poorly surface-
exposed and specific antibodies are non-neutralising in the absence of complement.
However, the amino acid sequence of the MlP-like protein contains a signal
peptidase II recognition sequence and, like the 12 kDa CRP, is thought to be a
lipoprotein associating with the inner chlamydial envelope.
Several chamydial proteins have been identified that share some homology
to members of the heat shock protein (hsp) family (Cerrone et al., 1991; Ho and
Zhang, 1994). Surprisingly, an envelope association has been reported for a hsp70
homologue, a DnaK-like homologue. Raulston et al. (1998) demonstrated that a
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recombinant of the hsp70 homologue of C. trachomatis attaches to epithelial cells
and associates with the chlamydial outer membrane. Zhong and Brunham (1992)
have also shown that certain C. trachomatis hsp70 antibodies neutralise infectivity
in vitro. Whether or not this hsp-like protein acts as an adhesin or a chaperonin in
the adherance process is unclear.
1.6 Genetics
The overall pace of research into this bacteria is slowed by the absence of
compatible genetic systems. Until now, there has been no well established,
convenient system for the removal, manipulation and re-introduction of genetic
material in chlamydiae. In addition, chlamydial genes do not express well in other
hosts. However, O'Connell and Maurelli (1998) have recently reported the
introduction of foreign DNA into the Cal 10 strain of C. psittaci. Engineering
shuttle plasmids containing control elements of the previously sequenced plasmid of
C. trachomatis L2 and which allow expression in E. coli, these researchers were
able to achieve the stable expression of chloramphenicol resistance in Cal 10.
Interestingly, these successful transformants did not result from transfection with
the specially designed shuttle plasmids but from an E. coli vector containing the
resistance gene. Although this work is in its infancy it marks a significant
advancement in Chlamydia research and offers hope that a convenient genetic
system is achievable in the foreseeable future. The introduction of mutations by this
method would accelerate our understanding of these complex bacteria. Until that




Chlamydia have one of the smallest prokaryotic genomes consisting of a
1045 Kbp circular chromosome, approximately lA of the size of the E. coli
chromosome. Assuming non-overlapping ORFs and no bi-directional transcription,
the chlamydial chromosomes have the capacity to encode from 400 to 600 proteins.
The sequencing of the C. trachmatis serovar D genome has recently been completed
as has the sequencing of the C. pneumoniae genome (Stephens et al., 1998).
Already this data has had a major impact on the study of Chlamydia, challenging
many of our previous beliefs. Access to the genome sequences of these two
chlamydial strains will initiate new research, dramatically increasing our
understanding of these complex bacteria. It is hoped that sequencing of the C.
psittaci genome will be achieved in the not too distant future.
Lovett et al. (1980) were the first to observe and isolate plasmids from
Chlamydia. Endonuclease restriction and Southern analysis indicated a significant
lack of DNA homology between C. trachomatis and C. psittaci plasmids. However,
endonuclease studies of several C. trachomatis serovars demonstrated that these
plasmids were highly conserved. High sequence homology implies an essential role
for these plasmids in the virulence or biology of Chlamydia. Indeed, plasmid
specific RNA has been found to be transcribed throughout the developmental cycle.
However, the plasmid is not essential for chlamydial growth or disease (Peterson et
al., 1990). Chlamydial plasmids have subsequently been sequenced (Sriprakash and
MacAvoy, 1987; Hatt et al., 1988; Black et al., 1989) and the expression of several
genes has been investigated (Pearce et al., 1991; Comanducci et al., 1993),
unfortunately the function of the encoded products remains unclear.
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The processes of differentiation between the EB and RB developmental
forms are undoubtedly mediated at the genetic level. Two methods of genetic
regulation are involved. First, regulation of the transcription of specific early and
late genes is essential for the systematic differentiation of these morphologically
distinct forms. The second process of genetic regulation is at the level of
chromosome structure. These regulatory mechanisms will be discussed in turn.
1.6.2 Chromosomal regulation
During transformation of RBs to EBs the chlamydial chromosome has been
observed to condense, resulting in the appearance of an electron dense body at the
centre of the cell. In contrast, RB chromatin appears more pleomorphic resembling
that seen in other bacteria. Recently, two lysine-rich proteins of 18 (Hackstadt et
al., 1991; Perara et al., 1992) and 23-32 kDa (Hackstadt et al., 1993) have been
identified in C. trachomatis and found to share sequence homology with the
eukaryotic histone HI-like proteins. They are thought to play a key role in
chromosome compaction during RB to EB transition. Both proteins are expressed
late in the lifecycle at a time when chlamydial DNA is undergoing condensation
accompanied by down-regulation of transcription and metabolic processes
(Hackstadt et al., 1991; Perara et al., 1992).
The best characterised of these is the 18 kDa protein designated Hcl, which
is conserved among all C. trachomatis serovars as well as C. psittaci (Peterson et
al., 1988). The chlamydial gene encoding Hcl, hctA, has been cloned and
sequenced. Expression of this gene in E.coli, revealed that the nucleoid of the Hcl-
expressing bacteria was highly condensed in comparison to the non-expressing
control, ultrastructurally reminiscent of corresponding structures in intermediate
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developmental forms of C. trachomatis (Barry et al., 1992; Barry et al., 1993).
These results suggest Hcl is sufficient to induce compaction of chromatin and may
mediate the higher order nuclear structure of EBs.
It is clear Hcl initiates these chromatin structural changes by directly
binding to DNA. Purified recombinant Hcl has been demonstrated to co¬
operatively bind double stranded DNA in vitro, forming a condensed spherical Hcl-
DNA complex (Christiansen et al., 1993). The formation of these complexes seems
largely independent of DNA concentration but highly dependent on protein
concentration, indicating co-operative binding of Hcl to DNA. This DNA binding
facility was found to be restricted to the carboxyl region of Hcl (Remacha et al.,
1996). However, compaction of the nucleoid is not complete in the absence of the
N-terminal domain.
In addition to the structural role in the condensation of the nucleoid,
expression of Hcl in E. coli is self limiting and down regulates transcription,
translation and replication at concentrations similar to those observed in chlamydial
EBs (Barry et al., 1993). However, expression of Hcl at sub-structural levels
results in a relaxation of the superhelical DNA structure accompanied by marked
changes in gene expression. These results suggest that He 1 may have many discrete
functions including the inhibition of replication, transcription and translation by
initiating the condensation of the nucleoid structure. This may be preceded by a
more subtle effect on gene expression resulting from a general relaxation of the
superhelical structure of the chromosome.
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1.6.3 Transcriptional regulation
The mechanisms that trigger and regulate gene expression in chlamydiae
have not been identified but are likely to occur at the level of transcription initiation.
Sarov and Becker (1971) were the first to reveal that EBs synthesise RNA using a
DNA-dependent RNA polymerase by observing the effects of the general RNA
polymerase inhibitor rifampin on differentiating EBs. RNA synthesis, courtesy of
this enzyme, is an early event in the chlamydial lifecycle, RNA being detected at 3
hours post-infection (Pollard et al., 1960). The polymerase molecule is a multi-
subunit enzyme composed of a, (3, (3' and a subunits (Koehler et al., 1990; Engel et
al., 1990). The core enzyme, 0X2(3(3', is a non-specific DNA binding protein.
Association of the a subunit with the core enzyme enables sequence specific DNA
recognition permitting the specific binding of the enzyme to the promoter
sequences.
Initial attempts to understand the mechanisms of regulation of gene
expression addressed the role of the a subunit. Using monoclonal antibodies and
PCR techniques, Engel and Ganem (1990) were able to identify and clone only one
chlamydial c subunit, identified as a66. However, the Chlamydia Genome Project
(Stephens et al., 1998) has recently identified two additional ORFs with homology
to known sigma factors. Interestingly, high sequence homology exist between the
a66 subunit and the a70 subunit of E. coli (Birkelund et al., 1988). Detailed
comparison reveals striking homologies in domains 2 and 4 (responsible for -10 and
-35 promoter region recognition and binding) with 93% and 67% identity
respectively (Mathews and Sriprakash, 1990). This level of homology is perplexing
when we consider that chlamydial genes typically do not have E. coli-like consensus
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promoter elements. Indeed, chlamydial promoter sequences appear to be different
from those of other prokaryotes, so much so that few chlamydial promoters tested so
far can function efficiently in E. coli. In vitro assay of promoter recognition
requirements using the a66 subunit reveal that chlamydial RNA polymerase can
tolerate considerably more variation at the -10 and -35 regions (Mathews and
Sriprakash, 1994; Douglas and Hatch, 1996). This suggests that promoter region
context and, perhaps, structure may play a significant role in the transcription.
Due to the apparent lack of consensus promoter sequences in the regions 5'
to the structural genes, most chlamydial genes are not efficiently expressed in E.
coli. Without the identification of a defined and recognisable promoter our
understanding of transcriptional regulation in Chlamydia is limited. Presently,
promoters described for Chlamydia are based solely on the assumption that they are
immediately adjacent to the 5' mRNA region as determined by SI mapping and
primer extension. However, these techniques are prone to error.
1.7 Chlamydial vaccine development
Vaccines against the C. psittaci OEA strain represent the most successful
application of immunoprophylaxis for any disease of chlamydial aetiology. A series
of studies testing various forms of experimental vaccines culminated in the
development of an inactivated whole organism vaccine which formed the basis of a
commercial product (McEwen et al., 1951a; McEwen et al., 1951b; Foggie 1952).
This vaccine consisted of a crude suspension of egg-cultured chlamydial organisms
suitably inactivated and formulated as an emulsion in oil. Although not entirely
eliminating the disease, the vaccine reduced the incidence of OEA to an
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economically acceptable level for many years. In recent years, OEA has re-emerged
to become a prevalent cause of infectious lamb loss due to a reduction in the
efficacy of the commercially available vaccine (Linklater and Dyson, 1979).
The antigenic properties of MOMP have been studied in detail since the
landmark discovery that MOMP purified from SDS gels was capable of raising
antibodies which could neutralise the infectivity of C. trachomatis in vitro
(Caldwell and Perry, 1982). Vaccine preparations based on chlamydial outer
membrane complexes, which are highly enriched for the MOMP in its native form,
have been shown to be protective against chlamydial disease in sheep (Tan et al.,
1990), guinea pigs (Batteiger et al., 1993), and mice (de Sa et al., 1995; Pal et al.,
1997). However, experimental vaccines based on denatured or non-native
recombinant MOMP preparations have yielded, at best, only partial protection (Pal
et al., 1997).
These results clearly make MOMP the primary candidate for a sub-unit
vaccine against chlamydial infection and current research into the design of such a
vaccine has focused on the use of highly immunogenic oligopeptides and cloned
recombinant MOMP fragments (Su and Caldwell, 1992; Murdin et al., 1993; Zhong
et al., 1994). The observation that neutralising mAbs specific to MOMP recognise
either linear or conformational epitopes, prompted the use of oligopeptides to mimic
neutralising B-cell epitopes of MOMP. Ideally, the chosen B-cell epitope should be
widely recognised and contain an appropriate T-cell epitope which will serve to
elicit an immunological memory. In addition, candidate peptides need to be
delivered in such a way as to induce a potent mucosal immune response, by the
production of IgA and IgG antibodies, and a swift recall response after the organism
is encountered. Results using oligopeptide based vaccines have been disappointing,
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perhaps because the immunogens do not induce protective cellular and humoral
immune responses recalled by native epitopes on the organism. This suggests that a
successful vaccine may need to incorporate both sequential and conformational
information in order to elicit a protective immune response.
The future of chlamydial vaccine development may lie with the relatively
new technique of DNA vaccination (Lui, 1995). DNA vaccination provides
protective immunity following the expression of the foreign protein by the hosts
expression machinery. The utilisation of the host expression systems allows the
foreign protein to be presented to the host immune system in a more recognisable
way, analogous to that which occurs during natural infection by an intracellular
pathogen. Using a murine model of pneumoniae, induced by the mouse
pneumonitus isolate of C. trachomatis, Zhang et al. (1997) reported a protective
immune response after intra-muscular DNA immunisation with the chlamydial gene
encoding the MOMP. The MOMP DNA vaccine resulted in the production of
significant levels of protective immunity from lung challenge, however, sterile
immunity was not achieved. The authors have suggested that levels of protective
immunity may be increased by the delivery of the vaccine to the mucosal surfaces
mimicking the natural routes of infection. The results of this research are
encouraging, however, the use of a anti-chlamydial DNA vaccine in humans may
still be some way off. Indeed, Pal et al. (1998) recently reported that inoculation of
Balb/c mice with a variety of eukaryotic expression vectors containing mature
MOMP constructs or DNA from the four variable segments of MOMP from the
mouse pneumonitis strain of C. trachomatis failed to protect against a genital
challenge.
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Clearly, significant problems stand in the way of an effective anti-
chlamydial vaccine. In general, protective MOMP epitopes appear to be serovar
specific therefore making the development of a universal vaccine for Chlamydia
very difficult. In addition, the possible role of DTH in the pathogenesis of acute
chlamydial infection make the choice of vaccine target crucial (Section 1.3).
Despite these significant obstacles, the search for an effective vaccine continues to
be a realistically achievable goal.
1.8 The major outer membrane protein
1.8.1 Structure
The MOMP is a surface exposed, integral membrane protein of
approximately 40 kDa comprising, at least, 60% of the total outer membrane protein
content (Caldwell et al., 1981). Surface exposure of MOMP is indicated by the
susceptibility of MOMP from EBs to trypsin digestion, radio-iodination and
recognition by monoclonal antibodies. Baehr et al. (1988) have suggested that the
MOMP is also exposed to the periplasm.
MOMP cannot be called cysteine-rich in comparison with other chlamydial
envelope proteins, however, amino acid analysis has indicated that seven cysteine
residues within the MOMP sequence are conserved in all 4 currently recognised
species of Chlamydia. These conserved cysteines are thought play a crucial role in
maintaining the structural integrity of the elementary body forming intra- and inter-
molecular disulphide bonds (Section 1.5.1) (Newhall and Jones, 1983). Despite a
relatively large proportion of MOMPs amino acids being designated as hydrophobic
(43 % in C. trachomatis serovar L2) - charged, polar and hydrophobic residues are
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distributed evenly throughout the sequence (Stephens et al., 1986). This results in
the lack of a linear hydrophobic sequence sufficiently long to form a transmembrane
oc-helix and is suggestive of a (3 sheet secondary structure.
Several bodies of work have suggested that MOMP may be post-
translationally glycosylated. Swanson and Kuo (1991) reported that an N-linked
carbohydrate was associated with MOMP. Isolated MOMP bound specifically to
concanavlin A, wheat germ agglutanin and Dolichos biflorus agglutanin in a lectin
binding assay. These lectins recognise oc-D-mannose, D-N- acetylglucosamine and
a-N-acetylgalactosamine. Determination of the glycan structure of MOMP was
hampered by the difficulty in obtaining sufficient amounts of purified carbohydrate.
However, using a sensitive 2-D sugar mapping technique, Kuo et al. (1996)
analysed the structure of the MOMP glycan and found it to contain high mannose
type oligosaccharides, and bi- and tri-antennary complex oligosaccharides with
terminal galactose. Although convincing, these results do not determine the nature
of the association between MOMP and its alleged glycan. It is possible that the
oligosaccharide is not covalently bound to MOMP, merely associated by a non-
covalent specific binding interaction. As discussed previously, MOMP is thought to
specifically bind glycosaminoglycans, for example heparin, and such an interaction
could account for the results of these researchers. Unpublished observations of this
laboratory support this hypothesis (Herring, A.J., personal communication). Full
length recombinant MOMP proteins are found to give an identical molecular mass
on SDS-PAGE gels to that observed with the native protein. As it is unlikely that
the recombinant MOMP is being post-translationally glycosylated by E. coli,
glycosylation of native MOMP would result in an apparent difference in molecular
mass.
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There is a growing body of evidence suggesting that MOMP exists as an
oligomer within chlamydial outer membranes. Several groups have shown MOMP
forms disulphide bond cross-linked multimers, based on the original observation
that MOMP could not be solubilised without the use of a reducing agent (Hatch et
al., 1981). Purified MOMP, solubilised in octyl-glucoside and reduced with
dithiothreitol gives an apparent molecular mass, by SDS-PAGE analysis, almost 3
times that observed for the heat-denatured SDS-treated protein (McCafferty et al.,
1995; de Sa et al., 1995). The observed molecular mass of 110 kDa is suggesting
that MOMP forms trimers. The molecular mass estimated for non-denatured protein
by SDS-PAGE analysis is only an apparent molecular mass and is very dependent
on protein conformation. However, analysis of MOMP multimers by sucrose
density gradient centrifugation indicated that the oligomers had an approximate
sedimentation coefficient of 7.2 S - consistent with the value of 6.8 S for E. coli
porin trimers (McCafferty et al., 1995).
The maintenance of the oligomeric structure of MOMP may well be due to
its close association with LPS, the only other component of chlamydial outer
membranes proven to be surface exposed. Using the crosslinking agent
disuccinimidyl selenodipropionate (SSP), Birkelund et al. (1988) were able to
crosslink MOMP to LPS. MOMP oligomers were observed at 100 and 110 kDa,
however, only in the presence of LPS. No polymeric complexes of MOMP without
LPS were detected. It may well be the case that LPS is required to stabilise the
multimeric structure of MOMP.
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1.8.2 Sequence analysis
The gene for MOMP, termed ompl or ompA, was first sequenced in C.
trachomatis serovar L2 and consisted of a 1182 bp open reading frame encoding a
394 amino acid protein containing 9 cysteine residues (Stephens et al., 1986). The
known amino terminal amino acid was preceded by a 22 amino acid signal sequence
which conformed in structure to that of other outer membrane protein signal
sequences.
Comparative analysis of the entire ompl sequence among several serovars of
C. trachomatis demonstrated that the gene is 84-97% identical at the nucleotide and
amino acid levels (Kaltenboeck et al., 1993; Fitch et al., 1993). Although
nucleotide variation is distributed throughout the entire ORF, analysis of deduced
amino acid sequences of MOMP genes from C. trachomatis and C. psittaci reveal
that amino acid variation is clustered into 4 variable segments (VS I-IV) (Stephens
et al., 1987). These 4 variable regions intersperse five constant regions thought to
be buried within the cell membrane. In contrast, the VSs are thought to be surface
exposed due to their accessibility to antibodies and susceptibility to trypsin
digestion and radio-iodination (Su et al., 1988).
1.8.3 Antigenicity
The antigenic diversity of C. trachomatis and C. psittaci MOMPs has been
attributed to the four sequence-variable segments (Stephens et al., 1987; Stephens et
al., 1988b). Using murine monoclonal antibodies and overlapping synthetic
peptides some epitopes have been mapped to specific regions of the MOMP
(Stephens et al., 1988b). With one exception (Conlan et al., 1988), epitopes of all
specificities have been mapped to one of the 4 variable regions. Available mapping
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data largely focuses on the serovars of C. trachomatis. On the basis of these
studies, it can be concluded that cross-reactive epitopes, such as species, subgroup
and serogroup-specific epitopes reside in VS4 while serovar-specific epitopes reside
in VS1 or VS2. VS IV is the largest of the hypervariable regions of C. trachomatis
and C. psittaci domains and is located near the carboxy terminus of the protein.
Different serovars of C. trachomatis have been distinguished both by direct
sequence analysis of VS IV (Yuan et al, 1990) and by restriction fragment length
polymorphism (RFLP) analysis (Gaydos et al., 1992a; Yang et al., 1993). The
identification of minor differences in the nucleotide sequence of this variable region
have been employed to differentiate strains of the same C. trachomatis serovar from
different individuals.
To date, only a few studies have examined the MOMP-encoding genes of
the C. pneumoniae strains. Sequence comparison of entire ompl genes from two
different isolates (AR 39 and IOL207) in regions comparable with VS IV of C.
trachomatis, showed a high level of conservation (Gaydos et al., 1992b). In
contrast, to C. trachomatis and C. psittaci, the ompl sequences of C. pneumoniae
isolates appear to be conserved. The reason for this lack of polymorphism is
unclear, however it has been suggested that it is an indication of the evolutionary
youth of C. pneumoniae. In addition, it has been proposed that the MOMP of C.
pneumoniae is less immunogenic and antigenically complex. Serological results
appear to be conflicting. Campbell et al. (1990) and Black et al. (1991) found weak
or no reactivity of C. pneumoniae patient sera with MOMP by immunoblotting
studies. At the 9th International Symposium on Human Chlamydial Infection,
Christiansen et al. (1998) reported that they could not detect MOMP on the surface
of C. pneumoniae EBs. These researchers hypothesised that proteins ranging from
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97-99 kDa (homologous to the pomp family identified in C. psittaci, Section 1.5.2)
may form a folded layer at the surface of the EB thereby protecting MOMP and
other proteins from surface exposure. Paradoxically Persson and Peykani (1998)
reported at the same meeting that the oligomeric form of MOMP from C.
pneumoniae was recognised by many monoclonal antibodies specific to C.
pneumoniae and that this polymeric form of MOMP was also reactive with human
sera.
1.8.4 Neutralisation
Significantly, both monospecific polyclonal and monoclonal antibodies to
epitopes located in VS1, 2 and 4 can neutralise chlamydial infectivity in vitro
(Lucero and Kuo, 1985) and in vivo (Peterson et al., 1988; Zhang et al., 1987). In
general it is believed that antibodies directed to serovar and subspecies-specific
epitopes are protective, while those recognising species-specific epitopes are not,
although there can be exceptions (Peeling et al., 1984). Studies have shown that
neutralisation is dependent on the binding of bivalent immunoglobulin G (IgG) (Su
and Caldwell, 1991). Depending on host cell culture conditions, the mechanism of
action appears to be due to the prevention of attachment of elementary bodies to the
host cell or, in some cases, inhibition of a post-internalisation process. As bivalent
IgGs were used in these neutralisation assays, antibody mediated aggregation of the
chlamydial inoculum could not be excluded as a possible neutralisation mechanism.
However, Su and Caldwell (1991) demonstrated that monovalent Fab antibodies to
serovar and subspecies epitopes on VS1 could neutralise infectivity of C.
trachomatis in HaK cells thereby removing aggregation as a possible mechanism of
neutralisation. Confusion still surrounds the requirement of complement to achieve
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neutralisation. Su et al. (1991) found that monovalent Fab fragments of a MOMP-
specific mAb neutralised infectivity of an A-serovar of C. trachomatis in both HeLa
and HaK cells, but intact IgG3 caused neutralisation only in HaK. HeLa 229 cells
were found to possess Fc receptors and the authors suggested that this may account
for the inconsistencies observed in the requirement for complement to achieve
neutralisation.
The demonstration that some neutralising mAbs recognise linear epitopes
has concentrated efforts on designing a MOMP sub-unit vaccine based upon using
oligopeptides or cloned recombinant fragments. However, it is believed that a
successful peptide vaccine may require structural information (conformational
epitopes) to elicit antibodies which maximally cross-react with native neutralisation
epitopes on the organism. These results underline the importance of MOMP as the
immunodominant antigen of Chlamydia.
1,8.5 MOMP genetic regulation
Using techniques such as primer extension and SI nuclease analysis,
Stephens et al. (1988a) proposed that the ompl gene of C. trachomatis L2 had two
tandem promoters arranged upstream from the single copy structural gene. One of
these promoters (PI) produced an mRNA transcript detectable at as little as 4 h post
infection. The second promoter (P2) was responsible for production of a slightly
larger transcript, appearing at 12 h post infection coinciding with the onset of binary
fission. Stephens et al. (1988a) hypothesised that the smaller transcript was
produced constituitively while the longer transcript was developmentally regulated
perhaps to provide supplemental transcription as binary fission commenced.
Interestingly, again using primer extension and SI nuclease analysis, Yuan et al.
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(1990) discovered that the GPIC and mouse pneumonitis strains of C. psittaci had 3
and 4 different sizes of ompl transcripts respectively. These varying transcripts
were again attributed to transcription from multiple tandem promoters.
The identification of multiple tandem promoters is disputed by the work of
Douglas and Hatch (1995). Again using primer extension these researchers
identified two transcription initiation sites identical to those seen by Stephens et al.
(1988a) in the L2 serovar of C. trachomatis. However, employing an alternative
technique where the two putative promoter sites are cloned into a transcription assay
vector only promoter P2 initiated transcription. Tandem transcript bands were
identified from this cloned promoter, however, they are believed to result from
imprecise termination of the transcript. Douglas and Hatch (1995) propose that P2
is the only active ompA promoter generating the longer transcript.
1.8.6 Function
With such a predominance in the chlamydial outer membrane, the function
of MOMP has been the focus of much attention. However, problems purifying
native MOMP or obtaining recombinant MOMP in a native form have hampered the
study of structure/function relationships for this protein. Despite this, MOMP is
thought to be multifunctional with a role both in the infectious process (Section
1.4.1) and in the maintenance of structural rigidity via disulphide bond cross-linking
within the EB outer membrane (Hatch 1996; Newhall 1987) (Section 1.5.1).
Perhaps the most convincing proposed function of MOMP is that of a
chlamydial porin. MOMP shares many biochemical properties with gram negative
porin proteins. The general amino acid composition of MOMP is very similar to the
porins of Neisseria gonorrhoea and E. coli. In addition, MOMP forms SDS-
48
resistant oligomers (Section 1.8.1), has an acidic pi and has a molecular mass within
the range of 30-40 kDa, all properties common to porins. To date, the only research
to directly test this porin channel hypothesis was that of Bavoil et al. (1984). Using
the technique of liposome swelling, they demonstrated that chlamydial outer
membrane complexes of C. trachomatis contained water-filled pores. Due to the
overwhelming presence of MOMP, in comparison with other proteins, in such outer
membrane preparations it was assumed that MOMP was the likely pore-forming
protein.
It is clear that MOMP's pore-forming activity would be primarily utilised at
the intracellular, RB stage of the chlamydial lifecycle. Bavoil et al. (1984) proposed
that the reduction of the outer membrane disulphide bonds, during EB to RB
transition, 'opened' chlamydial pores allowing the uptake of ATP and other
nutrients. Evidence supporting this hypothesis included activation of the COMC
pores by treatment with dithiothreitol, and the blocking of re-oxidation with
iodoacetimide.
1.9 Aims and objectives
The wide ranging objective of this study was the structural and functional
characterisation of the MOMP of the OEA isolate of C. psittaci. More specific aims
were to fully investigate the MOMP porin hypothesis of Bavoil et al. (1984) at the
molecular level, using planar lipid bilayer reconstitution and, at the structural level,
by CD analysis of the purified protein. In order to achieve these specific objectives
it was necessary to develop methods of purification which would yield useful
amounts of structurally native MOMP. It is hoped that the assignment of a definite
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function to MOMP, in addition to more detailed structural information, will help




2.1 Chlamydial culture and growth
The ovine abortion isolate of C.psittaci, S26/3, was used throughout this
study (McClenaghan et al., 1984). Mycoplasma-free McCoy cells were used for the
cell culture of chlamydial organisms. Cells were grown in 225 cm2 flasks in RPMI
1640 (Gibco) supplemented with 5% (v/v) newborn calf serum (NBC), 0.2% (w/v)
sodium bicarbonate, 1% (w/v) HEPES, 0.1 mg/ml Streptomycin, 25U/ml Nystatin
and 5pg/ml Gentimicin. Confluent monolayers were obtained after approximately 3
days. Cells were infected with Chlamydia by incubation with RPMI, supplemented
as above, containing 1% (v/v) chlamydial inoculum (5 x 107 inclusion forming units
(EFU)), transport medium (0.2 M sucrose, 7 mM K2HPO4, 4 mM KH2PO4, 5 mM L-
glutamic acid, 0.0016% (w/v) phenol red, 10% (v/v) foetal bovine serum (FBS),
0.05 mg/ml Gentimicin, 0.2 mg/ml Streptomycin and 25 U/ml Nystatin) and ljlg/ml
of cycloheximide. Flasks were incubated at 37°C for 3-7 days. This inoculum was
produced from an isolate of C. psittaci S26/3 recovered from a field outbreak of
ovine abortion and grown in yolk sacs of day old chick embryos, the isolate was
further passaged in tissue culture, harvested and stored, as described above, in liquid
nitrogen. Chlamydial cultures used for the purification of MOMP, were harvested
and stored at -70°C. Cultures used as inocula were harvested at approximately 3
days post-infection and stored in sterile transport medium at -70°C.
2.2 SDS-PAGE
Discontinuous SDS PAGE was carried out as described by Laemmli (1970)
using 12.5% or 10% mini slab gels (Mini Protean II, BioRad) run at a constant
voltage of 200 V for approximately 1 h. 12.5% large format gels (Protean II,
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BioRad), used to prepare samples for electroelution, were run overnight at 100 V
constant voltage. Samples were dissolved in Laemmli sample buffer containing 2%
(w/v) SDS and 5% (v/v) 2-mercaptoethanol (Sigma), and boiled for 3 min or left
unboiled prior to loading. A range of molecular mass standards were included in
each run, the 'Electran' calibration kit for SDS-PAGE (BDH) with molecular
weights ranging from 12.5-78 kDa, the Mark 12 wide-range protein standards
(Novex) ranging from 2.5-200 kDa or the SeeBlue pre-stained standards (Novex)
ranging from 4-250 kDa.
2.2.1 Techniques involved in the staining of SDS-PAGE gels
2.2.1.1 Coomassie staining and destaining. Coomassie staining was routinely used
to visualise proteins analysed by SDS-PAGE by incubating gels in 0.1% (w/v)
Coomassie Brilliant Blue R250/50% (v/v) methanol/7.5% (v/v) acetic acid for
approximately 30 min. Gels were destained by washing gels in 7% (v/v) acetic
acid/25% (v/v) methanol.
2.2.1.2 Silver staining of protein gels. Silver staining of SDS-PAGE gels was
accomplished using the method described by Morrisey (1981). Gels were initially
pre-fixed in 50% (v/v) methanol/10% (v/v) acetic acid for 30 min. This was
followed by a second pre-fixative wash in a 5% (v/v) methanol/7% (v/v) acetic acid,
again for 30 min. Fixation was achieved by a 30 min wash in 10% (v/v)
glutaraldehyde (Sigma). The gel was then washed thoroughly in 5 x 1L of distilled
water over a 2 h period and incubated in a 5 (lg/ml DTT solution for 45 min.
Without rinsing, the gel was then placed in a 0.1% (w/v) AgN03 solution, again for
45 min. After rinsing in distilled water for 30 sec, the gel was developed in 100 ml
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3% (w/v) NaiCCh /50 jLll formaldehyde (BDH). Development was stopped by the
addition of 5 ml 3M citric acid.
2.2.1.3 Copper chloride staining. Proteins which were to be excised from gels for
electroelution were visualised by copper chloride staining (Lee et al., 1987).
Following electrophoresis, SDS-PAGE gels were rinsed in distilled water for 5 min,
and agitated in a 0.3 M copper chloride (Sigma) solution for at least 5 min. On
removal from the stain, gels were washed for 3 x 2 min in distilled water and then
placed on a dark surface to highlight the negative staining of the proteins. Protein
bands of interest were excised using a clean scalpel.
2.2.1.4 SYPRO™ Orange protein stain. SYPRO™ Orange (BioRad) was used as an
alternative stain for the visualisation of proteins prior to electroelution, following
SDS-PAGE analysis, gels were incubated in 7.5% (v/v) acetic acid/0.02% (v/v)
SYPRO Orange, with gentle agitation for 30 min. They were then removed from
the staining solution and rinsed in 7.5% (v/v) acetic acid for 30-60 seconds to
remove excess stain from the gel surface. Protein bands were visualised by UV
illumination using a UVtransilluminator (Hybaid). Gels images were documented
using a UVP camera and video copy processor (Mitsubishi).
2.3 Protein Blotting
2.3.1 Semi-dry blotting
Proteins separated by SDS-PAGE were transferred onto nitrocellulose
membrane (Schleicher and Schuell, Dassel, Germany) or PVDF membrane
(Immobilon P, Millipore U.K. Ltd) using a semi-dry transfer apparatus (Milliblot
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SDE system, Millipore) with a constant current of 1.2 mA/cm2 of gel for 20 min.
Membranes were pre-soaked in distilled water for 15 min prior to transfer. The
transfer sandwich consisted of 1 filter paper soaked in 0.3 M Tris/10% (v/v)
methanol (anode buffer 1), 3 filters soaked in 25 mM Tris/10% (v/v) methanol
(anode buffer 2), the SDS-PAGE gel and membrane followed by 3 filters soaked in
25 mM Tris/10% (v/v) methanol/15 mM glycine (cathode buffer).
2.3.2 Wet blotting
Proteins analysed under non-denaturing conditions on SDS-PAGE were
transferred onto PVDF membrane by wet blotting under mild conditions, in the
absence of methanol (McCafferty et al., 1995). The samples were transferred
overnight at a constant 30 V in a BioRad Miniblot system (BioRad). The transfer
buffer used was 25 mM Tris/200 mM glycine (pH 8.6). Following blotting, the
membranes were processed as described in Section 2.3.3. Proteins to be analysed
by N-terminal amino acid sequencing were transferred onto PVDF membranes, as
described above, by wet blotting in the following transfer buffer: 50 mM sodium
borate/20% (v/v) methanol/0.02% (v/v) 2-mercaptoethanol.
2.3.3 Antibody binding and detection
Nitrocellulose membranes were incubated for 2 min in a 10% (w/v) solution
Ponceau S (Sigma) to identify tracks and confirm the success of protein transfer.
Membranes were then washed for 3 x 1 min in a solution of 0.1% (w/v) Tween 20
(Sigma)/phosphate buffered saline (PBS), pH 7.4 (PBST), and incubated in the
same solution for 30 min at room temperature to block non-specific protein
adsorption to the membranes. Following the blocking procedure, the membranes
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were rinsed (3x2 min) in PBST and incubated with optimally diluted primary
antibody (see Table 1) for 1 h at room temperature, all subsequent washes and
antibody dilutions were in PBST. The membranes were subsequently washed (3x5
min) and probed with optimally diluted (usually 1/1000 unless stated) alkaline
phosphatase-conjugated rabbit anti-mouse IgG secondary antibody for 1 h at room
temperature. Following final washing (3x5 min), proteins recognised by the
primary antibody were visualised by incubating the filters in a substrate solution
containing 100 mM Tris-HCl, pH 9.5/100 mM NaCl/50 mM Mg2Cl2/0.4 mg mF1
nitro blue tetrazolium chloride (Boehringer)/0.2 mg ml"1 5-bromo-4-chloro-3-
indoyl-phosphate (Boehringer). Colour development was stopped by washing the
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2.3.4 Techniques involved in the staining of membranes
2.3.4.1 Protogold staining of PVDF membranes: Following overnight transfer of
protein onto PVDF membrane, as described in Section 2.3.2, membranes were
washed in PBS for 2 x 5 min and incubated in PBS containing 0.3% (v/v) Tween 20
(Sigma) at 37°C for 30 min, to block unoccupied binding sites. Membranes were
then washed 3x5 min in PBS, again containing 0.5% (v/v) Tween 20, and 3x1
min with distilled water to remove any buffered salts. These washing steps
dramatically reduce background staining and were followed by the incubation of the
membranes in Protogold, a stabilised colloidal gold solution (British Bio-Cell,
Cardiff, UK). Optimum staining times varied between 2-4 h, depending on the
concentrations of protein involved. After staining, membranes were washed in
distilled water and dried for storage.
2.3.4.2 Coomassie staining of PVDF membranes: The staining of protein bands
on PVDF membranes for excision and N-terminal sequencing was achieved using
an adapted Coomassie Blue protocol. PVDF membranes were rinsed (3x2 min)
with distilled water and saturated with 100% (v/v) methanol for 20 seconds.
Membranes were then stained in 40% (v/v) methanol/1% (v/v) acetic acid
containing 0.1% (w/v) Coomassie Brilliant Blue R-250 (Sigma). Once the required
staining was achieved, usually within one min, the membrane was destained in 50%
(v/v) methanol and finally rinsed with distilled water. Protein bands of interest were
excised using a clean scalpel and finally sequenced by the Microchemical Facility,
AFRC Institute of Animal Physiology and Genetics Research, Babraham,
Cambridge, UK.
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2.4 Purification of MOMP
2.4.1 Differential solubilization of MOMP
MOMP was solubilised from sarkosyl (sodium lauroyl sarcosinate) (Sigma)
extracted preparations of the OEA isolate of C. psittaci, as described previously
(McCafferty et al., 1995). Briefly, 20 mg of EBs/RBs from tissue culture harvest
were suspended in 2% (w/v) sarkosyl and incubated at 37°C for 1 h. After
centrifugation for 30 min at 100,000 x g, the pellet was resuspended in 2% (w/v)
sarcosyl containing 10 mM DTT (Sigma) and incubated at 37°C, again for 1 h.
Finally, the pellet was resuspended in 2% (w/v) OG (Boehringer) containing 10 mM
DTT, incubated for 2 h at 37°C and centrifuged for 30 min at 100,000 x g. The
supernatant, which contained solubilised MOMP, was collected and stored at -20°C.
Solubilization of MOMP was attempted using a variety of detergents to
ascertain if these could improve the purity of solubilised MOMP, in comparison to
the OG/DTT solubilised sample. The pellet resulting from incubation in
sarcosyl/DTT was re-suspended in the following detergents in the presence of 10
mM DTT and incubated for 2 h at 37°C: 2% (w/v) octyl polyoxoethylene (POE)
(Bachem Feinchemikalien); 2% (w/v) sodium deoxycholate (Sigma); 2% (w/v)
sodium dodecyl sulphate (Sigma) and 2% (w/v) Hecameg (BDH). Following this
incubation, samples were centrifuged for 30 min at 100,000 x g. The resulting
pellets and supernatants were collected and analysed by SDS-PAGE and Western
blotting.
2.4.2 Sucrose density centrifugation
0.1 ml OG/DTT solubilised MOMP was layered onto a 5-20% (w/v) linear
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gradient of sucrose (BDH). Gradients were prepared using the method described by
McCafferty et al. (1995) and left to diffuse at room temperature for 5 h. After
sample loading, gradients were centrifuged at a constant temperature of 20°C in a
Beckman SW55 rotor for 16 h at 130,000 x g. 1 ml samples collected in a fraction
collector using a peristaltic pump (P-3, Pharmacia), were analysed by SDS-PAGE.
An adaptation of this protocol, where a 60% (w/v) cushion of the centrifugation
medium Nycodenz (Nyegaard Diagnostica, Oslo, Norway) was added to the base of
the sucrose gradient, was also carried out in an attempt to stop MOMP forming an
insoluble pellet.
2.4.3 Preparative isoelectric focusing
Preparative isoelectric focusing was achieved using the MinipHor protein
fractionator (Rainin Protein Technologies, Inc). Focusing was carried out according
to manufacturers' instructions. Briefly, the system was filled with a 1% (v/v)
ampholyte (0.2% pH 3-10 and 0.8% pH 5-7)/10% (v/v) glycerol solution. The
ampholytes were pre-focused at a constant 1000 V for 45 min before protein
samples were loaded. 1-3 ml of protein sample were loaded directly onto the pre¬
formed gradient and focused at 1000 V for 30 min followed by a further 10 min at
500 V. Fractions were collected in 0.8 ml aliquots and analysed by SDS-PAGE.
2.4.4 Electroelution
The model 422 Electro-Eluter (BioRad) was used to recover proteins from
SDS-PAGE gel slices. Excised protein bands were washed 3 x 10 min in 0.25 M
Tris, pH 9.3 containing 0.25 M EDTA (Sigma). Gel slices were equilibrated prior to
electroelution in elution buffer (25 mM Tris/192 mM glycine/0.1% (w/v) SDS,
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pH8.3) at room temperature for 1 h. Electroelution was carried out according to
manufacturers' instructions at a constant current of 8-10 mA/glass elution tube for
at least 3 h. Eluted proteins were collected and stored at -20°C.
2.4.5 Hydroxyapatite chromatography
MOMP was purified by non-denaturing hydroxyapatite chromatography,
primarily using the technique described by Caldwell et al. (1981) with some minor
modifications. Briefly, 15-20 mg of EBs/RBs from tissue culture harvest were
suspended in 2% (w/v) sarkosyl (Sigma) and incubated for 1 h at 37°C. Following
centrifugation for 30 min at 100,000 x g the pellet was resuspended in 2% (w/v)
SDS/PBS/1 mM DTT and incubated for 1 h at 37°C. 7 mg of the MOMP-enriched
SDS extract was equilibrated in 0.01 M sodium phosphate, pH 6.4/1 mM DTT/0.1%
(w/v) SDS (column equilibration buffer) and fractionated by hydroxyapatite
chromatography in the continued presence of SDS using the technique of Moss and
Rosenblum (1972). The MOMP-enriched sample was loaded onto a pre-
equilibrated hydroxyapatite column (BioRad) (5 cm x 1 cm) using a peristaltic
pump at a rate not exceeding 0.5 ml/min and the column was then washed with
equilibration buffer until the absorbance at 280 nm was below 0.05. Fractions were
eluted using a linear gradient of 0.1-0.6 M sodium phosphate, pH 6.4 containing 1
mM DTT and 0.1% (w/v) SDS at a rate not exceeding 0.1 ml/min and the
absorbance at 280 nm monitored. Those fractions showing increased absorbance at
280 nm were analysed by SDS-PAGE and by immunoblotting using the MOMP-
specific monoclonal antibody 4/11 (Table 1).
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2.5 Protein estimation
Protein concentration was determined by gel densitometry using the BioRad
GS-670 imaging densitometer and by using the bicinchoninic acid protein assay
(BCA; Pierce). Bovine serum albumin (BSA) was used as a standard.
2.6 Structural analysis of MOMP
2.6.1 Secondary structure prediction
Secondary structure predictions of MOMP from C. psittaci OEA subtype
were performed using DNAStar DNA/protein sequence analysis software
(DNASTAR, Inc.). The secondary structure prediction alogarithms applied to the
MOMP sequence were Chou-Fasman (Chou and Fasman, 1978) and Garnier-
Robson (Gamier et al., 1978).
2.6.2 Circular dichroism
CD analysis of OG/DTT-solubilised MOMP and hydroxyapatite-purified
MOMP was performed on a Jasco J-600 spectrophotometer with a pathlength of
0.02cm, averaging 16 scans between wavelengths of 190 nm and 260 nm for each
sample. The spectrophotometer was blanked using buffer alone. Secondary
structure estimations were obtained using the CONTIN procedure of Provencher




2.7.1 2-D gel electrophoresis
2-D gel electrophoresis of OG/DTT solubilised MOMP was performed
using the Mini Protean II 2-D electrophoresis cell (BioRad). Focusing was carried
out according to the manufacturers' instructions. Briefly, the first dimension
polyacrylamide tube gels containing a 1.6% (v/v) pH 5- 7 and a 0.4% (v/v) pH 3-10
ampholyte mix (BioRad) were cast in capillary tubes. Samples were equilibrated for
30 min at room temperature in first dimension sample buffer which also contained a
1.6% (v/v) pH 5-7 and a 0.4% (v/v) pH 3-10 ampholyte mix (9.5 M urea/2% (v/v)
Triton X-100 (Sigma)/5% (v/v) 2-mercaptoethanol). The ampholytes within the
tube gels were focused, prior to the loading of the samples, by applying 200 V for
10 min, 300 V for 15 min and 400 V for 15 min. Following loading, samples were
focused at a constant of 500 V for 10 min and 750 V for 3.5 h. After first
dimension focusing, the tube gels were flushed from the capillary tubing and
equilibrated in second dimension SDS sample equilibration buffer (0.0625 M Tris-
HC1, pH 6.8/2.3% (w/v) SDS/5% (v/v) 2-mercaptoethanol/10% (w/v)
glycerol/0.0025% (w/v) bromophenol blue) for 30 min. Tube gels were then placed
on the top of 12.5% gels for SDS-PAGE in the second dimension (Section 2.2).
The resulting 2D-gels were silver stained (Section 2.2.1.2).
2.7.2 Isoelectric focusing
Isoelectric focusing was carried out using the XCell II Mini-Cell
electrophoresis system (Novex) in conjunction with precast 5% (w/v)
polyacrylamide, non-denaturing IEF gels (Novex). Gels with an ampholyte range of
pH 3-10 and pH 5-7 were run using the buffering system recommended by the
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manufacturer. Briefly, pH 3-7 IEF gels were run with a cathode buffer of 0.6%
(w/v) lysine (Sigma) and anode buffer of 0.08% (w/v) phosphoric acid, while pH 3-
10 gels were separated in 0.35% (w/v) arginine/0.3% lysine buffer (cathode) and
0.08% phosphoric acid buffer (anode). Following sample loading, gels were run at
100 V constant voltage for 1 h, 200 V for 1 h and 500 V for 30 min. The
approximate current during this time was 5 mA/gel. The gels were fixed on
completion of focusing in a 12% (v/v) trichloroacetic acid solution for 30 min and
then silver stained as described in Section 2.2.1.2. Alternatively, the proteins were
transferred onto PVDF membrane using an adapted Western blotting protocol.
Protein transfer was carried out using the BioRad Miniblot system (BioRad) and a
0.7% (v/v) acetic acid (pH 3.0) transfer buffer at 10 V constant voltage for 1 h.
2.8 Molecular biology techniques
2.8.1 Agarose gel electrophoresis
DNA was analysed by conventional agarose gel electrophoresis. Agarose
concentrations ranging from 0.8-2.0% (w/v) were prepared in TAE electrophoresis
buffer (40 mM Tris-acetate, pH8.0/l mM EDTA) in the presence of 0.5 |ig of
ethidium bromide per ml. Gels were run in TAE buffer at a constant voltage of 60
volts. A range of molecular weight standards were included in each run, usually a 1
kb DNA Step ladder or (])X174/Hae III markers (both from Gibco). DNA fragments
were visualised by UV illumination using a Hybaid transilluminator. Gel
documentation was provided by UVP camera and video copy processor
(Mitsubishi).
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2.8.2 C. psittaci OEA tMOMP construct
The C. psittaci MOMP construct contained the coding region for a truncated
form of the protein, hence the name "t"MOMP (Hering et al., 1998). The tMOMP
construct consisted of the coding region of C. psittaci OEA isolate MOMP,
beginning at the first natural methionine, cloned into pET-22b (+). On induction,
the construct produced a shortened protein lacking the first 16 amino acids of
MOMP. Expression of the tMOMP construct in this study was as described for the
C. pneumoniae recombinant MOMP construct in Section 2.8.12.
2.8.3 C. pneumoniae tMOMP construct
2.8.3.1 Polymerase chain reaction (PCR)
The cloning and expression of the C. pneumoniae recombinant MOMP,
described in the following sections, was largely based on that of the C. psittaci
tMOMP construct (Herring et al., 1998)(Section 2.8.2). The C. pneumoniae
MOMP gene was amplified by PCR from C. pneumoniae strain IOL207 genomic




5'-AGCGGCCGCTCAGAATCGAACT-3' for C. psittaci (GenBank Accession
Number X51859) and C. pneumoniae (GenBank Accession Number M69230),
respectively. Primers were designed using the program Oligo. PCR reactions were
carried using the Expand Long Template PCR System (Boehringer). 50 |ll final
reaction volumes containing template DNA, 300 nM upstream and downstream
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primers, 350 pM dNTPs (Boehringer), PCR buffer (including 1.75 mM Mg2+) and
Pwo/Taq polymerase. Reactions were overlayed with sterile mineral oil (Sigma) to
prevent evaporation. PCR conditions were as follows: a 2 min denaturation at 94°C
for 1 cycle; followed by 45 sec denaturation at 94°C, 30 sec annealing at 44°C and
40 sec extension at 68°C for 30 cycles; and a final 7 min extension at 68°C for 1
cycle.
2.8.3.2 Purification of DNA fragments from agarose gels
PCR products, utilised for cloning, were fractioned by electrophoresis in low
melting point agarose (Boehringer). Bands of interest were excised and purified
from the agarose gel slice using a QIAquick gel extraction kit (Qiagen), according
to the manufacturers' instructions and based on the protocol of Vogelstein and
Gillespie (1979).
2.8.3.3 Ligation of PCR products into the pGEM-T cloning vector
PCR products were cloned into the T-vector, pGEM-T (Promega). The T-
vector system takes advantage of the non-template dependent addition of a single
deoxyadenosine to the 3' end of PCR products by thermostable Taq which can be
ligated to the single 3'-T overhangs of the vector. The gel-purified PCR products
were ligated into pGEM-T using the T4 DNA ligase enzyme (Promega) in a total
reaction volume of 10 pi : T4 DNA ligase buffer (30 mM Tris-HCl, pH 7.5/10 mM
MgCL/lO mM DTT / 1 mM ATP), containing 50 ng of vector, insert DNA [at an
insert:vector molar ratio of 3:1 or 1:1] and 1 Weiss Unit/pl T4 DNA ligase
(Promega). Concentrations of vector and insert DNA were estimated by comparison
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with DNA molecular weight markers of known concentration. The molar mass
ratio for DNA molecules was estimated using the following formula: [ng vector x
insert size (kb)/ vector size (kb)] x molar ratio of insert:vector = ng of insert
required]. Following overnight incubation at 6 °C, the ligation mixes were
transformed into chemically competent XL-1 blue cells (Section 2.8.9).
2.8.3.4 Dephosphorylation of restriction endonuclease-digested pET-22b (+)
The pET-22b (Novagen) expression vector was digested with restriction
enzymes, Notl and Ndel (Promega), in preparation for ligation with the
C. pneumoniae MOMP DNA fragment excised from pGEM-T (Section 2.8.3.5).
The 5' ends of the linearised vector were dephosphorylated using calf intestinal
alkaline phosphatase (CIAP) (Promega). Routinely, 1U CLAP was added to the RE
digestion reaction mix in CIAP reaction buffer (Promega) and incubated for lh at
37°C. The reaction was stopped by adding 5 mM EDTA/0.5% (w/v) SDS, then
adding proteinase K to a final concentration of 100 pg/ml and finally incubating at
56 °C for 30 min. The DNA was extracted by adding an equal volume of
phenol:chloroform:isoamyl alcohol, vortexing for 1 min, centrifuging at 9,000 x g
for 5 min and removing the upper aqueous layer. The DNA was precipitated by
adding ammonium acetate (freshly prepared) (final concentration of 2.5 M), 3
volumes of 100% (v/v) ethanol and placing on ice for 30 min. After centrifugation
at 9,000 x g for 30 min, the pellet was washed with 0.5 ml 70% (v/v) ethanol.
Following centrifugation, again at 9,000 x g for 15 min, the pellet was air dried and
solubilised in nuclease-free water.
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2.8.3.5 Ligation into pET-22b (+) expression vector
The C. pneumoniae MOMP DNA fragment was excised from pGEM-T
using restriction enzymes Ndel and Notl and ligated into the pET-22b expression
vector, as described in Section 2.8.3.3. The ligation mix was initially transformed
(Section 2.8.7.3) into competent (Section 2.8.3.6) XLl-Blue cells (Stratagene),
which lacks the gene for T7 RNA polymerase to allow examination of the construct
sequences. The pET construct was subsequently transformed into expression host
BL21 (DE3), which contains the T7 RNA gene, and was induced as described in
Section 2.8.4.
2.8.3.6 Preparation of competent cells
Competent BL21 (A DE3) and Epicurian Coli XL-1 Blue cells were prepared
using the following protocol. Glycerol stocks were streaked out onto agar plates
containing the appropriate antibiotic (tetracycline for XL-1 Blue and none for BL21
cells) and incubated at 37°C overnight. One colony was picked from each plate and
used to inoculate 10 ml of L-broth containing the appropriate antibiotic which was
then incubated in a shaking incubator overnight at 37°C. 1 ml of these overnight
cultures was added to 100 ml of L-broth plus antibiotic, pre-warmed to 37°C.
Cultures were incubated in a shaking incubator at 37°C until the absorbance at 600
nm, as measured on a Beckman DU-600 spectrophotometer, reached 0.4. After
cooling on ice, cultures were centrifuged at 1500 x g for 10 min. The resulting
pellet was resuspended in O.lx its original volume in ice cold transformation and
storage solution (TSS) (10% (w/v) polyethylene glycol (PEG) 8000 (BDH)/20 mM
MgCl2/ 5% (v/v) DMSO (Sigma)/L broth). The cells were stored at -70°C in 0.3-
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0.5 ml aliquots.
2.8.3.7 Transformation of competent cells
In this study, PCR inserts were ligated into pGEM-T and transformed into
XL-1 Blue for the purpose of propagation and storage. Restriction endonuclease
excised inserts were ligated into pET-22b (+) and transformed into XL-1 Blue for
the purpose of propagation and to allow examination of construct sequences, and
then transformed into BL21 (A.DE3) for transient expression.
50 pi of competent cells (Section 2.8.3.6), thawed on ice, were added to 2 (ll
ligation mixture (Section 2.8.3.3 and 2.8.3.5) and left on ice for 20 min. Cells were
transformed by heat shock at 42°C for exactly 45 seconds. Following heat shock,
transformation mixes were placed on ice for a further 2 min before 0.5 ml SOC
medium (2% (w/v) tryptone/0.5% (w/v) yeast extract/10 mM NaCl/2.5 mM KC1/10
mM MgC^/lO mM MgSO^OmM glucose) was added to each reaction. After
incubation for 1 h at 37°C, 50-200 pi of the reaction mixes were plated out on L-
agar plates containing ampicillin (50 pg/ml), tetracycline (30 (ig/ml), X-gal (5-
bromo-4-chloro-3-indoyl-(3-D-galactopyranoside) (Sigma) (80 (ig/ml) and IPTG
(isopropyl-thiogalactoside) (Sigma) (0.5 mM). IPTG and X-Gal were added for
blue white colour selection of recombinant colonies when plating out pGEM-
T/XLl-Blue transformants (No IPTG or X-Gal was added when plating out pET
transformants). pGEM-T contains a multiple cloning site in the a-peptide coding
region of the (3-galactosidase enzyme. When appropriate strains of E. coli are used,
insertional inactivation of the a-peptide allows recombinant clones to be directly
identified by colour screening on plates containing the lactose analogue X-gal and
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an inducer of the lac operon, IPTG. Non-recombinant colonies synthesise p-
galactosidase, which breaks down X-gal to a blue product resulting in blue colonies,
while the recombinant colonies synthesise an inactive form of the enzyme and
remain white. The plates were incubated at 37°C overnight. White colonies were
picked and inoculated into 10 ml of L-broth containing ampicillin and tetracycline
when selecting for XL-1 Blue recombinant colonies and ampicillin for BL21 (DE3)
colonies. The broths are then incubated in a shaking incubator at 37°C overnight.
2.8.3.8 Preparation of plasmid DNA
10 ml of overnight bacterial culture was centrifuged at 1500 x g for 10 min
at room temperature. Plasmid DNA was purified using a QIAprepTM kit (Qiagen),
according to manufacturers' guidelines. The QIAprep kit protocol is based on the
modified alkaline lysis method of Birnboim and Doly (1979) where bacterial cells
are lysed in NaOH/SDS lysis buffer. After neutralisation, chromosomal DNA is
precipitated by the addition of guanidine-HCl, the precipitate is pelleted by
centrifugation at 9,000 x g, the supernatant containing plasmid DNA is removed and
is adsorbed onto a silica-based gel by centrifugation in the presence of high salt and,
after washing, the plasmid DNA is eluted using TE buffer (10 mM Tris, pH8.0/l
mM EDTA).
2.8.3.9 Restriction endonuclease digestion of DNA
Restriction enzymes were purchased from Boehringer and MBI Fermantas
and used with appropriate incubation buffers, as recommended by the manufacturer.
Routinely, 10 U enzyme/pg DNA was used per reaction.
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2.8.4 Inclusion body preparation
BL21 (XDE3) cells transformed with recombinant MOMP from either OEA
C. psittaci or C. pneumoniae, in expression vector pET-22b (+) were picked from
agar plates and used to inoculate 10 ml L-broth containing ampicillin (lOOpg/ml).
Cultures were grown for approximately 2 h at 37°C and then centrifuged at 1500 x g
for 10 min. The supernatant was discarded and 400 ml of fresh L-broth containing
ampicillin (lOOpg/ml) was used to resuspend the resulting pellet. Again the culture
was incubated at 37°C until its absorbance at 600 nm, as measured on a Beckman
DU-600 spectrophotometer, reached 0.6-0.7. At this point, 1.5 ml of the culture
was removed and used as the 0 h control. IPTG (Boehringer) was added to the
remaining culture to a final concentration of 1 mM. The culture was incubated for a
further 3-3.5 h at 37°C, then centrifuged at 4,000 x g to harvest the cells. The cells
were washed in 100 ml PBS and centrifuged at 4,000 x g for 10 min. The resulting
pellet was resuspended in 100 ml TESL (0.25 M Tris, pH 8/1 M sucrose/50 mM
EDTA/24 mg ml"1 lysozyme (Sigma)) and incubated at room temperature for 15 min
before centrifugation at 12,000 x g. The pellet was then washed in 100 ml TES
(0.25 M Tris, pH 8/1 M sucrose/50 mM EDTA), centrifuged at 12,000 x g and the
resulting pellet was resuspended in 80 ml TE buffer. This suspension was sonicated
for 6 x 15 sec with 1 min intervals between bursts and then centrifuged at 7,000 x g
for 15 min. This pellet was then washed twice in 80 ml PBS, again centrifuged at
7,000 x g before the resulting pellet was resuspended in 1ml PBS.
Inclusion body-expressed MOMP was analysed by SDS-PAGE and prepared
for planar lipid bilayer incorporation (Section 2.10.1). 50 pi of inclusion body
protein, suspended in PBS, was centrifuged at 9,000 x g for 5 min. The supernatant
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was removed, the resulting pellet suspended in 2% (w/v) octyl glucoside/10 mM
DTT and incubated at 37°C for lh. Following incubation the sample was again
centrifuged at 9,000 x g for 5 min. The resulting supernatant was removed and
stored at -20°C, in 5 pi aliquots until use, for bilayer incorporation
2.8.5 In vitro cell-free coupled transcription/translation
The E. coli T7 S30 extract system for circular DNA (Promega) was used for
the coupled transcription/translation of a truncated MOMP construct, tMOMP. This
system simplifies the transcription/translation of DNA sequences cloned in plasmids
or X vectors containing a T7 promoter by providing an extract containing a T7
polymerase for transcription and all the necessary components for translation. This
kit is prepared using a modification of the method described by Yang et al. (1980).
Briefly, tMOMP DNA (<4 pg), prepared using a QIAprepTM pq as
described in Section 2.8.3.8, was incubated with an amino acid mixture, S30 pre-
mix without amino acids, T7 S30 extract and nuclease-free water in a final reaction
volume of 50 pi according to manufacturers' instructions (Promega). Reactions
were incubated at 37°C for 2 h and then placed on ice for 5 min. The PinPoint™
vector provided by the manufacturer was used as a control. Translated proteins
were detected using radioactive labelling by adding [35S] L-methionine
(l,2000Ci/mmole specific activity and concentration of 15 mCi/ml) to the reaction
mixture. Resulting proteins were analysed by SDS-PAGE, blotted onto
nitrocellulose membrane, which was used to expose x-ray film (Fuji) and developed
using a X-ograph Compact x 2 imager (X-ograph Imaging Systems, Malmesbury,
U.K.).
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2.9 Recombinant C. pneumoniae MOMP antibody production
2.9.1 Antigen preparation
The aqueous phase of the C. pneumoniae recombinant MOMP vaccine was
prepared as follows: Glutaraldehyde was added to the antigen suspension to a final
concentration of 0.01% (v/v), mixed well by vortexing and left at room temperature
for 30 min, with further vortexing at 5 min intervals for the first 15 min. The
inactivation of the antigen by glutaraldehyde was quenched by the addition of
sterile filtered glycine to a final concentration of 10 mM. This reaction mixture was
mixed thoroughly then incubated at 4°C for 5 min. Finally, Thimerosal (Sigma)
was added to this aqueous phase of the antigen to a final concentration of 0.01%
(v/v).
The aqueous phase of the antigen was mixed 70/30 (adjuvant/aqueous
phase) with the adjuvant Montanide ISA 773 (Seppic, Paris, France). Initially the
adjuvant was homogenised using the Ultra Turrax T25 homogeniser, with a S25 KG
probe, at 8,000 rpm. The aqueous phase was added to the adjuvant in 2-3 ml
aliquots while homogenising. To avoid overheating of the antigen mixture,
homogenisation was stopped every 10-20 sec for 10 sec. Once the entire aqueous
phase had been added to the adjuvant, the suspension was homogenised in 10 sec
bursts (with 10 sec pauses between bursts), through 6 cycles. This was repeated
with homogenisation at 9,000 rpm and finally 13,500 rpm, for 3 cycles. Sterility of
the emulsified antigen was checked by streaking out on agar plates (in the absence
of antibiotics), incubating at 37°C and monitoring for bacterial growth. The antigen
was stored at 4°C until inoculation.
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2.9.2 Antiserum production
Animals (3 x rabbits, plus 3 x guinea pigs) were injected subcutaneously
with purified recombinant C. pneumoniae MOMP (Section 2.8.4) (100 pg per dose)
prepared with adjuvant Montanide ISA 773. Animals were immunised twice, 3
weeks apart, and each dose was administered at 2 different sites (inoculation
volume did not exceed 0.25 ml). Intra venous blood samples were taken before the
first inoculation. At 3 week post final vaccination animals were anaesthetised using
Halothane with NO2 and O2 and bled out. Sera was prepared by allowing samples to
clot overnight at 4°C before centrifugation at 3,000 x g for 20 min. The serum was
then removed and stored in aliquots at -20°C.
2.10 Planar lipid bilayer reconstitution and channel analysis
2.10.1 MOMP bilayer reconstitution
MOMP was incorporated into 0.3 mm diameter lipid bilayers cast at room
temperature from a 30 mg/ml decane suspension of diphytanoyl phosphatidylcholine
(Avanti Polar Lipids, AL, USA) using equipment and techniques similar to those
described by Williams (1995) and depicted in Figure 1.1. Briefly, a small amount
of lipid (~1 pi) was drawn across a 300pm hole in a polystyrene partition separating
two solution-filled chambers (600pl) which were designated "cis" and "trans" .
Bilayers formed spontaneously as observed by monitoring the increase in membrane
capacitance which accompanied thinning. The bilayer capacitance was measured
using a triangle waveform pulse of 100 Hz at 100 mV. The "cis" side of the bilayer
was voltage clamped at a potential relative to the "trans" side using a Biologic RK-
300 patch clamp amplifier (Intracel, Royston, U.K.). The relative potential applied
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Figure 2.1 Schematic representation of the planar lipid bilayer set-up.
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across the bilayer was termed the "holding potential" or "voltage clamp potential".
Transmembrane currents were low-pass filtered (10 kHz, 8-pole Bessel filter) and
digitally recorded. All the bilayers used had a conductance of <10 pS and a
capacitance of >250 pS. Bilayers of this size have a relatively large capacitance.
When large changes are made to the holding potential (eg: switching from 0 mV to
+/- 80 mV) the bilayer momentarily becomes charged, and the charge then
dissipates almost immediately to give rise to an exponentially-decaying current
transient. This is referred to as the "bilayer capacitative current transient" and is
superimposed on channel recordings made immediately after large changes in the
holding potential, giving them a characteristic "curved" appearance.
To incorporate channels, purified detergent-solubilised native MOMP
(Section 2.4.1), or detergent-solubilised recombinant MOMP (Section 2.8.4), was
added to the cis chamber to a final concentration of 1 ng/ml, in the presence of a salt
gradient, 250 mM KC1 cis versus 50 mM KC1 trans (buffered with 10 mM Tris-
HC1, pH 7.4). The solutions bathing the bilayer were changed by perfusion (at least
10 volumes) as required. Opening and closing of the ion channel gave rise to square
shaped pulses of current which are termed "unit currents". Membrane current and
holding (voltage clamp) potentials are displayed according to a standard convention,
quoting the holding (clamp) potential in the cis chamber, with positive
transmembrane (upgoing) currents representing a net flux of cations flowing cis to
trans, or a net flux of anions flowing in the opposite direction.
2.10.2 Channel analysis
Channel recordings were post-filtered (see Figure Legends) to reduce high
frequency noise and analysed using the program pClamp 6 (Axon Instruments, CA,
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USA). In the presence of a salt gradient either side of the bilayer, the reversal
potential is defined as the holding potential that exactly balances the tendency for
ions to diffuse down their chemical concentration gradient. Relative ionic
permeabilities were calculated from measured reversal potentials using appropriate
forms of the Goldman-Hodgkin-Katz (GHK) equation. Briefly, with the same
monovalent salt in both chambers.
Er = -RT/zF.ln(Pc[C], + Pa[A]c/Pc[C]c + Pa[A],)
where Er is the reversal potential, P is permeability, A and C are the anion and
cation, and c and t represent cis and trans, respectively. R is the gas constant, T is
room temperature, z is valency and F is the Faraday constant. Concentrations were
corrected for ionic activities using activity coefficients obtained from standard
tables.
2.10.3 Additions to bilayer solutions
2.10.3.1 Monoclonal antibodies. Antibodies (Table 1) (final dilution of 1/1000) in
50 mM KC1, 10 mM Tris-HCl, pH 7.4 and 1 mg/ml BSA were added to both the cis
and trans chambers. MOMP channel activity, in the presence of antibodies, was
observed and recorded for a minimum of 15 min.
2.10.3.2 Oxidising agents. 10-500 mM Cu2+-phenanthroline (Boehringer), hydrogen
peroxide (Sigma) or oxidised glutathione (Sigma) in 50 mM KC1, 10 mM Tris-HCl,
pH 7.4 were added to the cis and trans chambers. Channel activity in bilayers
bathed in these buffers were monitored over a period of at least 30 min.
2.10.3.3 ATP. ATP was added to the bilayer in the form of 10 mM Na+-ATP
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(Boehringer), 10 mM Tris-HCl, pH 7.4 in both the cis and the trans chambers.
More concentrated solutions were achieved by the addition of Na+-ATP to the
chambers from a concentrated stock solution. For multivalent ATP4" ion in the
presence of Na+, the theoretical Er for a ATP4" selective channel was estimated from
the Nerst equation. The activity ratio of 100 mM Na+-ATP: 10 mM Na+-ATP was
measured using the Na+ ionophore gramicidin (Gennis, 1989).
2.11 Heparin/Heparan sulphate studies
2.11.1 Heparin titration
McCoy cell monolayers were established in 7 ml vials, containing glass
coverslips, by seeding at 2 x 1CP cells/ml in cell culture medium (Section 2.1) and
incubating at 37°C for 24 h. Cell culture medium was then aspirated and cell
monolayers were incubated in fresh medium containing a 10~4 dilution of C.
psittaci inoculum and 0-500 U/ml of heparin (sodium salt from ovine intestinal
mucosa) (Sigma) for 1 h at 37°C. Following this incubation, cell culture medium
was again aspirated, cell monolayers were washed with 3 x 1 ml PBS and incubated
with fresh culture medium for 3 days at 37°C. Infected cell monolayers on plastic
coverslips were then removed from culture medium, fixed and stained using the
Giemsa method (Section 2.11.3). Coverslips were then mounted on glass slides and
counted to determine the number of inclusion bodies. Each experiment was carried
out in triplicate.
2.11.2 Heparitinase treatment of C. psittaci OEA isolate EBs
5 x 10^ inclusion forming units/ml of the OEA isolate of C. psittaci were
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incubated in 0-2.0 U/ml heparitinase IE (Sigma) in PBS containing 0.1 mM
phenylmethylsulfonyl fluoride (PMSF) for 1 h at 37°C. Following heparitinase
treatment the chlamydiae were washed by centrifugation (9000 x g, 10 min) in 2 x 1
ml PBS and resuspended in 1 ml of cell culture medium. McCoy cell monolayers in
cell culture medium, as described above, were incubated at 37°C for 3 days.
Infected cell monolayers, on glass coverslips, were harvested, fixed, stained and
counted as described in Section 2.11.3.
2.11.3 Fixing and Giemsa staining of infected cell coverslips
Infected cell monolayers on plastic coverslips were removed from culture
medium and fixed by incubation in 100% (v/v) methanol (Fisons) for at least 5 min.
The coverslips were then immersed in 5% (v/v) Giemsa stain (BDH) for 20 min.
The Giemsa-stained coverslips were then washed for approximately 30 sec in water.
Following washing, the coverslips were immersed for 30 sec in the following
solutions: 100% (v/v) acetone (Fisons); 65% (v/v) acetone/35% (v/v) xylene
(Fisons); 50% (v/v) acetone/50% (v/v) xylene; 35% (v/v) acetone/65% (v/v) xylene;
and 100% (v/v) xylene. Stained coverslips were mounted onto glass slides using
DPX mountant (BDH) and left to dry at room temperature for lh. Inclusion bodies
present on infected coverslips were counted using bright field illumination at a
magnification of x 400.
2.11.4 Binding of [-^S] heparin to non-denatured MOMP
MOMP solubilised in OG-DTT was run on a SDS-PAGE gel under non-
denaturing conditions, as described in Section 2.2. Protein was transferred onto
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nitrocellulose membranes. Non-specific binding sites on membranes were blocked
by a 3 h incubation in PBS containing one of the following: 5% marvel/0.05%
Tween 20; 0.5% Tween 20/5% marvel; 0.1% gelatin/0.5% Tween 20; 0.1%
gelatin/0.05% Tween 20; and 1% polyethylene glycol (PEG). Membranes were
washed for 2 h in PBS with changes of wash buffer every 10 min and then incubated
in PBS containing 30mCi of [N - Sulphonate-35s]Heparin (Amersham) for 2 h.
Following this incubation, membranes were washed for 2 h in PBS, air-dried and









Despite many years of intensive study, the lack of structural information
leaves unanswered many questions as to how MOMP may fulfil its suggested
diverse functions (Bavoil et al., 1984; Su et al., 1990). Structural studies are
hampered firstly by the difficulty of growing chlamydiae in bulk and subsequently
by problems with purifying and solubilising a protein which is both highly
disulphide bond cross-linked (Newhall, 1987) and normally resides in a
hydrophobic environment. These factors have made it necessary to rely on analytical
techniques that require relatively small quantities of protein. In addition, due to the
extensive disulphide bond cross-linking present in MOMP, expression of
recombinant protein which refolds to achieve native conformation has been almost
impossible. The inability to refold recombinant MOMP, and the difficulties in
obtaining large quantities of purified native protein, suggest that x-ray
crystallography of MOMP is, at present, an unrealistic goal. However, reliable
preliminary structural information can be obtained using techniques, such as circular
dichroism, which require far less protein. Structural information may lead to the
establishment of a MOMP structural model which, in turn, will aid the development
of future MOMP-based vaccines.
The two primary goals of this project were (1) to gain structural information
for MOMP, using techniques such as CD and (2) to directly test the MOMP porin
hypothesis (Section 1.8.6) at the molecular level using the planar lipid bilayer
system. In both these cases maintaining the structural integrity of purified MOMP
was essential. Taking this into consideration suitable methods for purifying MOMP
had to be developed. The prohibitively small amounts of protein resulting from the
growth of chlamydiae in cell culture also limited the methods of purification which
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could be employed. Indeed, the techniques used for determination of structure and
function were not compatible with several traditional purification protocols. These
limitations prompted the adoption of many different, sometimes novel, techniques
in the search for the most successful method of MOMP purification.
3.2 Purification of MOMP
3.2.1 SDS-PAGE and immunoblot analysis of OG-DTT-solubilised MOMP
SDS-PAGE and immunoblotting analyses of the MOMP-enriched fraction
solubilised using OG-DTT illustrate the purity of the MOMP preparation used in
planar lipid bilayer analysis (Chapter 4). Silver staining of this sample identified a
38 kDa protein corresponding to the MOMP, as well as contaminant proteins of
approximately 90 kDa (Fig. 3.1). These contaminants were identified as the
OMP90 (formerly POMP) family, which has been previously described
(Longbottom et al., 1998b), by Western blot analysis with OMP90-specific
monoclonal antibodies (Fig. 3.2 [A]). Using the more sensitive Protogold protein
stain, Western blots of the OG-DTT fraction revealed more clearly the
contamination with OMP90 proteins, no other protein contaminants were visible
(Fig. 3.2 [B]). Western blots of the OG-DTT solubilised MOMP-enriched fraction
probed with mAbs specific for the oligomeric (All and 4/11, see Table 1) and
monomeric (4/11) forms of MOMP demonstrated that under relatively non-
denaturing conditions (MOMP is SDS-resistant if unboiled) MOMP is present as an
oligomer with an apparent molecular mass of 100 kDa (Fig. 3.3), and that the
MOMP-enriched fraction denatured by boiling gives rise to a 38 kDa monomer








Figure 3.1 SDS-PAGE analysis of OG-DTT-solubilised MOMP-enriched
preparations by silver staining. Molecular masses are indicated.
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Figure 3.2 Western blot analysis of OG-DTT-solubilised MOMP-enriched
preparations. The OG-DTT-solubilised MOMP-enriched preparation was subjected
to SDS-PAGE on 12.5 % gels, immunoblotted, and probed with (A) mAbs 181 and



















Figure 3.3 Western blot analysis of OG-DTT-solubilised MOMP-enriched
preparations. The OG-DTT-solubilised preparation was subjected to SDS-PAGE on
12.5% gels and probed using (A) mAb 4/11 (sample loaded without boiling, lane (a)
and sample loaded after boiling, lane (b)) and (B) mAb All (sample loaded without








Western blot analysis of OG-DTT solubilised MOMP probed with
monoclonal antibody 4/11 revealed an antigenic protein with a molecular weight of
approximately 36 kDa (Figure 3.3 A [lane b]). Despite a very strong reaction when
probed with 4/11, this protein was barely visible by Coomassie staining. N-terminal
amino acid sequencing of this protein did not result in a decipherable sequence. It
was hypothesised that this protein was the result of cleavage of the MOMP at a
putative acid-labile site (Appendix I), however, incubation of recombinant tMOMP
and electroeluted native MOMP in solutions with a pH as low as 2, to demonstrate
acid lability, did not result in the appearance of a similar protein.
3.2.2 Differential solubilisation of MOMP
An attempt was made to solubilise MOMP from chlamydial outer membrane
complexes using various detergents which it was hoped might improve the purity of
recovered MOMP. SDS-PAGE analysis of fractions solubilised in 2% (w/v)
solutions of the various detergents, as well as the resulting pellets, indicated that
MOMP could only be solubilised from COMCs by incubation in SDS or OG. The
presence of DTT was also found to be required for the solubilisation of MOMP.
With all other detergents MOMP was found in the pellet. Indeed, OG was only able
to solubilise MOMP at a critical concentration of 2% (w/v), at lower concentrations
MOMP was recovered in the pellet. As estimated by densitometry, the SDS
solubilised MOMP accounted for only 65% of the total protein content, while OG-
solubilised MOMP accounted for 80%. These detergent solubilised fractions were
found to contain many other contaminant proteins in addition to MOMP, as
observed by Coomassie staining.
89
3.2.3 Isoelectric focusing
Isoelectric focusing on precast polyacrylamide, non-denaturing IEF gels (pH
5-7) resulted in the focusing of OG-DTT solubilised MOMP between pH 5-6, as
estimated using standard pi markers, and visualised by silver staining (Fig. 3.4). In
addition, analysis of this OG-DTT solubilised MOMP by 2-D gel electrophoresis
(pH3-10) resulted in the focusing of MOMP at pH 5.5, again estimated using
standard markers. The OMP90 proteins, also present in the OG-DTT solubilised
sample, were not visably focused by either of these methods.
Preparative isoeloectric focusing, using the MinipHor protein fractionator,
was attempted to further purify MOMP from the OG-DTT solubilised fraction, on
the basis of pi. SDS-PAGE and Western blotting analyses of the fractions eluted
from the 0.8% pH 4-7 and 0.2% pH 3-10 gradient revealed that MOMP tightly
focused in fractions ranging from pH 5-6. The 90 kDa proteins appeared focused
over several fractions ranging from pH 4-7. Silver staining and Western blots
probed with mAbs 4/11 or 0040 and 181 (anti-OMP90 proteins, see Table 1) were
used to visualise eluted protein. However, recovery of focused MOMP was only
45% and so this protocol was not used routinely for purification.
3.2.4 Electroelution
SDS-PAGE and immunoblot analysis of the MOMP-enriched fraction
solubilised using OG-DTT under relatively non-denaturing conditions (Section 2.2),
*
revealed a 100 kDa band which reacted with anti-MOMP mAb 4/11. This band was
successfully electroeluted, resulting in an eluted MOMP concentration of
approximately 0.03 mg/ml. The recovery rate was estimated at 60 %. Using the







Figure 3.4 Isoelectric focusing of OG-DTT-solubilised MOMP-enriched
preparations. OG-DTT-solubilised MOMP was focused on a pre-cast 5% (w/v)
polyacrylamide, non-denaturing gel with an ampholyte range of pH 3-10and silver
stained, pi markers are indicated.
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fraction revealed no other protein contaminants. Electroeluted MOMP was used in
planar lipid bilayer studies (Chapter 4), however it could not be routinely
reconstituted in bilayers due to the presence of SDS in the sample.
3.2.5 Sucrose density gradient centrifugation
The pellet and 1 ml fractions resulting from the centrifugation of 0.1 ml
OG/DTT solubilised MOMP through a 5-20% (w/v) linear gradient of sucrose
(Section 2.4.2) were solubilised in Laemmli buffer and analysed by SDS-PAGE
(Fig. 3.5). Silver staining revealed that the pellet contained at least 80% MOMP, as
estimated by densitometry. MOMP was not present in the fractions of the sucrose
gradient. It was impossible to solubilise this MOMP-rich pellet by any other method
than boiling in Laemmli buffer. In an attempt to stop the pelleting of MOMP at the
base of the sucrose gradient, OG-DTT solubilised MOMP was centrifuged into a
60% (w/v) Nycodenz cushion. However, MOMP was again pelleted through this
cushion. The pelleting of MOMP through a sucrose gradient, and indeed through a
60% (w/v) Nycodenz cushion, illustrates its propensity to form high molecular
weight oligomers. Unfortunately, our inability to solubilise the MOMP-enriched
pellet, without boiling in SDS sample buffer, meant that this relatively pure sample
could not be used for structural analysis or planar lipid bilayer reconstitution
studies.
3.2.6 Hydroxyapatite chromatography
The most successful method for purifying native, conformational MOMP
was hydroxyapatite chromatography in the presence of SDS. Figure 3.6 shows the
silver stained SDS-PAGE analysis of fractions eluted from a hydroyapatite column
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Figure 3.5 SDS-PAGE analysis of fractions and pellet resulting from centrifugation
of OG-DTT-solubilised MOMP through a sucrose density gradient. OG-DTT-
solubilised MOMP was loaded onto a 5-20% (w/v) sucrose gradient and centrifuged
at 130,000 x g for 16 h. The resulting pellet and fractions were subjected to SDS-




21 22 23 24 25 30
FRACTIONS
Figure 3.6 SDS-PAGE analysis of the hydroxyapatite-purified MOMP-enriched
preparation. Fractions eluted from the hydroxyapatite column (5 by 1 cm) loaded
with the 2% (w/v) SDS-solubilised MOMP-enriched preparation were subjected to
SDS-PAGE on a 12.5% gel, under reducing conditions.
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under relatively 'non-denaturing' conditions (Section 2.4.5). Although fractions 20-
30 contained significant amounts of MOMP oligomer (100 kDa) only fractions 25-
30 contained very few contaminant proteins. MOMP oligomer accounted for >90%
of the hydroxyapatite purified protein therefore enabling structural analysis by CD
to be carried out (Section 3.3.2). Unfortunately, the protocol used to purify MOMP
for structural studies could not be employed during the purification of MOMP for
planar lipid bilayer analysis due to the destabilising effects of SDS on the bilayer.
Dialysis to remove SDS from hydroxyapatite purified fractions was not feasible
because of the small amounts of protein involved.
3.3 Structural analysis and characterisation of MOMP
3.3.1 Secondary structure prediction
Protein sequence analysis of MOMP from the OEA isolate of C. psittaci
using DNASTAR sequence analysis software prediction methods (Section 2.6.1)
produced conflicting results (Fig. 3.7). Garnier-Robson analysis (Gamier et al.,
1978) predicted the presence of substantial p-structure (42% P-sheet, 33% a-helix,
13% random coil and 12% p-turn). The Chou-Fasman alogarithm, based on the 64
protein method (Chou and Fasman, 1978) and predicting 80% accuracy in assigning
secondary structure, estimated that the structure of MOMP was predominantly a-
helix (56% a-helix, 30% p-sheet and 14% P-turn). Significantly both these
prediction alogarithms suggest the presence of large amounts of p-sheet structure




Figure 3.7 Secondary structure predictions of the OEA C. psittaci MOMP protein
sequence. Variable segments of the sequence are represented (VS).
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3.3.2 Secondary structure determination
Oligomeric MOMP, purified to >90% by hydroxyapatite chromatography
(Section 3.2.6), in the presence of SDS, achieved the criteria for accurate structural
analysis by CD. Fractions 25-30, which were eluted at a concentration of
approximately 0.3M sodium phosphate, were subjected to CD analysis in the far-
UV region (Price, 1996). The CD analysis of fraction 25, determined to have a
protein concentration of 0.053 mg/ml, as estimated by densitometry, is shown in
Figure 3.8. The spectrum of purified protein is consistent with the presence of a
large percentage of (3-structure, and prediction using the CONTIN procedure
(Provencher and Glockner, 1981) estimated 62 % +/- 10% (3-structure, 38% +/- 10%
random coil and a-helix at 0% +/- 1.8%.
CD in the far-UV region was also performed on a sample of OG-DTT
solubilised MOMP (results not shown), estimated to have a protein concentration of
0.1 mg/ml. MOMP comprised approximately 80% of the total protein content.
Secondary structure estimations, again calculated using the CONTIN procedure,
were: a-helix 47% +/-2.1%, (3 sheet 34% +/-2.5% and random coil 19% +/- 4.1%.
3.3.3 Association of LPS and MOMP oligomers
The close association between MOMP and LPS, demonstrated by cross-
linking studies (Birkelund et al., 1988), prompted us to look for the potential
association of LPS with the oligomeric form of MOMP. In the case of many
bacterial porins, oligomeric structure is thought to be stabilised, or even maintained,
by a close association with a LPS moiety. This may also be the case with MOMP.
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Figure 3.8 Circular dichroism spectra of hydroxyapatite-purified MOMP and








Figure 3.9 Western blot analysis of the OG-DTT-solubilised MOMP-enriched
preparation. The OG-DTT-solubilised MOMP-enriched preparation was subjected
















Figure 3.10 Western blotting transfer properties of oligomeric and monomeric
MOMP. OG-DTT-solubilised MOMP was subjected to SDS-PAGE on 12.5% gels,
transferred similtaneously onto two PVDF membranes (A and B), and probed with
mAb 4/11 (samples a and c loaded without boiling, sample b loaded after boiling
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transferred onto PVDF membrane under relatively non-denaturing conditions and
probed with an LPS-specific monoclonal antibody, 13/4, are shown in Figure 3.9.
No LPS was found to associate with oligomeric MOMP at 100 kDa, instead it
migrated in the dye front. Therefore, close association of LPS would not appear to
be essential in the maintenance of oligomeric assemblies of MOMP. However,
Western blot analysis of MOMP under non-denaturing conditions and probed with
MOMP-specific monoclonal antibody 4/11 (Fig. 3.3 A [lane b]) revealed the
continued presence of a small, but significant quantity of monomeric MOMP (38
kDa) in addition to oligomeric MOMP. It is conceivable that LPS migrating in the
dye front originates from these dissociated MOMP oligomers.
3.3.4 Western blotting transfer properties of oligomeric MOMP
An interesting observation was made during the transfer of non-denatured
and denatured MOMP onto PVDF membranes by overnight wet blotting (Section
2.3.2). Two membranes were placed in the blotting sandwich and the transfer of
both monomer and oligomer onto these membranes was monitored by probing with
MOMP-specific mAb, 4/11 (Fig. 3.10). Interestingly, the 100 kDa oligomer was
observed to transfer straight through the first membrane onto the second upon
immunoblotting. In contrast, monomeric MOMP was only detectable on the first
membrane.
3.4 Discussion
As discussed previously (Section 3.1), the purification of MOMP for
structural and functional analyses is limited by the requirement to maintain native
structure and by the inability to refold this highly disulphide bond crosslinked,
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hydrophobic protein to native conformation. Perhaps the most common method of
obtaining enriched preparations of native MOMP is via solubilisation of chlamydial
outer membrane complexes using OG-DTT (Bavoil et al., 1984). These highly
enriched MOMP preparations are, however, contaminated by the OMP90 family of
proteins which have recently been localised to the chlamydial outer membrane
(Longbottom et al., 1998a). The yield of MOMP from this protocol can often be
poor, with large quantities of MOMP being lost in the sarkosyl/DTT solubilisation
step. This may be attributed to a high ratio of RBs/EBs in the tissue culture harvest.
MOMP is not highly disulphide bond cross-linked in the RB developmental form
and sarkosyl/DTT may be sufficient to solubilise the majority of this MOMP, in
addition to a vast number of other membrane associated proteins. SDS-PAGE and
Western blotting analyses of the OG-DTT-solubilised sample confirm that under
relatively 'non-denaturing' conditions, MOMP forms a 100 kDa oligomer.
However, the determination of molecular weight under these conditions is
unreliable. Indeed, the term SDS-resistant, applied to proteins apparently forming
high molecular mass oligomers in the absence of boiling in SDS sample buffer, is
misleading. It may be the case that such proteins are not 'fully' denatured in the
presence of SDS and the resulting mis-folded proteins appear as high molecular
weight oligomers upon SDS-PAGE. However, in the case of MOMP, there is
supplimentary evidence suggesting that it spontaneously forms oligomeric
structures, most probably trimers. The results of sucrose density gradient
centrifugation by McCafferty et al. (1995) determined that MOMP had a
sedimentation coefficient equivalent to that of porin proteins which have had their
trimeric structure confirmed by x-ray crystallography (Cowan, et al., 1992; Schulz,
1996).
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The propensity of MOMP to form high molecular weight oligomers was
further illustrated by the pelleting of OG-DTT solubilised MOMP following
centrifugation through a 5-20% (w/v) sucrose density gradient. This technique was
used as an attempted method of MOMP purification and was successful in that the
recovered pellet contained >90% MOMP. However, the pellet could not be re-
solubilised in a form that would maintain structural information and therefore could
not be used in the pursuit of the two main aims of structural analysis by CD and
planar lipid bilayer reconstitution.
The Western blotting transfer properties of the oligomeric and monomeric
forms of MOMP are markedly different. The high molecular weight oligomer
transfers through PVDF membrane much more rapidly than the 38 kDa monomer.
This observation may be explained by the increased number of exposed
hydrophobic regions in the denatured protein in comparison to the more folded
oligomer.
Immunoblotting of OG-DTT solubilised MOMP with the MOMP-specific
mAb 4/11 revealed strong reactivity with a 36 kDa protein. Analysis of the MOMP
primary sequence revealed the presence of a putative N-terminal acid-labile site.
Mild acidic conditions are known to cause hydrolysis of polypeptides at sites distal
to Asp-Pro residues (Landon, 1977) and it was hypothesised that this highly
immunogenic protein resulted from such a reaction in MOMP. Should this have
been the case, it would have posed interesting questions as to the possibility of this
cleavage reaction taking place in the mildly acidic environment of the inclusion
body. Would this Asp-Pro site be sufficiently exposed in the folded protein to allow
the cleavage reaction to take place? If so, what would be the effect of such a
reaction on the conformation of MOMP and what would be the physiological
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implications? In an attempt to begin answering some of these questions the 36 kDa
protein was N-terminally sequenced to ascertain if the protein was, indeed, cleaved
at the Asp-Pro site. Unfortunately, no decipherable sequence could be obtained. In
addition, incubation of recombinant MOMP in acidic conditions did not result in
cleavage suggesting that the highly immunogenic protein does not result from acid
hydrolysis. Alternatively, it may be the case that the 36 kDa protein results from the
aberrant folding of MOMP which has not been entirely denatured by boiling in SDS
sample buffer. Mis-folding may have further exposed the site recognised by 4/11
explaining the strong reaction of this mAb upon immunoblotting.
CD analysis of hydroxyapatite-purified MOMP confirmed the presence of a
large proportion of p-structure (62%) (Provencher and Glockner, 1981), as
suggested by secondary structure prediction alogarithms (Section 3.3.1). This level
of p-structure is very similar to that observed in gram negative bacterial porin
proteins. Several porins have been crystallised and subjected to x-ray diffraction
leading to the development of a generalised porin structural model which may be
applicable to MOMP (Cowan et al., 1992). Each porin subunit is thought to consist
of 16 transmembraneous P strands with lengths ranging from 6 to 17 residues. The
16 strands form a completely anti-parallel P barrel, in which all strands are
connected to their neighbours. These porin subunits associate to form a trimer of p
barrels giving rise to three distinct diffusion channels through the outer membrane.
Whether or not this model can be applied to MOMP remains to be seen. The only
previously described model depicting a possible structural arrangement of MOMP
in the outer membrane was proposed by Baehr et al. (1988). Using information
from immuno-mapping and proteolytic digestion studies, they suggested that
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MOMP is arranged as 8 anti-parallel transmembrane spanning regions across the
membrane with the 4 VS forming surface exposed loops. Clearly this arrangement
of MOMP is unfeasible. In this model the predicted transmembrane spanning
regions range from approximately 28 to 51 residues in length. Even if a
transmembrane (3-sheet was angled in relation to the plane of the membrane, it
would be extremely unlikely to reach such lengths. Indeed, the length of these
proposed membrane spanning regions would also exceed the number of residues
required to form a transmembrane a-helix (20-25 residues). The generalised 16
strand anti-parallel (3-sheet model of the porin proteins has been mapped onto the
MOMP sequence and is discussed in greater detail in Chapter 7. The relatively high
proportion of random coil, calculated from the MOMP spectrum, may be attributed




PLANAR LIPID BILAYER RECONSTITUTION OF NATIVE
MOMP FROM THE PEA SUBTYPE OF CHLAMYDIA PSITTACI
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4.1 Introduction
The 40 kDa MOMP is a common component of all 4 species of Chlamydia
and is present in both the EB and RB developmental forms. MOMP has been
studied in great detail since the landmark discovery that the protein, recovered from
SDS gels, was capable of raising antibodies which could neutralise the infectivity of
C. trachomatis in vitro (Caldwell and Perry, 1982). Vaccine preparations based on
chlamydial outer membrane complexes, highly enriched for MOMP in its native
form, have been shown to be protective against chlamydial disease in sheep (Tan et
al., 1990), guinea pigs (Batteiger et al., 1993) and mice (de Sa et al., 1995; Pal et
al., 1997). Most recently, protection in mice was demonstrated using a DNA
vaccine comprising only the MOMP gene (Zhang et al., 1997). Clearly, these
results make MOMP the primary candidate for a sub-unit vaccine against
chlamydial infection.
Despite the understandable interest in MOMP, resulting in many years of
intensive study, there has yet to be a definitive functional assignment to this protein.
As discussed in Section 3.1, problems purifying native chlamydial MOMP or
obtaining recombinant MOMP in a native form have hampered the study of a
structure/function studies. However, MOMP has been implicated in many aspects
of chlamydial pathogenesis and has been suggested to be multifunctional. Its
predominance in the outer membrane of Chlamydia (>60% of the total protein
mass), has resulted in the investigation of MOMP's role in the infectious process
(Su et al., 1996). In addition, MOMP is believed to play a significant part in
maintaining the structural integrity of the outer membrane of the EB (Newhall and
Jones, 1983). The cysteine rich proteins of the chlamydial envelope, including
MOMP, are believed to form a disulphide bond crosslinked supramolecular
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structure, which may act as a functional replacement for the traditional
peptidoglycan S-layer (Hatch, 1996).
Bavoil et al. (1984) used the liposome swelling technique to demonstrate that
the chlamydial outer membrane contained pores and, due to its predominance in the
outer membrane, MOMP was proposed as the likely pore-forming protein. With
subsequent cloning and sequencing of the MOMP gene (Stephens et al., 1986), it
became clear that MOMP has an acidic isoelectric point and charge distribution
appropriate to a porin protein. Sequence comparisons of MOMP from different
serovars combined with immunochemical analysis have identified variable surface
exposed segments of the molecule similar to those found in other porins. More
recently, MOMP solubilised in OG-DTT was shown to form an oligomer, with
electrophoretic and sedimentation properties consistent with a trimeric structure
(McCafferty et al, 1995). These oligomers resisted complete denaturation with
SDS in a way similar to classical gram-negative porin molecules, which are also
trimers. The primary aim of this study was to carry out a direct test of the 'porin
channel' hypothesis at the molecular level by reconstitution of native, oligomeric
MOMP into the planar lipid bilayer system.
4.2 Planar lipid bilayer analysis of MOMP
4.2.1 Planar lipid bilayer reconstitution
OG-DTT solubilised MOMP (Fig. 3.1) incorporated spontaneously into
planar lipid bilayers within 5-10 min of addition, to give rise to ion channel-like unit
currents. The process of insertion was unaffected by the presence of a positive or
negative holding potential. Bilayers were cast primarily from a decane suspension
of diphytanoyl phosphatidylcholine (chosen because it is a very robust bilayer lipid),
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however, MOMP bilayer incorporation was unchanged when alternative lipids were
used. The resulting unit currents were not seen at 0 mV, despite the presence of an
ion gradient (250 mM KC1 versus 50 mM KC1, see Section 2.10.1). This suggested
that channel opening was a voltage-dependent process. Channel incorporation into
the bilayer appeared to be autocatalytic, in that the rate of incorporation accelerated
markedly following the initial appearance of unit currents. After the first evidence
of channel incorporation, the solution in the cis chamber was changed by perfusion
to prevent further MOMP bilayer fusion, effectively limiting the channel content of
the bilayer. Finally, it was confirmed that the addition of equivalent amounts of
OG-DTT alone had no effect.
Figure 4.1 shows bilayer traces, with the same solutions on both the cis and
trans side of a bilayer that had been exposed to OG-DTT solubilised MOMP. The
data were obtained by switching the holding potential from 0 mV to either +80 mV
or -80 mV as indicated. Bursts of channel openings are superimposed on bilayer
capacitative transients (Section 2.10.1). These bursts of opening are typical, with
unresolvably-fast activation of multiple unit conductances. Following this burst of
activation, the maintainence of high holding potentials resulted in the voltage-
dependent closure of the activated channels. This inactivation process was
repeatedly shown to be asymmetric between positive versus negative holding
potentials, suggesting the unit channels had a common functional (and therefore,
presumably, a defined structural) orientation. Normally, the appearances on
switching were similar to those shown in Figure 4.1, with more open/closed
transitions at negative compared to positive potentials, but in some experiments all








Figure 4.1 Ion channel recordings from OG-DTT-soIubilised MOMP in a bilayer
bathed in 50 mM KC1-10 mM Tris-HCl (pH7.4). (A) Holding potential switched
from 0 to +80 mV. (B) Holding potential switched from 0 to -80 mV. Recordings
were low-pass filtered at 100 Hz and show decaying capacitative transients
representing the discharge of the typically large bilayer capacitance transient (-300
pF).
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bursts of activity seen after switching to negative holding potentials normally
contained more unit currents than those seen at positive potentials. Channel
openings elicited by switching to positive holding potentials declined to a "steady-
state" equilibrium level of activity more rapidly than bursts elicited by switching to
negative holding potentials. The use of a robust bilayer lipid enabled membrane
potentials to be clamped as high as +/- 200 mV without breakage, however, the
maximum number of unit currents generally appeared to occur at +/- 60 mV or
above.
4.2.2 Identification of MOMP as the channel forming protein
Two types of experiment confirmed that MOMP was the channel-forming
protein within the OG-DTT solubilised sample. Firstly, identical channel behaviour
(and an identical rate of channel incorporation) was obtained using similar
quantities of MOMP that had been highly-purified, either by hydroxyapatite
chromatography (Section 3.2.6), or by excision and electroelution from SDS-PAGE
gels (Section 3.2.4), as seen with OG-DTT solubilised MOMP. The hydroxyapatite
purified sample (Fig. 3.6) was known to contain >90% MOMP, while MOMP
constituted 100% of the total protein content of the electroeluted sample (both
estimated by densitometry). Reconstitution of these MOMP samples into the
bilayer resulted in the appearance of unit channels identical in amplitude and
behaviour to those observed upon incorporation of the OG-DTT solubilised sample.
Switching holding potentials from 0 mV to +/- 80 mV caused the same unresolvably
fast activation of multiple unit conductances followed by successive, voltage-
dependent channel closure. Unfortunately, these highly purified samples of MOMP
could not be reconstituted into the bilayer routinely, as both contained SDS, which
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Figure 4.2 Effects of mAb A11 on the MOMP channel. The bilayer was bathed in
50 mM KC1-10 mM Tris-HCl (pH7.4): mAb All was added to both the cis and
trans chambers to a final dilution of 1/1000 in the presence of BSA (lmg/ml). (A)
Traces obtained after switching the holding potential from 0 to -80 mV before (left)
and 30 min after (right) the addition of mAb All. In each record, there is a typical
bilayer capacitative current transient superimposed on channel openings. (B)
Detailed appearance of an individual unit current before (left) and after (right) the
addition of A11. The dotted line represents the baseline level, corresponding to the















destabilises the bilayer. It was not possible to remove SDS from these fractions by
dialysis due to the prohibitively small amounts of protein involved.
Secondly, addition of a MOMP-specific monoclonal antibody, All (Table
1), affected both the open/closed transitions of the channel and the amplitude of the
unit currents (Fig. 4.2). Note that channels did not close completely in the presence
of All. These effects could not be reversed by perfusion with antibody-free
solutions over periods up to 30 min. Monoclonal antibody All is oligomer specific
in that it recognises only the oligomeric form of MOMP, not the denatured
monomer, by Western blotting analyses. Not only do these results confirm that
MOMP is the pore-forming protein of chlamydial outer membranes, they also
suggest that MOMP is arranged as an oligomer within the bilayer, consistent with
the proposed arrangement of MOMP in the outer membrane. Interestingly, the
addition of antibody 4/11 to bilayers containing OG-DTT solubilised MOMP had no
observable effect on the behaviour or amplitude of the resulting unit conductances.
MAbs 181 and 0040 (Table 1), specific to the C. psittaci OMP90 family of proteins
which are the main contaminants within the OG-DTT solubilised sample (Fig. 3.2),
had no observable effect on the characteristics of the unit currents. Additions of
other mAbs or 1 mg/ml BSA were also without effect (results not shown).
4.2.3 Properties of unit MOMP channels
Given that native MOMP tends to migrate as an oligomer, presumably a
trimer, under relatively non-denaturing conditions on SDS-PAGE, and knowing that
many classical porins are trimers, we measured the number of functional unit
currents that could be obtained following bilayer reconstitution of OG-DTT
solubilised MOMP. These individual conducting units of the channel (eg. levels 1,
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Figure 4.3 Continuous 40 s recording of MOMP channel activity in a bilayer bathed
in 100 mM KC1-10 mM Tris-HCl (pH7.4) (holding potential -70 mV, filtered at 200
Hz). The closed level of the channel (0) and three open levels (1, 2 and 3) are
indicated.
Figure 4.4 Amplitude histogram analysis of the 40 s continuous channel; recording




















































Number of Unitary Events
Figure 4.5 The maximum number of unit open levels counted in 25 individual
experiments.
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2 and 3 in Fig. 4.3) were identified and recorded while the channel was in "steady-
state". Analysis by all-points amplitude histogram of individual channels
consistently revealed three equally-spaced unit conductances (Fig. 4.4), suggesting
the presence of a "triple barrelled" structural arrangement. The number of unit
currents were counted in 25 independent experiments in which incorporated
channels were maximally-activated by switching between +120 and -120 mV. The
number of discrete individual conducting units are summarised in Figure 4.5 and
were, invariably, grouped in multiples of three, lending weight to the 'triple barrel'
hypothesis.
Unit currents were measured by amplitude histogram analysis (pClamp 6) to
construct open channel current-voltage (I/V) relationships in symmetrical KC1 (the
same concentration in both the cis and trans chambers) (Fig. 4.6). These were all
linear, the slope conductances were 120 +/- 18 pS, 210 +/- 25 pS and 310 +/- 32 pS
in 50, 150 and 300 mM KC1, respectively (mean +/-SD, n = 4). The plotting of
slope conductances versus ionic activities of KC1, resulted in a linear relationship
which appeared to rectify at much higher ionic concentrations (Fig. 4.7). Channel
recordings in concentrations of KC1 above 500 mM, in order to further investigate
the rectification of MOMP channel conductance, were not possible due to the
immeasurably high unit currents of channels in these ionic concentrations.
Careful inspection of the data revealed that MOMP channel closure was
incomplete, with a residual conductance equivalent to approximately 5% of the
fully-open state. In several MOMP channel recordings subconductance states were
also observed (Fig. 4.8). These substates were markedly noisier than the fully open
channel indicating unresolvably fast switching between states. However, substates,
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Figure 4.6 Current-voltage relationship of MOMP channels in symmetrical
concentrations of KC1 (each buffered with 10 mM Tris-HCl (pH7.4)). KC1
concentrations are 300 mM (a), 150 mM (o) and 50 mM (•). Error bars represent
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Figure 4.7 Analysis of C. psittaci MOMP channel slope conductance. Error bars
represent +/- standard error of the mean for four independent experiments.
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Figure 4.8 Illustration of C. psittaci MOMP channel subconductance states. The
bilayer was bathed in 50 mM KC1-10 mM Tris-HCl (pH7.4) and the holding
potential was -100 mV. This recording was low-pass filtered at 100 Hz. Channel
closed level denoted by solid line and SI-4 indicates subconductance states.
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Analysis of unit MOMP channels routinely takes place in solutions buffered
with Tris-HCl to pH 7.4. These conditions are unlikely to mimic those experienced
by MOMP in the outer membrane of phagocytosed EBs. Indeed, Schramm et al.
(1996) directly measured the pH of C. trachomatis-containing vesicles and found
that, despite the absence of a dramatic vesicle acidification as might have been
expected, the pH of the vesicle did fall to 6. In view of these results, some channel
recordings were made in KC1 solutions buffered to pH 6. Both channel size ( Fig.
4.9) and frequency of open/closed transitions increased significantly in 50 mM KC1
(buffered with 10 mM Tris-HCl, pH 6.0). The amplitude of unit channels increased
on average by 35%, in comparison to channels recorded in KC1 buffered to pH 7.4.
4.2.4 Ion selectivity and permeability of MOMP channels
The relative anion versus cation permeability of reconstituted MOMP
channels was calculated from reversal potentials (Section 2.10.2) measured in 250
mM KC1 cis versus 50 mM KC1 trans. A reversal potential of +10 +/- 4 mV (mean
+/- SD, n = 4) (Fig. 4.10) indicated that the channel was weakly anion selective,
PC1/PK = 2.0 +/- 0.84 (mean +/- SD, n = 4). In addition, the channels were shown to
be permeable to ATP. In the presence of 100 mM NaATP cis versus 10 mM
NaATP trans, a mean reversal potential of -11 +/- 1.9 mV (mean +/- SD, n = 10
independent experiments) was obtained with a unit conductance of approximately
80 pS. The ratio of ionic activities 100 mM NaATP: 10 mM NaATP, measured
using the Na+ ionophore gramicidin (Gennis, 1989), was 4.5. This corresponds to a
theoretical reversal potential (calculated using an adaptation of the Nernst equation)
of -39 mV for a solely Na+ selecting channel and +10 mV for a solely ATP4"
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Figure 4.9 Current-voltage relationship of MOMP channels in 50 mM KC1 buffered
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Figure 4.10 Current-voltage relationship of MOMP channels in a bilayer bathed in
250 mM KC1 (cis) and 50 mM KC1 (trans), each buffered with 10 mM Tris-HCl
(pH7.4). Arrow indicates the reversal potential. Error bars represent +/- standard
error of the mean for four independent experiments.
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ATP transport.
4.2.5 In vitro oxidation of MOMP channels
In view of the results obtained by liposome swelling indicating that the
reduction of disulphide bonds was necessary to fully open pores within the
chlamydial membrane (Bavoil et al., 1984), we attempted to oxidise our fully open
MOMP channels and observe any effects on channel behaviour. However, in vitro
oxidation of bilayer incorporated MOMP using increasing amounts of hydrogen
peroxide, oxidised glutathione and Cu2+-phenanthroline had no observable effect on
any channel properties. It should be noted that continued channel activity was not
dependent on the presence of DTT within buffers bathing MOMP-containing
bilayers. Indeed, the addition of increasing amounts of DTT to solutions bathing
bilayers incorporating functional MOMP channels, had no observable effect on any
aspect of the channel characteristics.
4.3 Discussion
Using the technique of liposome swelling Bavoil et al. (1984).
demonstrated that outer membrane complexes of C. trachomatis contained water-
filled pores with an exclusion limit of 850-2250 Da. Due to its abundance in these
outer membrane preparations, it was postulated that MOMP was responsible, as a
'chlamydial porin'. This hypothesis is amply supported by both the structural and
functional results of this study.
The protocols used to purify MOMP for structural analysis (Section 3.3.2)
could not be employed during the purification of MOMP for routine reconstitution
experiments due to the destabilising effects of SDS (contained in both samples) on
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the bilayer. Unfortunately, dialysis to remove SDS from these highly purified
MOMP samples was not feasible because of the prohibitively small amounts of
protein involved. However, MOMP resulting from all these methods of
purification, formed SDS-resistant oligomers typical of classical gram-negative
porin proteins. Indeed, limited reconstitution of both these highly purified MOMP
fractions, into planar lipid bilayers, was attempted resulting in the appearance of
unit channels identical in amplitude and behaviour to those observed upon bilayer
incorporation of the OG-DTT solubilised sample. Not only do these results confirm
that MOMP is the channel forming protein of the OG-DTT sample, they also
suggest that LPS (not present in either of these highly purified MOMP fractions, as
confirmed by Western blotting) is not required to stabilise or maintain the
oligomeric structure of functional MOMP (Section 3.3.3). Subsequently, this has
also proven to be the case with the successful reconstitution of fully functional
native, recombinant MOMP channels in the absence of LPS (Chapter 5).
At a functional level, the insertion of MOMP into planar lipid bilayers
seemed to be autocatalytic, resembling that seen with other porins (Xu and
Colombini, 1996). It is possible that the correct insertion of one channel assisted
the correct orientation of other channel proteins, thereby accelerating subsequent
insertion. The preference shown by MOMP for a particular bilayer orientation was
demonstrated by the asymmetric response of the channel to holding potentials of
opposing polarity. Presumably this asymmetry of behaviour, also seen in other
porins, has a structural basis which, if known, may explain autocatalytic insertion.
The modification of channel amplitude and open/closed transitions by the
neutralising MOMP-specific mAb A11 was of particular significance. Not only did
this confirm that MOMP was the channel forming protein, it also reinforced the
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belief that MOMP is arranged as an oligomer in the bilayer. All only recognises
oligomeric MOMP as judged by Western blotting (McCafferty et al., 1995). This
posed the question - what is the minimal conducting unit of the MOMP channel?
From the results summarised in Figures 4.3 to 4.5 we suggest that each MOMP
molecule inserts into the bilayer as a trimer to give rise to 3 pores through the
membrane and, that switching to holding potentials of +/- 60 mV, and above,
promotes the opening of all 3 pores together. Thus, 2 MOMP trimers could give
rise to up to 6 pores with 6 unit currents. Voltage-dependent closure at maintained
high holding potentials meant that within a few seconds, the steady-state gating of
the channel resulted in only one or two "protochannels" in each trimer opening at
any one time. This type of "multibarrel" behaviour is common in porins (Nakae et
al., 1979), and a similar phenomenon has also been observed, and analysed in more
detail, in eukaryotic channel proteins (Hayman and Ashley, 1993; Clark et al.,
1997). It is somewhat surprising that mAb 4/11, which recognises both monomeric
and oligomeric MOMP, does not have an effect on channel properties. This
antibody is known to bind to the VSII of MOMP which is believed to form a surface
exposed loop. The significance of this result will be discussed more fully in
Chapter 7.
As demonstrated by Schramm et al. (1996), the pH of Chlamydia-laden
inclusions does not fall below 6 for up to 12 hours post infection. However, this
small drop in pH from 7 to 6 has been suggested to be sufficient to catalyse the
conversion of EBs to RBs. As MOMP is almost certain to function as a porin
within such an inclusion, properties of the MOMP channel were assessed in
equivalent acid conditions. Alteration of the buffer pH from 7.4 to 6.0 was
sufficient to increase unit current amplitude by an average of 35%. In addition,
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open/closed transitions occured more frequently. These results may be the result of
a re-arrangement of charged groups in the mouth of the MOMP channel due to the
increased environment of H+. Indeed, they suggest that MOMP only becomes fully
open within the mildly acidified inclusion.
What ions and metabolites would be translocated across the chlamydial
outer membrane by a MOMP porin? Previously, Chlamydia were thought to require
host-derived nucleotide triphosphates as an energy source and precursor of RNA
synthesis, prompting us to look at their transfer across the bilayer. The reversal
potential of -11 mV observed in asymmetric concentrations of NaATP corresponded
to the passage of substantial amounts of ATP across the bilayer. If the MOMP
channel was Na+-selective, allowing only the passage of Na+, we would
theoretically expect to see a reversal potential of -39 mV, alternatively if the
channel was only allowing the passage of ATP4" across the bilayer, a reversal
potential of +10 mV would be observed. Therefore a reversal potential of -11 mV
demonstrates the passage of both Na+ and ATP4" through the MOMP channel. The
identification of a route by which Chlamydia can take advantage of host nucleotide
triphosphates and other nutrients may also explain why antibodies specific to
MOMP neutralise infection. However, it now appears unlikely that Chlamydia
derive all their ATP from the host cell with the identification of genes encoding
ATP biosynthetic pathways by the Chlamydia Genome Sequencing Project
(Stephens et al., 1998). It may be the case that chlamydiae require host-derived
nucleotide triphosphates to kick start their own metabolism, alternatively, in times
of nutrient stress within the host cell the bacteria may then resort to the synthesis of
its own ATP. This area needs further investigation.
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In the EB, outer membrane proteins are disulphide bond cross-linked,
rendering the outer membrane largely impermeable. The transition into the
intracellular RB is coupled with a reduction of outer membrane disulphide bonds,
increasing membrane permeability. It is clear that MOMP's pore forming activity
would be primarily utilised at the RB stage of the chlamydial lifecycle. Bavoil et al.
(1984) proposed that the reduction of outer membrane disulphide bonds "opened"
chlamydial pores, allowing the uptake of ATP and other nutrients. Evidence
supporting this hypothesis included activation of the pores by treatment with DTT,
and the blocking of re-oxidation with iodoacetamide. Chemical modification was
not required to maintain functional 'open' channels from the OG-DTT-solubilised
MOMP. We also noted that we could not re-oxidise the putative free SH groups of
bilayer incorporated MOMP to close or inactivate the channels (mimicking the EB
to RB transition). However, the re-oxidation of disulphide bonds in the correct
pairings to close the channel may require the presence of other proteins, such as the
cysteine rich proteins absent from the OG-DTT-solubilised sample.
In this study we have shown that MOMP functions as a porin, and have
demonstrated a possible physiological function with the passage of nucleotide
triphosphates through the channel. A particularly significant aspect of the work is
that it provides a measurable criterion by which to assess recombinant MOMP for
native function (Chapter 5). These results have broad implications on the search for
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Due to the difficulties and expense inherent in the production of large
amounts of chlamydial antigen, the best approaches to vaccine development rely on
the production of recombinant antigen. In particular, research into the design of
MOMP sub-unit vaccines has been based on the use of highly immunogenic
oligopeptides and cloned recombinant fragments (Su and Caldwell, 1992; Murdin et
al., 1993; Zhong et al., 1994). The success of these vaccines has been disappointing,
perhaps because these immunogens do not induce protective cellular and humoral
immune responses elicited by natural infection with the organism. This suggests
that a successful vaccine may need conformational information in order to elicit a
long-lasting protective immune response.
Unfortunately, previous attempts to express functional, native MOMP in
heterologous expression systems have failed. Gram-negative bacteria such as E.
coli synthesise OMPs within the cytoplasm as precursor proteins with N-terminal
signal sequences. These precursor proteins are then translocated across the bacterial
inner membrane where the signal sequence is cleaved and are then sorted to the
outer membrane by one of two proposed pathways. The OMPs may be directly
inserted into the outer membrane via contact points between the two membranes
(Bayer et al., 1982). Alternatively, with the aid of periplasmic molecular
chaperones, OMPs may form folded intermediates within the periplasm before
being inserted into the outer membrane (Nikaido, 1994; Tommassen and de Cock,
1995). Almost without exception, recombinant MOMP expression results in protein
accumulating in the E. coli periplasm as an inclusion body. The exact reason for
this is unknown. Chlamydial signal sequences may not be recognised by E. coli and
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therefore signal sequence cleavage, following translocation across the inner
membrane, may not take place. It is possible that the retention of the signal
sequence may result in the aberrant folding of recombinant MOMP within the
periplasm thus preventing its transport to the outer membrane. Alternatively,
accumulation in the periplasm may be a consequence of the highly disulphide bond
cross-linked structure of MOMP. Incorrect disulphide bond pairings formed in the
periplasm may also lead to the misfolding of recombinant MOMP, resulting in its
accumulation and aggregation as an inclusion body.
It is clear that the ability to express recombinant MOMP and refold to
native conformation would have broad implications on the search for an effective
chlamydial vaccine. Indeed, the planar bilayer system used to demonstrate the
porin-like function of reconstituted native MOMP may provide a measurable
criterion by which to assess recombinant MOMP for native function.
5.2. Structural and functional analysis of recombinant C. psittaci MOMP
expressed in a cell-free transcription/translation coupled system
In view of the difficulties in expressing recombinant chlamydial MOMP in
E. coli cells (Section 5.1), expression in an alternative cell-free system was
attempted. The E. coli T7 S30 extract system for circular DNA was used for the
coupled transcription/translation of the truncated C. psittaci MOMP construct,
tMOMP (Section 2.8.2). This cell-free system contained all the necessary
components for transcription and translation. 3 jLtg of tMOMP DNA was used, and
translated proteins were radioactively labelled by adding [ S] L-methionine to the
reaction mixture. Recombinant C. psittaci MOMP expressed using the E. coli T7
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Figure 5.1 SDS-PAGE and Western blot analyses of C. psittaci tMOMP expressed
in the E. coli T7 S30 in vitro transcription/translation system. Radioactively
labelled, expressed protein (a) and uninduced T7 reaction mixture (b) were
subjected to SDS-PAGE analysis on 12.5% gels, blotted onto nitrocellulose








Figure 5.2 Western blot analysis of C. psittaci tMOMP expressed in the E. coli T7
S30 extract system. Expressed protein was run on 12.5% gels, immunoblotted, and
probed with mAb All (sample loaded without boiling, lane a) and mAb 4/11
(sample loaded without boiling, lane b; and after boiling, lane c).
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S30 extract system migrated as a single band with an apparent molecular mass of 37
kDa when analysed by SDS-PAGE after denaturing by boiling in SDS-sample
buffer in the presence of a reducing agent (Fig. 5.1). Three pig of tMOMP DNA
yielded approximately 35 |lg/ml of protein, as estimated by densitometry. Western
blot analysis showed that the 37 kDa protein was recognised by MOMP-specific
mAb 4/11. In contrast, SDS-PAGE analysis of cell-free expressed tMOMP, in
SDS-sample buffer (and reducing agent) but not fully denatured by boiling, revealed
a protein band with a molecular mass of 100 kDa. This band was interpreted to be
an oligomer of MOMP and was found to react with native MOMP-specific mAb
A11 upon immunoblotting (Fig. 5.2).
Planar lipid bilayer reconstitution of cell free expressed tMOMP resulted in
the appearance of unit channels identical in amplitude and behaviour to those
observed upon incorporation of the OG-DTT solubilised native MOMP (results not
shown). Unfortunately, this recombinant MOMP sample could not be routinely
reconstituted into the bilayer as the E. coli T7 S30 extract system reaction mixture
contained unknown detergents which destabilised the bilayer. No channel activity
was observed following the reconstitution of the uninduced E. coli T7 S30 reaction
mixture.
5,3 Cloning, expression and analysis of recombinant MOMP from C. psittaci and C.
pneumoniae
5.3.1. C. psittaci and C. pneumoniae recombinant MOMP cloning
The C. psittaci recombinant MOMP construct used in this study was
engineered previously at the Moredun Research Institute (Herring et al., 1998). It
encodes a truncated version of MOMP (termed tMOMP) starting at the first natural
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Figure 5.3 PCR product amplified from C. pneumoniae strain IOL207 genomic
DNA. Analysed on 2% (w/v) agarose gels with ethidium bromide.
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methionine, thus does not encode the first 16 amino acids of the mature protein. C.
pneumoniae tMOMP was engineered in a similar way.
The C. pneumoniae MOMP gene, amplified from C. pneumoniae IOL-207
genomic DNA, resulted in a 1.36 kb PCR fragment (Fig. 5.3) which was sub-
cloned into pGEM-T. The MOMP gene fragment was subsequently cloned into the
expression vector pET-22b (+) via restriction endonuclease sites Ndel and Notl.
Constructs were checked before transformation into E. coli expression host BL21
(DE3) and induced. Expressed products were determined to form inclusion bodies
which were isolated by a sonication and differential centrifugation procedure.
5.3.2. SDS-PAGE and immunoblot analysis of recombinant tMOMP
Inclusion body preparations of both the C. psittaci and C. pneumoniae
recombinant MOMPs routinely yield 10-50 mg/L of protein. SDS-PAGE analysis
of the recombinant proteins is shown in Figure 5.4. Both recombinant proteins
migrated with an apparent molecular mass of 37 kDa when solubilised in SDS-
sample buffer (including reducing agent) and denatured by boiling. Recombinant C.
psittaci MOMP was recognised by MOMP-specific mAb 4/11 following
immunoblotting (Fig. 5.5), however, this denatured protein did not react when
probed with native C. psittaci MOMP-specific mAb All (results not shown).
Indeed, a commercially available native C. pneumoniae MOMP-specific mAb also
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Figure 5.6 Western blot analysis of recombinant tMOMP from C. pneumoniae.
tMOMP was subjected to SDS-PAGE on 12.5% gels, immunoblotted, and probed
with anti-sera raised against the recombinant protein in rabbits (a to c) and guinea
pigs (d to f).
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5.3.3 C. pneumoniae recombinant tMOMP-specific antisera
Due to the failure of the commercially available native C. pneumoniae
MOMP-specific mAb to recognise denatured recombinant tMOMP by
immunoblotting, specific anti-sera was raised against this protein. Rabbits and
guinea pigs were inoculated with the purified recombinant protein (Section 2.9) and
at 3 weeks post final vaccination were bled out and sera prepared. Immunoblots of
the recombinant tMOMP were probed with the sera from each animal, at final
dilution of 1/500. A 37 kDa protein, corresponding to recombinant C. pneumoniae
tMOMP, was strongly recognised by sera from all animals (Fig. 5.6). Pre-
inoculation sera from these animals showed no reaction with the recombinant
protein.
5.4 Planar lipid bilayer analysis of recombinant MOMP
5.4.1. Reconstitution of C. psittaci and C. pneumoniae recombinant MOMPs
C. psittaci and C. pneumoniae OG/DTT-solubilised tMOMPs were
introduced to the cis chamber of the bilayer set-up in the presence of a 500 mM
KC1 cis versus 50 mM KC1 trans gradient. Under these conditions, recombinant
MOMP incorporated into the bilayer within 5-10 min of addition, to give rise to
ion-channel-like unit conductances. After the first evidence of channel
incorporation, the cis chamber was perfused with a minimum of 10 volumes of 50
mM KC1 to limit the bilayer channel content. However, channel incorporation
appeared to be autocatalytic, as previously described for native C. psittaci MOMP
(Section 4.2.1), and as a result further channel incorporation was not uncommon.
















Figure 5.7 Comparison of recombinant C. psittaci and C. pneumoniae MOMPs, and
the E. coli Omp proteins. Representative recordings of planar lipid bilayers
containing the indicated proteins in 300 mM KC1, 10 mM Tris-HCl, pH7.4, at a
holding potential {cis minus trans) of either -lOOmV (A, B) or -150 mV (C, D).
The dotted lines indicate unit current open levels (openings downwards at negative
potentials). Filtered at 100 Hz.
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5.4.2. Single channel recordings of recombinant tMOMPs
The single channel properties and gating behaviour of the recombinant
MOMP channels were studied in detail. Figure 5.7 shows representative ion-
channel recordings resulting from the bilayer incorporation of recombinant C.
psittaci (A) and C. pneumoniae (B, D) MOMPs, and native E. coli Omps (C). The
planar bilayer was voltage clamped at -100 mV or -150 mV as indicated (cis minus
trans) as indicated, and bathed in 300 mM KC1 containing 10 mM Tris-HCl (pH
7.4). Both C. psittaci and C. pneumoniae recombinant MOMPs routinely opened
to three distinct levels (1-3, as indicated in Fig. 5.7). This apparent trimeric
behaviour mimics that previously observed with native C. psittaci MOMP porin
(Section 4.2.3). The threshold potential required to close the C. psittaci
recombinant channel was higher than that required to close the native channel
(about -100 mV compared to -80 mV) (Section 4.2.1). The gating pattern (and
unit amplitude) of the recombinant C. pneumoniae MOMP channel was clearly
different from that of C. psittaci, and this porin required an even higher threshold
potential of -150 mV to bring about significant channel closure.
5.4.3. Comparison with E. coli Omps
In order to rule out the possibility that E. coli porins had contaminated C.
psittaci and C. pneumoniae MOMP preparations, outer membrane proteins of the
E. coli-type used to express these recombinants were solubilised in OG/DTT
(Section 2.4.1) and reconstituted into bilayers. These E. coli porins displayed very
different channel properties to those of the chlamydial porins (Fig. 5.7 and Table
2). The native E.coli Omps had a substantially lower conductance than the








(cis/trans)nativerecombinantrecombina tna ive 50/5012±18(4)383)NS 95(4)*84)**
g(pS)150/150210±2433)NS514)**nd 300/3002±(4)13)NS4 80.07(4)***nd Pci/K250/50.0± .8(4)0.323)***97(4)***.28±0.02)
***
result in significant channel closure. Furthermore, these channels were observed to
be more selective for cations than either of the recombinant MOMPs (see below
and Table 2). The Omp-like channels were never observed during any
reconstitution of the MOMP inclusion body proteins, and MOMP-like channels
could not be reconstituted from non-induced bacteria. This work was completed in
collaboration with R. H. Ashley.
5.4.4. Ion selectivity and conductance.
Comparison of the unit channel amplitudes of recombinant C. pneumoniae
and C. psittaci MOMPs revealed significant differences, summarised in Table 2.
The conductances of recombinant C. pneumoniae channels, measured over a range
of KC1 concentrations, were substantially higher than those of both recombinant
and native C. psittaci MOMP. However, conductances of recombinant C. psittaci
MOMP unit channels were not significantly different from the results reported for
the native channel protein. There was a significant shift in relative anion versus
cation selectivity between the C. psittaci native and recombinant porins. Both
recombinant channels were weakly cation-selective, while the native protein was
weakly anion selective.
5.4.5. Effect of oligomer-specific monoclonal antibody All on recombinant C.
psittaci MOMP channels
The recombinant C. psittaci porin exhibited the same asymmetric response
to holding potentials of opposing polarity as reported for the native protein (Section
4.2.1). Note the increase in 'flickery' closures for recombinant C. psittaci MOMP







Figure 5.8 Effect of native MOMP-specific mAb All on recombinant C. psittaci
channels. Bilayer bathed in 300 mM KC1, 10 mM Tris-HCl, pH7.4. mAb All
added to both the cis and trans chambers to a final dilution of 1/500 in the presence
of 1 mg/ml BSA. Note the difference in amplitude and the reduction in the number
of long lived channel closures. The solid line represents the baseline level,
corresponding to the closure of the unit conductance. Filtered at 100 Hz.
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Addition of a native C. psittaci MOMP-specific neutralising mAb, All, affected
both the gating of the recombinant channel and the amplitude of channel unit
conductances. Figure 5.8 shows a recording of channel behaviour before (upper
trace) and 2 min after the addition of 0.25% (v/v) mAb All to both the cis and
trans chambers (lower trace). The unit conductance amplitudes were significantly
reduced, and the unit conductances showed more frequent 'flickery' closures than
in the control trace. This antibody effect is very similar to that observed upon the
addition of mAb A11 to the native MOMP channel (Section 4.2.2). This work was
completed in collaboration with R. H. Ashley.
5.4,6. Effect of MOMP-specific antibodies on recombinant C. pneumoniae
MOMP channels
The addition of the commercially available C. pneumoniae native MOMP-
specific mAb had no discernible effect on the behaviour or properties of C.
pneumoniae tMOMP channels. Furthermore, tMOMP specific anti-sera (Section
5.3.3) failed to effect these recombinant channels when added to bilayer chambers
at a dilution of 1/250.
5.5. Discussion
The results presented in this chapter demonstrate the first successful
expression and functional reconstitution of recombinant MOMPs from Chlamydia
spp. We have shown that the recombinant C. psittaci protein is functionally similar
to the previously characterised native protein, in that it exhibits similar 'triple-
barrelled' behaviour and has similar conductance and gating behaviour.
Reconstitution of C. pneumoniae recombinant MOMP demonstrates that it has
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comparable conductance and selectivity properties to those of C. psittaci MOMP,
but a higher voltage threshold for gating. Secondary structural information
(Section 3.3.2) and confirmation of the ion channel function of chlamydial
MOMPs (Section 4.2.1) places these proteins firmly in the porin superfamily.
The channel gating characteristics, unit channel amplitudes and selectivity
of the chlamydial porins were vastly different from those of the E. coli Omp-like
channels purified from the non-induced bacteria. In addition, the amplitude and
gating of recombinant C. psittaci MOMP channels was modified by the addition of
native MOMP-specific mAb All. Not only does this result confirm that channel
activity results from MOMP reconstitution and not contaminant E. coli Omps, it
also demonstrates that recombinant MOMP is refolding to a functionally native
conformation. The addition of a commercially supplied mAb, reportedly C.
pneumoniae MOMP specific, had no effect on our recombinant C. pneumoniae
channels. In contrast to the MOMPs of the other chlamydial species, C.
pneumoniae MOMP appears to be less immunogenically and antigenically complex
(Section 1.8.3) (Campbell, et al., 1990; Black, et al., 1991). Indeed, surface
exposure of this MOMP has not been determined leading some researchers to
hypothesise that it lies beneath a layer formed by other chlamydial antigens
(Christiansen et al., 1998). In view of these results there must be some doubt over
the specificity of this antibody which has been raised against C. pneumoniae EBs.
Similarly, antisera specific to the recombinant protein also failed to have any effect
on the channel properties. These sera are likely to recognise linear epitopes on the
recombinant protein which may not be surface exposed when it refolds to native
conformation. This result mirrors that seen when mAb 4/11, specific to a linear
epitope in the VS2 region of the native protein, failed to effect native MOMP
channel function, while mAb All which recognises a conformational epitope
dramatically changed channel behaviour and characteristics. There is little doubt
that the porin-like ion channels resulting from reconstitution of solubilised
inclusion body preparations are recombinant MOMP channels with similar
characteristics to those observed with C. psittaci MOMP.
The crystal structure of several porins have been determined (Cowan et al.,
1992) and without exception these proteins have been found to form p-barrels
composed of 16 anti-parallel p-strands. Porin P-barrels have short intracellular
turns and longer external loops, one of which is an 'eyelet', a pore-confined loop
that greatly limits single channel conductance. Without this partial obstruction,
single channel conductance of porin p-barrels would be an order of magnitude
higher (Hille, 1992), yet conductance of MOMP is similar to that of the general
diffusion porins. We therefore speculate that chlamydial porins have a similar
structure. The difference in ion selectivity between C. psittaci recombinant and
native MOMP may be due to the 16 amino acid truncation of the recombinant
protein. If MOMP is structurally similar to other porins, as we suggest, this
truncation could result in the loss of 2 anti-parallel P-strands. This in turn would
result in the P-barrels having a slightly reduced diameter, and more importantly,
the surface loops, and therefore the channel mouth and eyelet region being arranged
in a slightly different way, accounting for the change in ion selectivity.
It is unlikely that all bacterially over-expressed, OG/DTT-solubilised
tMOMP is refolding to native conformation. Indeed, it may be bilayer insertion
itself that promotes the correct folding of very small amounts of the solubilised
proteins. This may also explain the native conformation attained by tMOMP
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expressed within the E. coli T7 S30 extract system. Although this system is cell-
free, it contains a crude extract of ruptured E. coli cells which is likely to contain
membrane fragments. Spontaneous insertion of recombinant C. psittaci MOMP
into membrane fragments may help the expressed protein to refold to native. This
will be discussed more extensively in Chapter 7.
The ability to reconstitute recombinant MOMP using the lipid bilayer system
provides a very sensitive means by which to perform detailed structure/function
studies on this important chlamydial antigen. In addition, the possible requirement
of membrane insertion in order to achieve native MOMP conformation has broad









The mechanisms by which chlamydiae attach to, and infect, eukaryotic host
cells are largely unknown. The initial binding of a bacteria to a target cell is a
critical determinant of cell and tissue tropism and thus of pathogenesis. Surface
components involved in attachment are likely to be key virulence determinants and
primary targets for future vaccine development.
Perhaps the most convincing current hypothesis for chlamydial attachment
to eukaryotic cells is that proposed by Zhang and Stephens (1992) (Section 1.4.1).
This involves the synthesis of a molecular mimic of heparan-sulphate by
Chlamydia, which can bind to host cells exploiting receptors used for eukaryotic
cell-cell interactions. Evidence supporting this hypothesis includes the inhibition of
attachment of radio-labelled C. trachomatis (Chen and Stephens, 1997) and
fluorescently labelled C. psittaci (Gutierrez-Martin et al., 1997) to eukaryotic host
cells by the addition of heparin or heparan sulphate and the abolition of infectivity
by the treatment of chlamydiae with heparan sulphate lyase. Undoubtedly the most
compelling evidence is the restoration of the ability of heparatinase-treated
chlamydiae to attach and infect host cells, by the addition of exogenous heparan
sulphate.
Chlamydial outer membrane proteins are thought to bind this molecular
mimic of heparan sulphate and present it to the host eukaryotic cell GAG receptors.
As yet, the identity of the chlamydial heparan-sulphate binding protein is unknown,
however, possible candidates include MOMP. Indeed, the specific binding of a
recombinant MOMP fusion protein to epithelial cells is inhibited by the addition of
heparan sulphate or by the heparitinase treatment of the cells. Furthermore, the
attachment of the recombinant MOMP fusion protein to a mutant cell line defective
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in heparan sulphate synthesis was markedly reduced (Su et al., 1996). These results
strongly suggest that the MOMP is the chlamydial GAG receptor.
The primary objective of the experiments described in the following chapter
was to provide some evidence of a direct association between MOMP and heparin
or heparan sulphate. In doing so, it was first necessary to demonstrate that the
attachment/infection of McCoy cells by the ovine abortion isolate of C. psittaci was
mediated by a GAG-dependent pathway. Despite some convincing evidence, it has
never been suggested that the GAG-mediated pathway is the only mode of
attachment and infection exploited by chlamydiae. Indeed, chlamydial infection is
believed to be a multifactorial process. However, the characterisation of at least one
potential mode of chlamydial attachment and entry into host cells has been an
important step.
6.2 Analysis of the GAG-dependent infection of McCoy cells by the OEA
subtype of C. psittaci
6.2.1 Dose response inhibition of infection by heparin
Recently, it has been demonstrated that C. trachomatis trachoma and LGV
biovars share the same GAG-dependent mechanism for infection of eukaryotic cells
(Chen and Stephens, 1997). These biovars have been shown to compete for the
same receptors on HeLa cells and their infectivity has been inhibited by the addition
of exogenous heparin/heparan sulphate. In this study attempts were made to show






Figure 6.1 Dose-dependent heparin inhibition of C. psittaci OEA isolate infection.
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Figure 6.2 Dose-dependent inhibition of C. psittaci OEA infection following
treatment of chlamydiae with heparitinase. Error bars represent ± standard error of
the mean of triplicate measurements from three separate experiments.
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The level of C. psittaci infection of McCoy cells in the presence of heparin,
calculated by a total count of inclusion bodies, exhibited dose-dependent inhibition.
As illustrated in Figure 6.1, the level of infection at each concentration of heparin
was calculated. Each data point represents the mean of triplicate measurements
made from three separate experiments. The addition of 5 units of heparin from
ovine intestinal mucosa was sufficient to reduce the infectivity of OEA subtype C.
psittaci by approximately 44%. Unlike the effect observed using the LGV biovar of
C. trachomatis, the dose-response curve showed no initial increase in the levels of
infection for OEA C. psittaci EBs at low levels of heparin. Indeed, infectivity
sharply declined upon the titration of increasing amounts of heparin. However, the
addition of 100 U/ml of heparin consistently resulted in a small, unexplained
increase in the level of infection. Although these results demonstrate that heparin
effectively inhibits infectivity of OEA C. psittaci this heparin mediated inhibition is
not complete. At titrations of heparin as high as 500 U/ml infectivity remained at
low levels (16% of the control). This remaining low level of infection may illustrate
the adaptability of chlamydiae to use an alternate method of attachment and entry
into the host cell. Maximal heparin inhibition of the C. psittaci OEA isolate was
obtained at approximately 10-50 U/ml of heparin, equivalent to that observed in C.
trachomatis LGV biovar.
6.2.2 Inhibition of infection by treatment of EBs with heparatinase
Heparitinase cleaves an N-acetyl-D-glucosamine linkage in heparan
sulphate. Digestion of LGV biovar EBs with this enzyme resulted in the
neutralisation of infectivity and attachment. In this study, the digestion of EBs with
heparitinase was attempted to confirm the GAG-dependent mechanism of infection
in the C. psittaci OEA isolate. Inhibition of infectivity was found to be dose-
dependent following treatment of EBs with heparitinase with maximum inhibition
occuring with 1.5 U/ml heparitinase (Fig. 6.2). Furthermore, infection was not
totally abolished following digestion treatment with 2 U/ml heparitinase (22% of
original infection remained). It is possible that levels of infection could have fallen
still further had increasing amounts of heparitinase been analysed. The reduction in
chlamydial infectivity observed following the treatment of EBs with heparitinase
was consistent with the inhibition of infectivity upon the addition of exogenous
heparin.
6.2.3 Association of oligomeric MOMP and [N - Sulphonate-^SsjHeparin
In view of the results of Su et al. (1996) suggesting that MOMP may be the
chlamydial GAG-receptor, an attempt was made to show a direct association
between oligomeric MOMP and radioactively labelled heparin. MOMP, solubilised
in OG-DTT, was run on SDS-PAGE gels under relatively non-denaturing
conditions, as described in Section 2.2. Under these conditions, MOMP migrates
with an apparent molecular mass of 100 kDa which is interpreted to be an oligomer,
presumably a trimer. The oligomeric form of MOMP reacts with monoclonal
antibodies raised against intact EBs and recognising only conformational epitopes
(Section 3.2.1). Western blots of these oligomers were incubated with [N-
Sulphonate 35s]heparin, washed with PBST, exposed on x-ray film and developed
by auto-radiography. Despite varying the exposure time to film and the method of
blocking non-specific binding to the membrane, background radioactivity remained
obtrusively high. However, 35S-labelled heparin did associate strongly with the
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MOMP oligomer, above background levels of radioactivity. Interestingly, this
increased heparin binding was not observed on Western blots of denatured,
monomeric MOMP suggesting a specific interaction between heparin and the
oligomeric form of MOMP. Until a method of blocking membranes can be found
which can reduce the non-specific binding of heparin, the possible specific
interaction between oligomeric MOMP and heparin cannot be fully characterised
using this technique.
6.3 Discussion
When studying mechanisms of attachment and infection within an in vitro
system it is essential to maintain an environment as close to that of the natural
infection as possible. Undoubtedly, no in vitro model will completely mimic the
conditions seen in vivo, however, if meaningful comparisons are to be drawn with
the natural infectious process, every effort must be made to mirror these natural
conditions. The present study has been largely based on the work of Chen and
Stephens (1997) on the attachment and infectivity of the C. trachomatis LGV and
trachoma biovars. Throughout the studies of Chen and Stephens, cells were
maintained in tissue culture medium containing cycloheximide. This compound
acts as an inhibitor of host cell protein synthesis and increases the susceptibility of
the cell to infection by chlamydiae. Clearly under these conditions the resulting
infection is not natural. EBs which may have been unable to infect an intact,
untreated cell may well have been able to establish infection within a
cycloheximide-treated epithelial cell. With this in mind, the McCoy cell cultures
used in this study of C. psittaci, OEA isolate infection were not maintained in
medium containing cycloheximide. This adapted system is undoubtedly closer to
160
the natural environment in vivo.
Despite these small alterations in methodology, C. psittaci OEA subtype
infection of McCoy cells exhibited the same dose-dependent inhibition, in the
presence of heparin, as observed by Chen and Stephens with the C. trachomatis
LGV and trachoma biovars. Maximal inhibition of infection was achieved using
equivalent heparin concentrations to those resulting in the maximum inhibition of
LGV attachment. However, unlike the effect on LGV, the dose-response curve
showed no increase in infectivity of C. psittaci EBs at low concentrations of
heparin. As in the case of both LGV and trachoma biovars, C. psittaci infection was
not entirely abolished by the addition of very high concentrations of exogenous
heparin, or by the treatment of EBs with heparitinase. These results suggest that
both GAG-dependent and independent mechanisms are involved in C. psittaci
infection. It may be concluded, however, that OEA subtype infection is dominated
by GAG-dependent mechanisms, with >80% infectivity being lost upon treatment
with heparitinase and the addition of high levels of exogenous heparin.
Tissue culture medium used in the experiments of Chen and Stephens, as
well as others, investigating the possible GAG-dependent infection of Chlamydia,
contained FCS, which is known to contain unidentified heparin chelating molecules
(Ohki and Kohashi, 1993). Clearly the levels of heparin required to inhibit
mechanisms of attachment and infection in these studies may be a great deal lower
in the absence of the heparin-binding FCS. The validity of adding such
unphysiological concentrations of heparin to an in vitro system and comparing these
results with the natural chlamydial infection is surely in question. In the absence of
FCS, more physiological concentrations of heparin may be required to produce
these inhibitory effects.
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In the view of the primary objective of this study, analysis of MOMP as a
potential chlamydial GAG receptor, it was not thought necessary to investigate
separately the mechanisms of attachment and infection of the OEA isolate of C.
psittaci. Therefore, from the data presented in this study it cannot be concluded if
the C. psittaci OEA isolate, like the trachoma biovar of C. trachomatis, has a GAG-
independent mechanism of attachment while retaining a GAG-dependent
mechanism of infection. Alternatively, as in the case of C. trachomatis LGV
biovar, both C. psittaci OEA attachment and infectivity may be GAG-dependent.
More in depth analysis is required to answer these remaining questions.
With the discovery that addition of exogenous GAGs inhibited attachment
and infection of C. trachomatis LGV and trachoma biovars (Chen and Stephens,
1997) and the GPIC strain of C. psittaci (Gutierrez-Martin et al., 1997), Stephens
proposed a highly plausible and unique model for chlamydial infection of eukaryotic
cells. He hypothesised that a heparan sulphate-like ligand, bound to the surface of
Chlamydia by a chlamydial GAG receptor, mediated infectivity by bridging the
bacteria and mammalian cell receptors. As the predominant protein of the outer
membrane, it has long been hypothesised that MOMP plays a key role in the
mechanisms of attachment and infection of chlamydiae. Naturally, MOMP was the
primary candidate for the heparan sulphate-like ligand receptor. Direct evidence
supporting this hypothesis was recently provided by Su et al. (1996). These
researchers discovered that the specific binding of a MOMP fusion protein to
epithelial cells was inhibited, in a dose-dependent manner, by the addition of
exogenous heparin. These results suggest that MOMP potentially functions as a
chlamydial GAG receptor.
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To illustrate any specific interaction between MOMP and heparin, Western
blots of oligomeric MOMP were probed with 35S-labelled heparin. Unfortunately,
the extremely high background levels of radioactivity, resulting from the non¬
specific binding of heparin to the membrane, obscured any potentially specific
interaction between heparin and MOMP. However, 35S-labelled heparin did appear
to associate strongly with the MOMP oligomer, above background levels of
radioactivity. Increased heparin binding was not observed on Western blots of
denatured, monomeric MOMP. Should these results be confirmed, after non¬
specific binding to membranes has been reduced, they suggest that a specific
interaction is taking place between heparin and oligomeric MOMP and that heparin
may be recognising a conformational epitope. Addition of increasing amounts of
unlabelled heparin to these Western blots, would result in a dose-dependent
decrease in the binding of radioactive heparin, should the association between
MOMP and heparin be that of receptor-ligand. Hopefully a successful method of
blocking these Western blots can be found and this work can be attempted.
The significance of these results depends upon the acceptance that Western
blots of MOMP, unboiled in SDS sample buffer, retain some of the structural
information of native MOMP. Clearly this is the case, when antibodies raised
against intact EBs recognise the oligomeric form of MOMP while failing to
recognise the denatured monomer (Section 3.2.1). The recognition of
conformational epitopes of native MOMP by radioactively-labelled heparin
validates the use of this experimental approach as a simplified model of natural
infection.
Previous investigations of binding between GAGs and proteins have
indicated the importance of contiguous clusters of basic amino acids within the
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protein primary sequence in the binding of heparin, with charge interactions thought
to be of primary importance (Cardin and Weintraub, 1989). Analysis of the amino
acid sequence of MOMP from C. psittaci OEA isolate reveals the presence of a
cluster of basic residues just downstream of the surface exposed VS IV region of the
protein. This run of basic amino acids (K_K_RK, amino acids 324-329) may form
an extended heparin binding site forming part of the surface exposed loop of the VS
IV region. Similar motifs have been identified in many organisms, in particular
within the envelope proteins of the flaviviridae (Chen et al., 1997).
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CHAPTER SEVEN
GENERAL DISCUSSION AND FUTURE WORK
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The initial aims of this study were to characterise structurally and
functionally the MOMP of C. psittaci. In particular, to investigate fully the MOMP
porin hypothesis, at the molecular level, using planar lipid bilayer reconstitution
and, at the structural level, by CD analysis of the purified protein. The assignment
of a definite function to MOMP, in addition to more detailed structural information,
should help to improve the design of future MOMP-based anti-chlamydial vaccines.
Purification of sufficient quantities of purified MOMP for structural and
functional analysis has long been hindered by two main factors. Firstly, the obligate
intracellular mode of growth of chlamydiae has hampered the large-scale production
of native chlamydial proteins for purification. Secondly, it is extremely difficult to
solubilise and purify a protein such as MOMP which is both highly disulphide bond
cross-linked and normally resides in a hydrophobic environment. Furthermore, in
order to get an accurate determination of secondary structure by CD analysis,
MOMP was required to be at least 90% pure. The most effective method of
purification, which also yielded protein of sufficiently high concentration for CD
analysis, was hydroxyapatite chromatography in the presence of SDS. Such analysis
showed that MOMP predominantly consists of a (3-sheet secondary structure (62%).
No a-helix was detected. The high 6-sheet content of MOMP is similar to that
calculated for bacterial porins previously characterised by X-ray crystallography
(Cowan et al, 1992). The relatively high proportion of random coil (38%),
calculated from the MOMP spectrum, may be attributed to its four surface exposed
variable segments. A preliminary structural model of MOMP incorporating this
information will be discussed more fully later.
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OG-DTT-solubilised MOMP reconstituted into planar lipid bilayers
incorporated spontaneously into the bilayer giving rise to ion channel-like unit
currents. Channel incorporation appeared to be autocatalytic, in that the rate of
incorporation accelerated markedly following the initial appearance of channel unit
currents. These results suggest that once one MOMP channel has inserted it may act
as a catalyst for further incorporation. This hypothesis could be confirmed using the
technique employed by Xu and Colombini (1996) in demonstrating the self-
catalysed insertion of the VDAC mitochondrial porin. In the study, the addition of
urea or guanidinium chloride (GdmCl) to the bilayer following initial channel
bilayer incorporation significantly accelerated the already apparent auto-catalytic
insertion of VDAC. However, no channel insertion occurred when GdmCl or urea
was added without prior incorporation of porin channels emphasising the
importance of pre-existing channels to catalyse the membrane insertion process. It
was suggested that urea and GdmCl accelerate this process by inducing structural
changes in channels already incorporated into the bilayer resulting in these channels
becoming better insertion catalysts. The preference shown by MOMP for a
particular bilayer orientation was demonstrated by the asymmetric response of the
channel to holding potentials of opposite polarity. This functional asymmetry
almost certainly has a structural basis which may help explain the process of self-
catalysed insertion. A preferred orientation suggests that there is an energetically
more favourable bilayer arrangement, presumably due to some MOMP structural
element. Once a single channel has spontaneously inserted into the bilayer in this
conformation it may interact with channels still in solution orientating them into this





In view of the modification of channel behaviour by MOMP oligomer-
specific mAb All and subsequent analysis of channel unit currents, a basic model
of the functional MOMP porin was developed, where MOMP inserts into the
bilayer as a trimer giving rise to 3 pores which traverse the membrane. This
hypothesis is consistent with the well characterised homo-oligomeric nature of
MOMP previously revealed by biochemical analysis (McCafferty et al., 1995), and
the "triple-barrelled" behaviour of other porins (Nakae, et al., 1979). The ultimate
confirmation of this proposed "triple-barrelled" MOMP model requires highly
sophisticated structural analysis. A long term aim must be to solve a representative
chlamydial MOMP crystal structure, possibly by molecular replacement analysis
based on E. coli OmpF or R. capsulatus porin. An alternative technique which
often requires no sample preparation, allowing the direct observation of native
samples under native or near-native conditions is atomic force microscopy. Using
these high resolution microscopes which have three dimensional measurement
capabilities, the barrels of individual porin trimers are clearly visible (Fig. 7.1).
Although this technique may provide a short term answer to this question, more
detailed structural information will still require analysis by x-ray crystallography.
Although mAb All affects both the gating and permeation of native
MOMP, its epitope, being conformationally-dependent, is unknown. However, it is
likely to be a sequence in the outer channel vestibule, which is surface exposed and
presumably immunogenic. This is consistent with the idea that the bound antibody
obstructs ion movements and intermittently occludes the channel, giving rise to the
observed "flickery" closing events. Indeed, these "flickery" closures are reminiscent
of the sub-conductance states observed in many MOMP channel recordings (Section
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4.2.3, Fig. 4.2). It may be the case that binding of mAb All locks the channel in
one of these many substates. MAb All has been shown to neutralise C. psittaci
infection in vitro (Buzoni-Gatel et al., 1990). It is tempting to speculate that the
partial occlusion of the MOMP channel by Al 1, demonstrated in bilayers, accounts
for the neutralisation of infection by preventing nutrient acquisition from the host
cell, or perhaps by preventing the acquisition of molecules required to trigger
development. This may explain why so many antibodies specific to MOMP
neutralise chlamydial infection.
With the identification of genes encoding ATP biosynthetic pathways by the
Chlamydia Genome Sequencing Project (Stephens et al., 1998) it now seems
unlikely that Chlamydia derive all their ATP from the host cell, as previously
thought. However, the passage of substantial amounts of ATP was demonstrated
through the chlamydial porin. It may be the case that host nucleoside triphosphates
are required to 'kick start' the metabolic activity of the RB following conversion
from the EB in the early stages of the developmental cycle. In truth, ATP may not
be the only thing to pass through MOMP porins. As demonstrated by ion selectivity
studies, MOMP channels are relatively unselective, particularly in comparison to the
E. coli porins which tend to be strongly cation selective (Nikaido, 1994). Perhaps
the MOMP chlamydial porin provides a means by which chlamydiae can non¬
selective^ 'sample' the contents of the host cell cytoplasm. In other porins, the
channel vestibule is an important region in terms of ionic selectivity. Investigation
of the amino acid residues of the MOMP channel vestibule by chemical
modification and, in the future, by site directed mutagenesis of recombinant MOMP
porins, may reveal more about the channels selectivity and physiological role.
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Enriched MOMP samples reconstituted in both this study and liposome
swelling studies (Bavoil et al., 1984) were solubilised in OG/DTT, however, they
may have originated from two different developmental forms of chlamydiae perhaps
explaining their different requirement for reducing agent. MOMP reconstituted in
liposome swelling studies was recovered from fractions of purified EBs while
MOMP used in this study was recovered from a mixture of both EBs and RBs. The
extensive disulphide bond crosslinking of the EB outer membrane almost certainly
holds MOMP porins in a tightly closed and constricted conformation in order to
maintain osmotic stability in an extracellular environment. It may be the case that
the addition of reducing agent during purification is not sufficient to relax the tightly
compacted conformation of MOMP purified from EB outer membranes, and
cysteine residues which are in close proximity in this conformation spontaneously
reform disulphide bonds effectively closing the channel. It is clear that MOMP's
pore forming activity would be primarily utilised at the RB stage of the chlamydial
lifecycle and MOMP purified from RB outer membranes is likely to be in a
functionally active, relaxed conformation unlikely to spontaneously reform
disulphide bonds resulting in the closure of the porin. It may not be possible to fully
investigate the significance of disulphide bond crosslinking in the
activation/inactivation of MOMP porins using the native protein. Functional
reconstitution of a recombinant MOMP provides a system in which the importance
of individual cysteine residues on porin behaviour can be directly assessed by site
directed mutagenesis.
The reconstitution of recombinant C. psittaci and C. pneumoniae MOMPs
reported in this study represents the first time native function has been demonstrated
for any recombinant chlamydial MOMP. The successful reconstitution of C.
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pneumoniae MOMP is particularly significant. It has been proposed that, in
contrast to the MOMPs of the other chlamydial strains, C. pneumoniae MOMP is
less immunogenic and antigenically complex (Campbell et al., 1990). Indeed,
Christiansen et al. (1998) reported that MOMP could not be detected on the surface
of C. pneumoniae EBs. These researchers hypothesise that the OMP90 family of
proteins form a folded layer at the surface of C. pneumoniae effectively shielding
MOMP from exposure on the surface. In view of the porin-like function of C.
pneumoniae MOMP demonstrated in this study, this hypothesis seems unlikely. It
is difficult to see how any porin can efficiently transport nutrients while lying
beneath a protective layer of proteins. A commercially available C. pneumoniae-
specific mAb and sera raised against the denatured recombinant protein both failed
to affect recombinant channel activity. As discussed previously (Section 5.5), there
may be some doubt regarding the specificity of this commercial mAb. The sera
raised against recombinant C. pneumoniae MOMP almost certainly recognises
sequence specific linear epitopes. As exemplified by studies on the C. psittaci
porin, antibodies recognising conformational epitopes are more likely to affect
channel characteristics than those specific to linear epitopes which may be buried or
inaccessible in the folded protein. Undoubtedly, future studies of the C.
pneumoniae MOMP channel should include a detailed comparison of the single
channel properties of the native and recombinant porin. Ideally, a mAb that
recognised conformational epitopes on the native protein and affected native
channel function could be used to determine the native or near-native conformation
of the recombinant porin. Few candidate mAbs have been reported, however,
Persson and Peykani (1998) have recently raised mAbs which are specific to an
oligomeric form of C. pneumoniae MOMP. It will be interesting to observe any
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VSI VSII VSIII VSIV
SALT BRIDGE
Figure 7.2 Schematic model of C.psittaciOEA MOMP transmembrane structure.
® Cysteine residues (amino acids 49, 52, 56, 141, 209,211 and 363).
[J Transmembrane P-strands (ranging from 8-17 amino acids in length).
Variable regions (VS) VSI (amino acids 85-105), VSII (amino acids 158-178),
VSIII (amino acids 238-258) and VSIV (amino acids 305-337).
N-terminal tail 22 amino acids in length and C-terminal tail 35 amino acids in
length.
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affects these mAbs may have on C. pneumoniae MOMP porin function.
Secondary structure information and confirmation of the ion channel
function of chlamydial MOMPs firmly places these proteins in the porin channel
superfamily. The crystal structures of several porins have been determined and
these proteins have been found to form a trimeric [3-barrel structure composed of 16
anti-parallel (3-strands (Cowan et al., 1992). In view of the results presented in this
study, it seems likely that chlamydial porins have a similar structure. The prediction
of porin structure from sequence data alone is very difficult, however, an attempt
has been made to map the amino acid sequence of OEA C. psittaci MOMP to the
porin structural model. Information concerning the four surface exposed VSs of
MOMP has also been incorporated into this model. As indicated in Figure 7.2, it is
possible to form a 16 anti-parallel (3-strand structure using the MOMP sequence
while maintaining the four surface exposed variable loops. Transmembrane (3-
strands in this model range from 9-17 residues. Interestingly, in this model, many
of the conserved cysteine residues, thought to form disulphide bond crosslinks with
other envelope and periplasmic proteins, are exposed on the periplasmic surface of
the membrane. The amino and carboxy termini of porins are usually linked by a salt
bridge within the 16th [3-strand of the structure forming a barrel-like structure which
is stabilised by inter-strand hydrogen bonds. The channel vestibule is formed by
surface exposed loops which extend towards the barrel axis, these loops pack tightly
together and are thought to initially limit entry to the pore on the basis of size and
charge. It is probable that the four surface-exposed variable loops of MOMP form
at least part of the channel mouth and that one of the loops of MOMP acts as the
"eyelet", a pore-confined loop that greatly reduces the dimensions of the pore and is
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thought to control voltage-dependent gating. There is a strong case for the VS3
region of MOMP being the eyelet. VS3 is the least immunogenic of the four
variable regions which may be due to its burial within the pore. In addition, VS3
consists of many charged and polar residues which are characteristic of a porin
eyelet. VS2 is also a candidate eyelet region of the MOMP pore. Mab 4/11
recognises a linear epitope within this region of MOMP, however, the addition of
4/11 to the bilayer has no effect on channel properties. The failure of 4/11 to
partially occlude the channel suggests that the VS2 loop may be inaccessible to the
antibody possibly because it is lining the MOMP pore and controlling voltage-
dependent gating. At present we can only speculate as to the identity of the MOMP
pore eyelet region. The sequence PEFGG which is conserved within the eyelet
region of many members of the porin superfamily (Cowan et al., 1992) is not
present within the MOMP sequence. As discussed previously, the crystal structure
of a least one chlamydial porin structure is needed before progress is made in
determining the important structural elements such as the porin eyelet. In the
meantime, site-directed mutagenesis may be used to probe the structure of potential
eyelet regions and the loops involved in forming the MOMP channel vestibule.
The reconstitution of recombinant MOMPs to native function and
conformation has broad implications on the future design of sub-unit vaccines. As
discussed previously (Section 5.1), a successful chlamydial vaccine may need to
comprise conformational information in order to elicit a long-lasting, protective
immune response. The native function and conformation attained by soluble
recombinant MOMP within a membraneous environment suggests a potential
means by which these immunogens can be introduced to the immune system
inducing protective cellular and humoral immune responses by recalling
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conformational native epitopes on the organism. Future vaccine studies could
involve the use of liposomes as a vector to present functionally and
conformationally native recombinant MOMP. The efficacy of liposomes as
vehicles for the presentation of antigens to the immune system has been shown for a
number of MOMPs from other bacteria (Gregoriadis, 1990). Liposomes are
versatile delivery systems and several factors can be altered to optimise the immune
response of liposome-associated antigens. The physico-chemical properties of the
liposome itself such as lipid composition, size and charge are particularly important.
However, in view of the autocatalytic bilayer insertion of MOMP, reported in
various lipid conditions, altering these properties should not unduly effect the
presentation of this antigen. In contrast to other delivery mechanisms, liposome-
associated antigens do not induce granulomas at the site of injection and
hypersensitivity is generally not a problem. The versatility of the liposome delivery
system creates a wide range of options for the design of an effective MOMP
subunit vaccine. Indeed, the planar lipid bilayer is on hand to assess the native
structure and function of these liposomal antigen formulations.
At what point and by what mechanism recombinant MOMP attains native
conformation are critical questions which must be addressed. In this study, MOMP,
expressed as an insoluble inclusion body within E. coli, was incubated in OG/DTT
for lh at 37°C, the insoluble product pelleted and the supernatant reconstituted into
bilayers. The conformational status of this OG/DTT solubilised MOMP is
unknown. There are two possible scenarios, the small quantities of MOMP
solubilised in OG/DTT from insoluble inclusion bodies may contain little or no
native conformational information only refolding to native structure upon insertion
into the bilayer. Alternatively, small quantities of soluble recombinant MOMP,
177
already folded into native conformation, may be expressed in association with the
inclusion body. This "conformational MOMP", presumably recovered in the
supernatant following solubilisation of the inclusion body in OG/DTT, may insert
directly into the bilayer. It is crucially important to find out which of these two
possibilities is actually taking place. The application of liposome-reconstituted
MOMP as a potential vaccine can only work if reasonable amounts of protein can
be reconstituted into the bilayer and attain native conformation. If insertion into a
membrane environment is sufficient to refold recombinant MOMP to native
conformation then inclusion bodies can be solubilised, perhaps using urea, then
successfully reconstituted into liposome. However, if a native or near-native
conformation is needed for successful membrane insertion it is difficult to see how
enough conformational protein can be produced from inclusion bodies, which are
usually solubilised by chaotropic agents, to manufacture a viable vaccine. The best
way to determine if conformation is required for membrane insertion may indeed be
to solubilise the MOMP inclusion bodies using a chaotropic agent such as GdmCl
and attempt reconstitution into bilayers.
The initial events of chlamydial pathogenesis, attachment of the infectious
EB to a susceptible cell followed by internalisation, remain poorly understood.
However, evidence suggesting that a GAG plays a significant role in this process is
mounting (Chen and Stephens, 1997; Gutierrez-Martin et al., 1997). Results
presented in this study indicate that C. psittaci OEA isolate infection is a
predominantly GAG-dependent process mirroring the results obtained with the
trachoma and LGV biovars of C. trachomatis and the GPIC strain of C. psittaci.
The chlamydial outer membrane protein which acts as the GAG receptor is
unknown, however, due to its predominance in the outer membrane, MOMP remains
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a strong candidate. Interestingly, in close proximity to the surface exposed VSIV
region of C. psittaci OEA MOMP is a run of basic amino acids (residues 324-329,
Appendix I) which is similar to heparin binding motifs identified in many other
organisms (Chen et al., 1997). High level non-specific binding of 35S-labelled
heparin obscured any potentially specific interaction between the GAG and native
MOMP on Western blots. However, labelled heparin did appear to associate
strongly with the oligomeric MOMP, above background levels of radioactivity.
Clearly, in view of the high non-specific binding of heparin in these experiments, an
alternative method of characterising any specific interaction between heparin and
conformational MOMP must be found. As reported in Section 3.2.5, the pellet
resulting from centrifugation of OG/DTT-solubilised MOMP through a 5-20% (w/v)
linear gradient of sucrose was highly enriched for MOMP (85% as estimated by
densitometry), therefore an interesting way of investigating the binding of heparin
may be to use sucrose density gradients. If OG/DTT-solubilised MOMP was
incubated with labelled heparin, and a specific interaction did take place, the label
would be expected to co-sediment with MOMP in the pellet following
centrifugation. An interesting aspect of this experiment is that other surface exposed
outer membrane proteins, such as the members of the OMP90 family, which may
also be involved in the process of attachment will be banded on this gradient and any
specific interaction between heparin and these proteins can also be characterised.
In the past MOMP has been implicated in almost every aspect of chlamydial
pathogenesis. This is perhaps not surprising, considering that most Chlamydia
research has centred around this fascinating protein. It is clear from the results
presented in this study that the primary function of MOMP is as a chlamydial porin.
In the future, bilayer reconstitution clearly offers an important route to detailed
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structure/function studies on recombinant chlamydial MOMPs and this work also
has broad implications for the production of improved immunogenic MOMP




Appendix I The DNA and amino acid sequence of C. psittaci OEA MOMP. The
four variable regions of the amino acid sequence are labelled (VS1-4). Regions of
the protein sequence susceptible to cleavage in mild acidic conditions are labelled
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The major outer membrane protein (MOMP) of Chlamydia species shares several biochemical properties
with classical porin proteins. Secondary structure analysis by circular dichroism now reveals that MOMP
purified from Chlamydia psittaci has a predominantly (1-sheet content (62%), which is also typical of bacterial
porins. Can MOMP form functional ion channels? To directly test the "porin channel" hypothesis at the
molecular level, the MOMP was reconstituted into planar lipid bilayers, where it gave rise to multibarreled
channels, probably trimers, which were modified by an anti-MOMP monoclonal antibody. These observations
are consistent with the well-characterized homo-oligomeric nature of MOMP previously revealed by biochem¬
ical analysis and with the triple-barreled behavior of other porins. MOMP channels were weakly anion
selective (PCIIPK ~ 2) and permeable to ATP. They may therefore be a route by which Chlamydia can take
advantage of host nucleoside triphosphates and explain why some anti-MOMP antibodies neutralize infection.
These findings have broad implications on the search for an effective chlamydial vaccine to control the
significant human and animal diseases caused by these organisms.
Members of the order Chlamydiales are distinguishable from
other bacteria by their obligate intracellular mode of growth
and their distinctive biphasic life cycle in which the small
spore-like extracellular and infectious form, the elementary
body (EB), alternates with the intracellular vegetative form,
the reticulate body (RB). The four main species currently
recognized. Chlamydia trachomatis, C. psittaci, C. pneumoniae,
and C. pecorum, are diverse pathogens that cause a range of
disease in both humans and animals. A common component of
all these species is the 40-kDa major outer membrane protein
(MOMP), present in both the EB and RB forms. The MOMP
is a multifunctional protein which is thought to have a role
both in the infectious process (3, 34-36) and in the mainte¬
nance of structural rigidity via disulfide bond cross-linking
within the EB outer membrane (13, 15, 26).
The antigenic properties of MOMP have been studied in
detail since the landmark discovery that MOMP purified from
sodium dodecyl sulfate (SDS)-gels was capable of raising an¬
tibodies which could neutralize the infectivity of C. trachomatis
in vitro (6). Protein sequence comparisons of MOMPs both
within (33) and between (18) species, combined with epitope
mapping studies (8, 43), have shown that the epitopes respon¬
sible for neutralization lie within four variable segments. Vac¬
cine preparations based on chlamydial outer membrane com¬
plexes, which are highly enriched for the MOMP in its native
form, have been shown to be protective against chlamydial
disease in sheep (37), guinea pigs (2), and mice (10, 28). How¬
ever, experimental vaccines based on denatured or nonnative
recombinant MOMP preparations have yielded, at best, only
partial protection (28). Most recently, protection was demon¬
strated in mice administered a DNA vaccine comprising only
the MOMP gene (42).
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t Present address: The Public Health Laboratory, Kingsdown. Bris¬
tol BS2 8EL, United Kingdom.
These results clearly make MOMP the primary candidate
for a subunit vaccine against chlamydial infection, but despite
many years of intensive study, the paucity of structural infor¬
mation leaves unanswered many questions as to how MOMP
fulfills its diverse functions. Structural studies are hampered
first by the difficulty of growing chlamydiae in bulk and subse¬
quently by problems with purifying and solubilizing a protein
which both is highly cross-linked and normally resides in a
hydrophobic environment. These factors have precluded at¬
tempts to crystallize the protein and have made it necessary to
rely on analysis techniques that require relatively small quan¬
tities of protein.
A recent report showed that MOMP solubilized with octyl
glucoside (OG) in the presence of dithiothreitol (DTT) was
oligomeric, with electrophoretic and sedimentation properties
consistent with a trimeric structure (21). These oligomers re¬
sisted denaturation with SDS in a way similar to that for clas¬
sical gram-negative porin molecules, which are also trimers
(27). The result was consistent with an early observation by
Bavoil et al. (3), who used liposome swelling to demonstrate
that the chlamydial outer membrane contained pores and, due
to its predominance in the outer membrane, that MOMP was
the likely pore-forming protein. In this paper, we report direct
evidence for porin function obtained by using native, oligo¬
meric MOMP incorporated into planar lipid bilayers. More¬
over, due to the traditional view that chlamydiae are required
to scavenge ATP from the host cell, we have investigated the
transport of ATP through the MOMP channel.
MATERIALS AND METHODS
Chlamydial culture. The ovine abortion isolate of C. psittaci, S26/3, was grown
in McCoy cells as previously described (22). Briefly, infected cells were grown in
RPMI 1640 (Gibco) supplemented with 5% (vol/vol) newborn calf serum, 0.2%
(wt/vol) sodium hydrogen carbonate, 1% (wt/vol) HEPES, streptomycin (0.1
mg/ml), nystatin (25 U/ml), gentamicin (5 p,g/ml), and cycloheximide (1 p-g/ml).
Purification of MOMP. The MOMP used for reconstitution into planar lipid
bilayers was purified from McCoy cells as described previously (3, 21). Secondary
structural analysis by circular dichroism (CD) was performed on MOMP purified
by nondenaturing hydroxyapatite chromatography as previously described (5).
Briefly, 15 to 20 mg of EBs/RBs from tissue culture harvests were suspended in
2% (wt/vol) Sarkosyl and incubated for 1 h at 37°C. After centrifugation for 30
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min at 100,000 x g, the pellet was resuspended in 2% (wt/vol) SDS in phosphate-
buffered saline (pH 7.4) and incubated for 1 h at 37°C. Seven milligrams of the
MOMP-enriched SDS extract was equilibrated with 0.01 M sodium phosphate
(pH 6.4) containing 1 mM DTT and 0.1% (wt/vol) SDS (column equilibration
buffer). This material was fractionated by hydroxyapatite chromatography in the
continued presence of SDS, using the technique of Moss and Rosenblum (24).
Briefly, the MOMP-enriched sample was applied to a preequilibrated hydroxy¬
apatite column (Bio-Rad) which was then washed with equilibration buffer, and
samples were eluted with a linear gradient of 0.1 to 0.6 M sodium phosphate (pH
6.4) containing 1 mM DTT and 0.1% (wt/vol) SDS. The fractions showing
increased absorbance at 280 nm were analyzed by SDS-polyacrylamide gel elec¬
trophoresis (PAGE) and by immunoblotting using the MOMP-specific mono¬
clonal antibody (MAb) 4/11.
The MAbs used in this study, specific to the monomeric (4/11) and oligomeric
(4/11 and All) forms of MOMP, have been previously described (4, 21). SDS-
PAGE and Western blotting were carried out as described previously (21).
Protein concentrations were determined by gel densitometry using a Bio-Rad
GS-670 imaging densitometer and/or bicinchoninic acid protein assay reagent
(Pierce).
CD. CD analysis of hydroxyapatite-purified MOMP was performed on a Jasco
J-600 spectrophotometer with a path length of 0.02 cm, averaging 16 scans
between wavelengths of 190 nm and 260 nm for each sample. The spectropho¬
tometer was blanked with 0.3 M sodium phosphate (pH 6.4) containing 1 mM
DTT and 0.1% (wt/vol) SDS. Secondary structure estimations were obtained by
the CONTIN procedure of Provencher and Glockner (30), which essentially
compares the spectrum to a database of spectra from known structures.
Planar lipid bilayer reconstitution and channel analysis. MOMP was incor¬
porated into 0.3-mm-diameter planar lipid bilayers cast at room temperature
from a 30-mg/ml decane suspension of diphytanoyl phosphatidylcholine (Avanti
Polar Lipids, Alabaster, Ala.), using equipment and techniques similar to those
described by Williams (38) as used in previous studies (7, 15). The cis side of the
bilayer was voltage clamped relative to the trans side, using a Biologic RK-300
patch-clamp amplifier (Intracel, Royston, United Kingdom). The relative poten¬
tial applied across the bilayer is called the holding potential or voltage-clamp
potential. Transmembrane currents were low-pass filtered (10-kHz cutoff, 8-pole
Bessel filter) and digitally recorded. All bilayers used had a conductance of <10
pS and a capacitance of >250 pS. Bilayers of this size have a relatively large
capacitance. When large changes are made to the holding potential (e.g., by
switching from 0 to ±80 mV), the bilayer momentarily becomes charged, and the
charge then dissipates almost immediately to give rise to an exponentially de¬
caying current transient. This is referred to as the bilayer capacitative current
transient and is superimposed on channel recordings made immediately after
large changes in the holding potential, giving them a characteristic curved ap¬
pearance.
To incorporate channels, purified detergent-solubilized MOMP was added to
the cis side to a final concentration of 1 ng/ml in the presence of a salt gradient,
250 mM KC1 cis versus 50 mM KC1 trans (buffered with 10 mM Tris-HCl |pH
7.4]). The solutions bathing the bilayer were changed by perfusion (at least 10
volumes) as required. Opening and closing of the ion channels give rise to
square-shaped pulses of current which are termed unit currents. Unit currents
and holding (voltage clamp) potentials are displayed according to a standard
convention, quoting the holding (clamp) potential in the cis chamber, with
positive transmembrane (upgoing) currents representing a net flux of cations
flowing cis to trans, or a net flux of anions flowing in the opposite direction.
Channel recordings were postfiltered (see figure legends) to reduce high-fre¬
quency noise and analyzed with the program pClamp 6 (Axon Instruments,
Foster City, Calif.).
In the presence of a salt gradient either side of the bilayer, the reversal
potential is defined as the holding potential that exactly balances the tendency
for ions to diffuse down their chemical concentration gradient. Relative ionic
permeabilities were calculated from measured reversal potentials by using ap¬
propriate forms of the Goldman-Hodgkin-Katz voltage equation (7, 17). Briefly,
with the same monovalent salt in both chambers, Er = —RT/zF.\n{Pc[C], +
Pa[AIJPc[C\c + PA [A],}, where Er is the reversal potential, P is permeability,
and C are the anion and cation, respectively, and c and t represent cis and trans,
respectively. R is the gas constant (8.314 JK-1 mol-1), T is room temperature
(298 K), z is valency, and F is the Faraday constant (9.6 X 104 C mol-1).
Concentrations were corrected for ionic activities by reference to activity coef¬
ficients obtained from standard tables.
Addition of components to bilayer solutions, (i) MAb All. The MOMP oli-
gomer-specific MAb All (final dilution of 1/1,000), which has previously been
described (4), was added to both the cis and trans chambers in 50 mM KC1-10
mM Tris-HCl (pH 7.4)—1 mg of bovine serum albumin (BSA) per ml.
(ii) Oxidizing agents. Ten to 500 mM Cu2+-phenanthroline, hydrogen perox¬
ide, or oxidized glutathione in 50 mM KC1-10 mM Tris-HCl (pH 7.4) was added
to the cis and trans chambers. Channel activity in bilayers bathed in these buffers
was monitored over a period of at least 30 min.
(iii) ATP. ATP was added by perfusion to the bilayer in the form of 10 mM
Na+-ATP-10 mM Tris-HCl (pH 7.4) in both the cis and trans chambers. More
highly concentrated solutions were achieved by the addition of Na+-ATP to the
chambers from a concentrated stock solution. For the multivalent ATP4- ion in
the presence of Na+, the theoretical reverse potential for an ATP4"-selective
A kDa B
7R mA -4— oligomer
66.2 — 100 kD
monomer ——+■ -






FIG. 1. SDS-PAGE and Western blot analyses of OG-DTT-solubilized
MOMP. (A) SDS-PAGE analysis of 2% (wt/vol) OG-10 mM DTT-solubilized
MOMP-enriched preparations by silver staining. (B) The OG-DTT-solubilized
preparation was subjected to SDS-PAGE on 12.5% gels, immunoblotted, and
probed with MAb 4/11 (sample loaded after boiling; lane a) and MAb All
(sample loaded without boiling; lane b). Molecular masses are indicated.
channel was estimated from the Nernst equation. The activity ratio of 100 mM
Na-ATP to 10 mM Na-ATP was measured by using the Na+ ionophore grami¬
cidin (11).
RESULTS
SDS-PAGE and immunoblotting analysis of OG-DTT-solu-
bilized MOMP. The results of SDS-PAGE and immunoblot¬
ting analyses of the MOMP-enriched fraction solubilized with
OG-DTT (Fig. 1) illustrate the purity of the MOMP prepara¬
tion used in planar lipid bilayer reconstitution. Silver staining
identified a 38-kDa protein corresponding to the MOMP; con¬
taminant proteins of approximately 90 kDa were also observed
(Fig. 1A). These contaminants were identified as the previ¬
ously described OMP90 (formerly POMP) family (19, 20) by
immunoblotting using OMP90-specific MAbs (results not
shown). Western blots probed with MAbs specific for the oli¬
gomeric (Fig. IB, lane b) and monomeric (Fig. IB, lane a)
forms of MOMP demonstrated that when MOMP is solubi¬
lized in SDS sample buffer at room temperature in the pres¬
ence of a reducing agent, it migrates with an apparent molec¬
ular mass of 100 kDa, which we interpret to represent an
oligomer. When fully denatured by boiling. MOMP migrates as
a monomer of 38 kDa. These results are typical of those ob¬
served with gram-negative porins and are identical to those
previously shown by McCafferty et al. (21).
Secondary structure determination. Figure 2 shows silver-
stained SDS-PAGE analysis of fractions eluted from a hy¬
droxyapatite column under relatively nondenaturing condi¬
tions. Although fractions 20 to 30 contained significant
amounts of MOMP oligomer (100 kDa), only fractions 25 to 30
contained very few contaminant proteins while retaining sig¬
nificant amounts of oligomer. MOMP oligomer accounted for
>90% of the hydroxyapatite-purified protein (as estimated by
densitometry), achieving the criteria for accurate structural
analysis by CD. Fractions 25 to 30, which were eluted at a
sodium phosphate concentration of approximately 0.3 M, were
subjected to CD analysis in the far-UV range; the spectrum
obtained for fraction 25 is shown in Fig. 3. The spectrum of
purified protein is consistent with the presence of a large per¬
centage of (3 structure, as indicated by the characteristic ab¬
sorption minima at approximately 215 nm. Analysis using the
CONTIN procedure (30) (see Materials and Methods) esti¬
mated 62% (3 structure, 38% random coil, and 0% a helix. The
CD spectrum of bovine heart mitochondrial porin in 0.1%
(wt/vol) OG, recorded on the same spectrophotometer and
known to contain 60% (3 structure (29), is shown for compar¬
ison.
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FIG. 2. SDS-PAGE analysis of the hydroxyapatite-purified MOMP-enriched
preparation. Fractions eluted from the hydroxyapatite column (5 by 1 cm) loaded
with the 2% (wt/vol) SDS-solubilized MOMP-enriched preparation (see Mate¬
rials and Methods) were subjected to SDS-PAGE on a 12.5% gel. under reducing
conditions (not boiled), and silver stained. Molecular masses are indicated.
Planar lipid bilayer reconstitution. OG-DTT-solubilized
MOMP incorporated into planar lipid bilayers within 5 to 10
min of addition, to give rise to ion-channel-like unit currents
(see Materials and Methods). Unit currents were not seen at 0
mV, despite the presence of an ion gradient (250 versus 50 ntM
KC1 [see Materials and Methods]). This finding suggested that
channel opening, or insertion, was a voltage-dependent pro¬
cess. Channel incorporation appeared to be autocatalytic, be¬
cause the rate of incorporation accelerated markedly following
the initial appearance of unit currents (40). After the first
evidence of channel incorporation, the solution in the cis
chamber was changed to limit the channel content of the bi¬
layer. Finally, it was confirmed that the addition of buffer alone
had no effect.
Figure 4 shows typical traces, with the same solutions on
both the cis and trans side of a bilayer that had been exposed
to MOMP. The data were obtained by switching the holding
potential from 0 to either +80 or -80 mV as indicated. Bursts
of channel openings are superimposed on bilayer capacitative
current transients (see Materials and Methods). The channels
exhibit voltage-dependent closure as the high holding poten¬
tials are maintained. Normally, the appearances on switching
were similar to those shown in Fig. 4, with more open/closed
transitions at negative compared to positive holding potentials,
but in some experiments all channels became incorporated in
the opposite orientation. In addition, the bursts of activity seen
after switching to negative holding potentials normally con¬
tained more unit currents than those seen at positive poten¬
tials. In the presence of diphytanoyl phosphatidylcholine (cho-
Wavelength (nm)
FIG. 3. CD spectra of hydroxyapatite-purified MOMP and bovine heart mi¬
tochondrial porin in the presence of 0.1% (wt/vol) OG.
A +80 mv
0 mV —
FIG. 4. Ion channel recordings from OG-DTT-solubilized MOMP in a bi¬
layer bathed in 50 mM KC1-10 mM Tris-HCl (pH 7.4). (A) Holding potential
switched from 0 to +80 mV. (B) Holding potential switched from 0 to —80 mV.
Recordings were low-pass filtered at 100 Hz and show decaying capacitative
transients representing the discharge of the typically large bilayer capacitance
(-300 pF).
sen because it is a very robust bilayer lipid), the membrane
potential could be clamped as high as ±200 mV without break¬
age, but the maximum number of unit currents generally ap¬
peared to occur at ±60 mV or above.
Two types of experiment confirmed that MOMP was the chan¬
nel-forming protein. First, channel behavior (and rate of channel
incorporation) obtained by using similar quantities of MOMP
that had been highly purified by hydroxyapatite chromatography
was identical to that seen with OG-DTT-solubilized MOMP.
This fraction was not reconstituted routinely, because its SDS
content destabilized the bilayer. Second, addition of the native
MOMP-specific MAb All affected both the open/closed tran¬
sitions of the channel and the amplitude of the unit currents
(Fig. 5). These effects could not be reversed by perfusion with
antibody-free solutions. Note that the channels did not close
completely in the presence of All (Fig. 5B). Additions of
other immunoglobulins or BSA (1 mg/ml) were without effect
(results not shown).
Properties of unit MOMP channels. Given that native
MOMP tends to migrate as an oligomer, presumably a trimer,
under nondenaturing conditions on SDS-PAGE, and knowing
that many classical porins are trimers (9, 23, 25), we measured
the number of functional unit currents that could be obtained
following bilayer reconstitution of MOMP. The number of
individual unit currents (e.g., levels 1, 2, and 3 in Fig. 6A) were
counted in 25 independent experiments in which incorporated
channels were maximally activated by switching between +120
and -120 mV. The numbers of discrete conducting units are
summarized in Fig. 6B.
Unit currents were measured (pClamp 6) to construct open-
channel current-voltage relationships in symmetrical KC1 (the
same concentration of KC1 in both the cis and trans chambers)
(Fig. 7). These were all linear; the slope conductances were
120 ± 18, 210 ± 25, and 310 ± 32 pS in 50, 150, and 300 mM
KC1, respectively (mean ± standard deviation [SD], n = 4).
Careful inspection of the data revealed that channel closure
was incomplete, with a residual conductance equivalent to
approximately 5% of the fully open state. In some recordings
we also observed subconductance states, but these substates,









FIG. 5. Effects of MAb All on the MOMP channel. The bilayer was bathed
in 50 mM KC1-10 mM Tris-HCl (pH 7.4); MAb All was added to both the cis
and trans chambers to a final dilution of 1/1,000 in the presence of BSA (1
mg/ml). (A) Traces obtained after switching the holding potential from 0 to -80
mV before (left) and 30 min after (right) addition of MAb All. In each record¬
ing, there is a typical bilayer capacitative current transient superimposed on
channel openings, but the openings are of much lower amplitude after addition
of MAb A11. (B) Detailed appearance of an individual unit current before (left)
and 30 min after (right) addition of MAb All. Note the difference in amplitude
and the reduction in the number of long-lived channel closures. The dotted line
represents the baseline level, corresponding to the closure of the unit conduc¬
tance. Currents were filtered at 100 Hz.
and the residual conductances of the closed states, were not
examined in detail.
In the light of results obtained by liposome swelling indicat¬
ing that reduction of disulfide bonds was necessary to fully open
pores within the chlamydial outer membrane, we attempted to
oxidize our fully open MOMP channels and observe any effects
on channel behavior. However, in vitro oxidation of bilayer-
incorporated MOMP with hydrogen peroxide, oxidized gluta¬
thione, or Cu2+-phenanthroline had no observable effect on
any channel properties.
Ion selectivity and permeability of MOMP channels. The
relative anion versus cation permeability of reconstituted
MOMP channels was calculated from reversal potentials (see
Materials and Methods) measured in 250 mM KC1 cis versus
50 mM KC1 trans. A reversal potential of +10.0 ± 4 mV
(mean ± SD, n = 4) indicated that the channel was weakly
anion selective: PcJPk ~ 2-0 ± 0.84 (mean ± SD, n = 4). The
channels were also permeable to ATP. In the presence of 100
mM Na-ATP cis versus 10 mM Na-ATP trans, a reversal po¬
tential of —11 ± 1.9 mV (mean ± SD, n = 10) was obtained,
with a unit conductance of approximately 80 pS. The ionic
activity ratio of 100 mM Na-ATP to 10 mM Na-ATP, mea¬
sured by using the Na+ ionophore gramicidin (11), was 4.5.
This corresponds to a theoretical (Nernstian) reversal poten¬
tial of -39 mV for a solely Na+ selecting channel and +10 mV
for a solely ATP4- selecting channel; hence, a reversal poten¬
tial of -11 mV suggests that there is substantial ATP trans¬
port.
DISCUSSION
In the search for an effective antichlamydial vaccine, efforts
have mainly concentrated on the proteins of the outer mem¬
brane. These proteins are likely to be the key virulence deter¬
minants of Chlamydia, involved in attachment, internalization,
and the prevention of phagolysosomal fusion, and are an ob¬
vious starting point for vaccine development. Primarily, re¬
search has focused on the MOMP which is the predominant
constituent of chlamydial outer membranes, comprising ap¬
proximately 60% of the protein mass. The MOMP remains the
only chlamydial protein shown unequivocally to be surface
exposed, and antibodies specific to the protein have been
shown to be protective (2, 28, 37). For these reasons, MOMP
remains the primary candidate for a chlamydial vaccine.
Problems purifying native MOMP or obtaining recombinant
MOMP in a native form have hampered the study of structure-
function relationships for this protein. Despite this, MOMP
has been implicated in many aspects of chlamydial pathogen¬
esis (3, 12, 34-36). Perhaps one of the most convincing, and
widely accepted, proposed functions is that of a "chlamydial
porin." Using the technique of liposome swelling, Bavoil et al.
(3) demonstrated that outer membrane complexes of C. tra¬
chomatis contained water-filled pores with an exclusion limit of
850 to 2250 Da. Due to its abundance in these outer membrane
preparations, it was postulated that MOMP, as a chlamydial
porin, was responsible. This hypothesis is amply supported by
both the structural and functional results presented in this report.
The protocol used to purify MOMP for structural studies
could not be employed during the purification of MOMP for
reconstitution experiments due to the destabilizing effects of
SDS on the bilayer. Unfortunately, dialysis to remove SDS
from hydroxyapatite-purified fractions was not feasible be¬
cause of the prohibitively small amounts of protein involved.
However, both methods, solubilization in OG-DTT and puri¬
fication by hydroxyapatite chromatography, resulted in the for¬
mation of SDS-resistant MOMP oligomers typical of classical
gram-negative porin proteins. Structural analysis by CD indi¬
cated that the secondary structure of MOMP was mainly 3
sheet (62%), similar to the high 3-sheet content of bacterial
porins previously characterized by X-ray crystallography (29).
The relatively high proportion of random coil, calculated from
the MOMP spectrum, may be attributed to its four surface-
exposed variable segments (1, 16, 41).
At a functional level, the insertion of MOMP into planar
lipid bilayers seemed to be autocatalytic, resembling that seen
with other porins (40). It is possible that the correct insertion
of one channel assisted the correct orientation of other chan¬
nel proteins, thereby accelerating subsequent insertion. The
preference shown by MOMP for a particular bilayer orienta¬
tion was demonstrated by the asymmetric response of the
channel to holding potentials of opposite polarity. Presumably
this asymmetry of behavior, seen in other porins, has a struc¬
tural basis (9, 23). The modification of channel amplitude and
open/closed transitions by the neutralizing MOMP-specific
MAb All was of particular significance, for it not only con¬
firmed that MOMP was the channel-forming protein but also
reinforced our belief that MOMP is arranged as an oligomer in
the bilayer, since All recognizes only oligomeric MOMP upon
Western blotting (4, 21). This posed the question, What is the
minimal conducting unit of the MOMP channel? From the
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FIG. 6. Analysis of the minimal conducting unit of the MOMP channel. (A) Contiguous 40-s recording of MOMP activity in a bilayer bathed in 50 mM KCI-10
mM Tris-HCI (pH 7.4) (holding potential —70 mV, filtered at 200 Hz). The closed level of the channel (0) and three unit open levels (1, 2. and 3) are indicated. (B)
Maximum number of unit open levels counted in 25 individual reconstitution experiments.
results summarized in Fig. 6, we suggest that each MOMP
molecule inserts into the bilayer as a trimer to give rise to three
pores through the membrane, and that switching to holding
potentials of ±60 mV and above promotes the opening of all
three pores together. Thus, two MOMP trimers could give rise
to up to six pores with six unit currents. Voltage-dependent
closure at maintained high holding potentials meant that
within a few seconds, only one or two protochannels in each
trimer were seen to be open at any one time. This type of
multibarrel behavior is common in porins (25), and a similar
phenomenon has been observed, and analyzed in detail, in
eukaryotic channel proteins (e.g., references 7 and 15).
What ions and metabolites would be translocated across the
chlamydial outer membrane by a MOMP porin? Previously,
chlamydiae were thought to require host-derived nucleoside
triphosphates as an energy source and precursor of RNA syn¬
thesis, prompting us to look at their transfer across the bilayer.




FIG. 7. Current-voltage relationship of MOMP channels in symmetrical con¬
centrations of KC1 (each buffered with 10 mM Tris-HCl [pH 7.4]). KC1 concen¬
trations are 300 mM (A), 150 mM (O), and 50 mM (•). Error bars represent ±
standard error of the mean for four independent experiments.
concentrations of Na-ATP corresponded to the passage of
substantial amounts of ATP across the bilayer. If the MOMP
channel were Na+ selective, allowing only the passage of Na+,
we would theoretically expect to see a reversal potential of —39
mV; alternatively, if the channel allowed the passage of only
ATP4' across the bilayer, a reversal potential of +10 mV
would be observed. Therefore, a reversal potential of —11 mV
demonstrates the passage of both Na+ and ATP4' through the
MOMP channel. The identification of a route by which chla¬
mydiae can take advantage of host nucleoside triphosphates
and other nutrients may also explain why antibodies specific to
MOMP neutralize infection. With the identification of genes
encoding ATP biosynthetic pathways by the Chlamydia Ge¬
nome Sequencing Project (32), it now appears unlikely that
chlamydiae derive all of their ATP from the host cell.
In the EB, outer membrane proteins are disulfide bond
cross-linked, rendering the outer membrane largely imperme¬
able. The transition into the intracellular RB is coupled with a
reduction of outer membrane disulfide bonds, increasing mem¬
brane permeability. It is clear that MOMP's pore-forming ac¬
tivity would be primarily utilized at the RB stage of the chla¬
mydial life cycle. Bavoil et al. (3) proposed that the reduction
of outer membrane disulfide bonds opened chlamydial pores,
allowing the uptake of ATP and other nutrients. Evidence
supporting this hypothesis included activation of the pores by
treatment with DTT and the blocking of reoxidation with io-
doacetamide. Chemical modification was not required to main¬
tain functional open channels from our OG-DTT-solubilized
MOMP. We also noted that we could not reoxidize the puta¬
tive free SH groups of bilayer-incorporated MOMP to close or
inactivate the channels (mimicking the EB-to-RB transition).
However, the reoxidation of disulfide bonds in the correct
pairings to close the channel may require the presence of other
proteins, such as the cysteine-rich proteins absent from the
OG-DTT-solubilized sample.
In this study, wc have shown that MOMP functions as a porin
and have demonstrated a possible physiological function with the
passage of nucleotide triphosphates through the channel. A par¬
ticularly significant aspect of the work is that it provides a mea-
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surable criterion by which to assess recombinant MOMP for
native function. Indeed, we have recently reconstituted a re¬
combinant MOMP into the planar lipid bilayer resulting in the
formation of ion channels with properties identical to those of
the native protein (39). These results have broad implications
on the search for an effective chlamydial vaccine.
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